发布求助
文献互助 智能选刊 最新文献

卷15

IF 3.1 3区 医学 Q2 ENDOCRINOLOGY & METABOLISM
Journal of Diabetes Investigation Pub Date : 2024-12-04 DOI:10.1111/jdi.14374
{"title":"卷15","authors":"","doi":"10.1111/jdi.14374","DOIUrl":null,"url":null,"abstract":"<p>50-g Oral glucose challenge test</p><p>Problems in screening for gestational diabetes mellitus by measurement of casual blood glucose levels at 24–28 gestational weeks, Tomimoto 1797–1802.</p><p>β-Cell dysfunction</p><p>Glucose metabolism partially regulates β-cell function through epigenomic changes, Kim 649–655.</p><p>β-Cells</p><p>Role of β-cell autophagy in β-cell physiology and the development of diabetes, Yasasilka 656–668.</p><p>β-Cell mass</p><p>Effects of glucokinase haploinsufficiency on the pancreatic β-cell mass and function of long-term high-fat, high-sucrose diet-fed mice, Shigesawa 1732–1742.</p><p>Accuracy</p><p>Impact of hematocrit levels on the accuracy of specific blood glucose meters: A hospital-based study, Pham 1472–1482.</p><p>Acyl-coenzyme A synthetase long-chain family member 4</p><p>Tanshinone IIA suppresses ferroptosis to attenuate renal podocyte injury in diabetic nephropathy through the embryonic lethal abnormal visual-like protein 1 and acyl-coenzyme A synthetase long-chain family member 4 signaling pathway, Zhu 1003–1016.</p><p>Adherence</p><p>Modification effect of receipt of diabetes care on the association between COVID-19 infection and HbA1c level during the first year of the coronavirus pandemic using a nationwide population-based database, Okada 953–963.</p><p>Prevalence of adherence to oral antidiabetic drugs in patients with type 2 diabetes: A systematic review and meta-analysis, Boonpattharatthiti 1614–1625.</p><p>Aging</p><p>Association of biomarkers and Barthel Index with occurrence of age-related adverse health outcomes in individuals with diabetes, Umamoto 1675–1683.</p><p>Alcohol drinking</p><p>The association between alcohol drinking and glycemic management among people with type 2 diabetes in China, Ye 237–244.</p><p>Aldehyde dehydrogenase 2</p><p>Mitochondrial ALDH2 improves β-cell survival and function against doxorubicin-induced apoptosis by targeting CK2 signaling, Karunakaran 684–692.</p><p>Algorithm</p><p>A consensus statement from the Japan Diabetes Society: A proposed algorithm for pharmacotherapy in people with type 2 diabetes—2nd edition (English version), Bouchi 1326–1342.</p><p>Alzheimer's disease-like complications of DM</p><p>Calpeptin improves the cognitive function in Alzheimer's disease-like complications of diabetes mellitus rats by regulating TXNIP/NLRP3 inflammasome, Qiao 1365–1376.</p><p>Angiopoietin-like 4</p><p>Angiopoietin-like 4 is a potential biomarker for diabetic kidney disease in type 2 diabetes patients, Wang 1763–1772.</p><p>Antidiabetic drugs</p><p>Cancer biology in diabetes update: Focusing on antidiabetic drugs, Kawakita 525–540.</p><p>Pancreatic beta-cell mass and function and therapeutic implications of using antidiabetic medications in type 2 diabetes, Moon 669–683.</p><p>Anti-inflammatory activity</p><p>High-density lipoprotein in diabetes: Structural and functional relevance, Lui 805–816.</p><p>Anti-oxidative activity</p><p>High-density lipoprotein in diabetes: Structural and functional relevance, Lui 805–816.</p><p>Area under the C-peptide curve</p><p>Association between area under the C-peptide curve during an oral glucose tolerance test and diabetic retinopathy in type 2 diabetes patients, Zhang 315–325.</p><p>Arginine vasopressin deficiency</p><p>Coexistence of type 2 diabetes mellitus, arginine vasopressin deficiency, and Marfan syndrome: A case report, Le 964–967.</p><p>Arterial stiffness</p><p>Association between glycemia risk index and arterial stiffness in type 2 diabetes, Cai 614–622.</p><p>Asia</p><p>Changing landscape of diabetes in Asia – What are the unmet needs?, Luk 402–409.</p><p>Aspirin</p><p>Low-dose aspirin for prevention of cardiovascular mortality in patients with type 2 diabetes and chronic kidney disease: A real-world nationwide cohort study, Lin 459–467.</p><p>Asprosin</p><p>The correlation between serum asprosin and left ventricular diastolic dysfunction in elderly patients with type 2 diabetes mellitus in the community, Liang 608–613.</p><p>Association analysis between serum asprosin and metabolic characteristics, Complications in type 2 diabetic patients with different durations, Ma 1781–1787.</p><p>Asthma</p><p>A case of type 2 diabetes mellitus with weight gain and worsening of glycemic management after tezepelumab administration for severe bronchial asthma, Umamoto 388–390.</p><p>Atherosclerosis</p><p>High glucose promotes atherosclerosis by regulating miRNA let7d-5p level, Wang 711–724.</p><p>Coexistence of high visceral fat area and sarcopenia is associated with atherosclerotic markers in old-old patients with diabetes: A cross-sectional study, Sato 1510–1518.</p><p>Autoimmunity</p><p>Diabetes treatment by conversion of gut epithelial cells to insulin-producing cells, Accili 797–804.</p><p>Autophagy</p><p>Role of β-cell autophagy in β-cell physiology and the development of diabetes, Yasasilka 656–668.</p><p>Average age at death</p><p>Causes of death in Japanese patients with diabetes based on the results of a survey of 68,555 cases during 2011–2020: Committee report on causes of death in diabetes mellitus, Japan Diabetes Society (English version), Nakamura 1821–1837.</p><p>Average real variability</p><p>Prognostic value of longitudinal HbA1c variability in predicting the development of diabetic sensorimotor polyneuropathy among patients with type 2 diabetes mellitus: A prospective cohort observational study, Lai 326–335.</p><p>Behavioral change</p><p>Internet of things-based approach for glycemic control in people with type 2 diabetes: A randomized controlled trial, Bouchi 1287–1296.</p><p>Beta-cell function</p><p>Association between area under the C-peptide curve during an oral glucose tolerance test and diabetic retinopathy in type 2 diabetes patients, Zhang 315–325.</p><p>Bioinformatics</p><p>Identification and validation of voltage-dependent anion channel 1-related genes and immune cell infiltration in diabetic nephropathy, Lin 87–105.</p><p>Bioinformatics analysis</p><p>Immunoglobulin heavy constant gamma 1 silencing decreases tonicity-responsive enhancer-binding protein expression to alleviate diabetic nephropathy, Hu 572–583.</p><p>Biomarker</p><p>Association of biomarkers and Barthel Index with occurrence of age-related adverse health outcomes in individuals with diabetes, Umamoto 1675–1683.</p><p>Biomarkers</p><p>The role of lipid dysregulation in gestational diabetes mellitus: Early prediction and postpartum prognosis, Zhang 15–25.</p><p>Identification and validation of voltage-dependent anion channel 1-related genes and immune cell infiltration in diabetic nephropathy, Lin 87–105.</p><p>Birth weight</p><p>Maternal birth weight as an indicator of early and late gestational diabetes mellitus: The Japan Environment and Children's Study, Tagami 751–761.</p><p>Association between infant birth weight and gestational weight gain in Japanese women with diabetes mellitus, Fujikawa Shingu 906–913.</p><p>Blind</p><p>Characterization of the visually impaired patients with diabetes mellitus in Japan, Sugihara 882–891.</p><p>Blood glucose</p><p>Delayed dinnertime impairs glucose tolerance in healthy young adults, Nakamura 172–176.</p><p>Effects of hybrid closed-loop system on glycemic control and psychological aspects in persons with type 1 diabetes treated with sensor-augmented pump: A prospective single-center observational study, Akiyama 219–226.</p><p>A novel predictive model for optimizing diabetes screening in older adults, Lin 1403–1409.</p><p>Blood glucose monitors</p><p>Impact of hematocrit levels on the accuracy of specific blood glucose meters: A hospital-based study, Pham 1472–1482.</p><p>Body composition</p><p>Body composition and risk of gestational diabetes mellitus: A univariable and multivariable Mendelian randomization study, Gao 346–354.</p><p>Body mass index</p><p>Eating behaviors and incidence of type 2 diabetes in Japanese people: The population-based Panasonic cohort study 15, Toyokuni 1017–1025.</p><p>Calpain-2</p><p>Calpeptin improves the cognitive function in Alzheimer's disease-like complications of diabetes mellitus rats by regulating TXNIP/NLRP3 inflammasome, Qiao 1365–1376.</p><p>Cancer</p><p>Cancer biology in diabetes update: Focusing on antidiabetic drugs, Kawakita 525–540.</p><p>Cardio-ankle vascular index</p><p>Systematic Coronary Risk Evaluation 2-Diabetes risk.</p><p>Predictive value of Systematic Coronary Risk Evaluation 2-Diabetes risk model and arterial stiffness for cardiovascular events in the Asian population with type 2 diabetes mellitus, Suwannasom 1266–1275.</p><p>Cardiovascular autonomic neuropathy</p><p>Improvement of heart rate variability after metabolic bariatric surgery in Korean subjects with obesity, Jang 1773–1780.</p><p>Cardiovascular disease</p><p>Health impacts of new-onset diabetes in women post-gestational diabetes mellitus: Insights from Hong Kong's territory-wide data, Zhang 772–781.</p><p>Associations of fasting plasma glucose with all-cause mortality and cardiovascular events in older Chinese diabetes patients: A population-based cohort study, Wang 1129–1139.</p><p>Interpretable machine learning models based on shear-wave elastography radiomics for predicting cardiovascular disease in diabetic kidney disease patients, Dai 1637–1650.</p><p>Cardiovascular diseases</p><p>Risk stratification for cardiovascular disease based on prior coronary artery disease, cerebrovascular disease and type 2 diabetes mellitus, Oe 1464–1471.</p><p>Casual blood glucose</p><p>Problems in screening for gestational diabetes mellitus by measurement of casual blood glucose levels at 24–28 gestational weeks, Tomimoto 1797–1802.</p><p>Cause of death</p><p>Causes of death in Japanese patients with diabetes based on the results of a survey of 68,555 cases during 2011–2020: Committee report on causes of death in diabetes mellitus, Japan Diabetes Society (English version), Nakamura 1821–1837.</p><p>CCP</p><p><i>Cordyceps cicadae</i> polysaccharides attenuate diabetic nephropathy via the miR-30a-3p/TRIM16 axis, Zheng 300–314.</p><p>Cell encapsulation</p><p>Long-term efficacy of encapsulated xenogeneic islet transplantation: Impact of encapsulation techniques and donor genetic traits, Park 693–703.</p><p>Cesarean</p><p>Post-load glucose is a stronger predictor of adverse pregnancy outcomes than first-trimester HbA1c in women without gestational diabetes, Rajabi 914–921.</p><p>Children</p><p>Influence of disease course and comprehensive management on blood glucose level in children and adolescents with type 2 diabetes mellitus, Wu 1026–1033.</p><p>Children and adolescents</p><p>Clinical significance of coefficient of variation in continuous glucose monitoring for glycemic management in children and adolescents with type 1 diabetes, Urakami 1669–1674.</p><p>China</p><p>Type 1 and type 2 diabetes mortality burden: Predictions for 2030 based on Bayesian age-period-cohort analysis of China and global mortality burden from 1990 to 2019, Dong 623–633.</p><p>Chinese Han population</p><p>Association of RPS26 gene polymorphism with different types of diabetes in Chinese individuals, Song 34–43.</p><p>Cholesterol efflux</p><p>High-density lipoprotein in diabetes: Structural and functional relevance, Lui 805–816.</p><p>Chorea</p><p>Diabetic striatopathy: Hyperglycemic chorea/ballism successfully treated with L-dopa, Tsukaguchi 1524–1527.</p><p>Chronic kidney disease</p><p>Low-dose aspirin for prevention of cardiovascular mortality in patients with type 2 diabetes and chronic kidney disease: A real-world nationwide cohort study, Lin 459–467.</p><p>Chronic kidney disease progression</p><p>Risk factors for chronic kidney disease progression over 20 years for primary prevention in Japanese individuals at a preventive medicine research center: Focus on the influence of plasma glucose levels, Minami 1434–1443.</p><p>Circ_0068087</p><p>Circ_0068087 knockdown attenuates high-glucose-induced human tubular epithelial cell injury in a microribonucleic acid/progestin and adipoQ receptor 3-dependent manner in diabetic nephropathy, Liu 159–171.</p><p>Claims analysis</p><p>Associations between income/employment status and diabetes care processes, health behaviors, and health outcomes in Japan: A cross-sectional study using claims data linked to a questionnaire survey, Yamaoka 1684–1695.</p><p>Claims data</p><p>Implementation rate of diabetic self-management education and support for Japanese people with diabetes using the National Database, Ihana-Sugiyama 861–866.</p><p>Clinical</p><p>Patient-reported outcomes and treatment adherence in type 2 diabetes using natural language processing: Wave 8 of the Observational International Diabetes Management Practices Study, Chan 1306–1316.</p><p>Clinical epidemiology</p><p>Modification effect of receipt of diabetes care on the association between COVID-19 infection and HbA1c level during the first year of the coronavirus pandemic using a nationwide population-based database, Okada 953–963.</p><p>Clopidogrel</p><p>Recurrent hypoglycemia induced by clopidogrel: A case report and mini review, Du 275–281.</p><p>Coefficient of variation</p><p>Clinical significance of coefficient of variation in continuous glucose monitoring for glycemic management in children and adolescents with type 1 diabetes, Urakami 1669–1674.</p><p>Coefficient of variation of R-R intervals</p><p>Simplified electrophysiological approach combining a point-of-care nerve conduction device and an electrocardiogram produces an accurate diagnosis of diabetic polyneuropathy, Hayashi 736–742.</p><p>Cognition</p><p>Global cognition and executive functions of older adults with type 1 diabetes mellitus without dementia, Nagasawa 922–930.</p><p>Cognitive impairment</p><p>Sodium–glucose cotransporter 2 inhibition through henagliflozin ameliorates cognitive impairment in patients with type 2 diabetes, Zhang 1596–1603.</p><p>Cohort study</p><p>Maternal birth weight as an indicator of early and late gestational diabetes mellitus: The Japan Environment and Children's Study, Tagami 751–761.</p><p>Remnant cholesterol, but not other traditional lipids or lipid ratios, is independently and positively related to future diabetes risk in Chinese general population: A 3 year cohort study, Li 1084–1093.</p><p>Combined approaches</p><p>Targeting PI3K/AKT and MEK/ERK pathways for synergic effects on improving features of peripheral diabetic neuropathy, Pham 1537–1544.</p><p>Commentary</p><p>Long-term safety and efficacy of SGLT2 inhibitor use in older east Asians with type 2 diabetes, Takahashi 63–66.</p><p>Pituitary gland agouti-related peptide cells: Novel player controlling glucose metabolism, Takahashi 67–69.</p><p>Dipeptidyl peptidase-4 inhibition targeting vascular senescence as a novel treatment for atherosclerosis, Yen 143–144.</p><p>Glucose-dependent insulinotropic polypeptide receptor systems in the hypothalamus and the brainstem regulate feeding and weight through distinct pathways, Yada 283–284.</p><p>Advancements and challenges in pancreatic islet transplantation: Insights from the Collaborative Islet Transplant Registry, Lee 423–425.</p><p>Deciphering the causal tapestry between cardiorespiratory fitness and type 2 diabetes mellitus, Ko 426–428.</p><p>Birthweight and risk of diabetes in later life, Sheu 557–558.</p><p>Effects of dipeptidyl peptidase-4 inhibition <i>in vivo</i>: Dipeptidyl peptidase-4 inhibitor/gut microbiome crosstalk suggests novel therapeutic options for diabetes management, Yasuda 704–706.</p><p>Gut microbiota dysbiosis as a novel pathogenic factor of diabetic peripheral neuropathy, Niimi 817–819.</p><p>Commentary on association of glycemic index and glycemic load with type 2 diabetes, cardiovascular disease, cancer, and all-cause mortality, Hsieh 1545–1547.</p><p>Regulation of glucose and energy metabolism through actions of glucagon-like peptide-1 and glucose-dependent insulinotropic polypeptide, Zenimaru 1725–1726.</p><p>Commentary on “Intra-islet a-cell Gs signaling promotes glucagon release”, Kitamura 1727–1728.</p><p>Complications of diabetes</p><p>Glycemic variability: Measurement, target, impact on complications of diabetes and does it really matter? Mo 5–14.</p><p>Continuous glucose monitoring</p><p>Glycemic variability: Measurement, target, impact on complications of diabetes and does it really matter? Mo 5–14.</p><p>Comparative effects of fixed-dose mitiglinide/voglibose combination and glimepiride on vascular endothelial function and glycemic variability in patients with type 2 diabetes: A randomized controlled trial, Tanaka 449–458.</p><p>Association between glycemia risk index and arterial stiffness in type 2 diabetes, Cai 614–622.</p><p>Glycemic variability is associated with sural nerve conduction velocity in outpatients with type 2 diabetes: Usefulness of a new point-of-care device for nerve conduction studies, Morita 1075–1083.</p><p>Possible etiological role of impaired endogenous double strand RNA editing in β-cells in type 1 diabetes, Imai 1171–1173.</p><p>A sneak peek into chronic glucose exposure and insulin secretion impairment through translatome, Helena 1174–1176.</p><p>Clinical significance of coefficient of variation in continuous glucose monitoring for glycemic management in children and adolescents with type 1 diabetes, Urakami 1669–1674.</p><p>Theragnostic utility of continuous glucose monitoring in post-gastrectomy hypoglycemia, Son 1696–1699.</p><p>Continuous subcutaneous insulin infusion</p><p>Fulminant type 1 diabetes, an underrecognized and unique subtype of type 1 diabetes: A case series from Singapore, Tan 786–789.</p><p>Corneal confocal microscopy</p><p>Circulating netrin-1 levels are reduced and related to corneal nerve fiber loss in patients with diabetic neuropathy, Mondal 1068–1074.</p><p>Cortisol</p><p>An exploratory study of factors in disordered eating behavior in diabetes self-management in Japan, Tsukamoto-Kawashima 874–881.</p><p>COVID-19</p><p>Association of serum amyloid A and prognosis in people with diabetes and COVID-19: A retrospective cohort study, Qu 44–51.</p><p>Type 1 diabetes, COVID-19 vaccines and short-term safety: Subgroup analysis from the global COVAD study, Chatterjee 131–138.</p><p>Modification effect of receipt of diabetes care on the association between COVID-19 infection and HbA1c level during the first year of the coronavirus pandemic using a nationwide population-based database, Okada 953–963.</p><p>COVID-19 pandemic</p><p>Comparing the screening methods for gestational diabetes mellitus before and during the COVID-19 pandemic: A systematic review, Sun 500–516.</p><p>C-peptide index</p><p>Short-term recovery of insulin secretion in response to a meal is associated with future glycemic control in type 2 diabetes patients, Enkaku 437–448.</p><p>Comparison of efficacy and safety of insulin degludec/liraglutide and insulin glargine U-100/lixisenatide in individuals with type 2 diabetes mellitus using professional continuous glucose monitoring, Kawaguchi 598–607.</p><p>Critically ill</p><p>Between blood glucose and mortality in critically ill patients: Retrospective analysis of the MIMIC-IV database, Li 931–938.</p><p>Cross-sectional studies</p><p>Association between gastrointestinal symptoms and insomnia in patients with type 2 diabetes: The KAMOGAWA-DM cohort study, Minamida 946–952.</p><p>Cross-sectional study</p><p>Relationship between diabetes treatment status and occupational accidents, Ogasawara 899–905.</p><p>CYP1B1</p><p>MiR-488-3p facilitates wound healing throughCYP1B1-mediated Wnt/β-catenin signaling pathway by targeting MeCP2, Zuo 145–158.</p><p>Cystatin C</p><p>Causal association between cystatin C and diabetic retinopathy: A two-sample Mendelian randomization study, Ruan 1626–1636.</p><p>Diabetes</p><p>Association of serum amyloid A and prognosis in people with diabetes and COVID-19: A retrospective cohort study, Qu 44–51.</p><p>Overnutrition in the early postnatal period influences lifetime metabolic risk: Evidence for impact on pancreatic β-cell mass and function, Burton 263–274.</p><p>Low-dose aspirin for prevention of cardiovascular mortality in patients with type 2 diabetes and chronic kidney disease: A real-world nationwide cohort study, Lin 459–467.</p><p>Inverted U-shaped associations between serumuric acid and fasting - plasma glucose level in non-diabetic, pre-diabetic, and diabetic adults: A population-based study in China, Shi 483–490.</p><p>Cancer biology in diabetes update: Focusing on antidiabetic drugs, Kawakita 525–540.</p><p>Type 1 and type 2 diabetes mortality burden: Predictions for 2030 based on Bayesian age-period-cohort analysis of China and global mortality burden from 1990 to 2019, Dong 623–633.</p><p>Performance of different machine learning algorithms in identifying undiagnosed diabetes based on nonlaboratory parameters and the influence of muscle strength: A cross-sectional study, Xu 743–750.</p><p>Diabetes treatment by conversion of gut epithelial cells to insulin-producing cells, Accili 797–804.</p><p>Relationship between diabetes treatment status and occupational accidents, Ogasawara 899–905.</p><p>Prevalence, awareness, treatment and control of type 2 diabetes in southeast China: A population-based study, Hu 1034–1041.</p><p>Remnant cholesterol, but not other traditional lipids or lipid ratios, is independently and positively related to future diabetes risk in Chinese general population: A 3 year cohort study, Li 1084–1093.</p><p>Impact of diabetes on the prognosis of patients with oral and oropharyngeal cancer: A meta-analysis, Xu 1140–1150.</p><p>Optimizing lipid control in Taiwanese diabetic patients: A collaborative consensus by the Diabetes Association of the Republic of China (Taiwan) and the Taiwanese Association of Diabetes Educators, Shen 1151–1160.</p><p>Prevalence of adherence to oral antidiabetic drugs in patients with type 2 diabetes: A systematic review and meta-analysis, Boonpattharatthiti 1614–1625.</p><p>Association of biomarkers and Barthel Index with occurrence of age-related adverse health outcomes in individuals with diabetes, Umamoto 1675–1683.</p><p>Diabetes complications</p><p>Relationship between elevated circulating thrombospondin-1 levels and vascular complications in diabetes mellitus, Guo 197–207.</p><p>Sheffield One-Stop Service: A potential model to improve the screening uptake of diabetic peripheral neuropathy and other microvascular complications of diabetes, Sloan 1355–1362.</p><p>Diabetes duration</p><p>Association analysis between serum asprosin and metabolic characteristics, Complications in type 2 diabetic patients with different durations, Ma 1781–1787.</p><p>Diabetes mellitus</p><p>Association of RPS26 gene polymorphism with different types of diabetes in Chinese individuals, Song 34–43.</p><p>Relationship between elevated circulating thrombospondin-1 levels and vascular complications in diabetes mellitus, Guo 197–207.</p><p>Development and validation of a prediction model for self-reported hypoglycemia risk in patients with type 2 diabetes: A longitudinal cohort study, Xu 468–482.</p><p>Social deprivation and diabetic kidney disease: A European view, Casey 541–556.</p><p>Improvements of myocardial strain and work in diabetes patients with normal ejection fraction after empagliflozin treatment, Cheng 851–860.</p><p>Association between infant birth weight and gestational weight gain in Japanese women with diabetes mellitus, Fujikawa Shingu 906–913.</p><p>Association between gastrointestinal symptoms and insomnia in patients with type 2 diabetes: The KAMOGAWA-DM cohort study, Minamida 946–952.</p><p>Association between variation in hemoglobin A1c levels and diabetes therapy-related quality of life in patients with diabetes, Imai 1042–1046.</p><p>Medical database analysis of the association between kidney function and achievement of glycemic control in older Japanese adults with type 2 diabetes who started with oral antidiabetic drugs, Suzuki 1057–1067.</p><p>Postpartum life interventions to prevent type 2 diabetes in women with gestational diabetes: A systematic review and meta-analysis, Wang 1115–1128.</p><p>Predictive value of Systematic Coronary Risk Evaluation 2-Diabetes risk model and arterial stiffness for cardiovascular events in the Asian population with type 2 diabetes mellitus, Suwannasom 1266–1275.</p><p>A novel predictive model for optimizing diabetes screening in older adults, Lin 1403–1409.</p><p>A real-world disproportionality analysis of semaglutide: Post-marketing pharmacovigilance data, Du 1422–1433.</p><p>Neonatal diabetes mellitus around the world: Update 2024, Barbetti 1711–1724.</p><p>Diabetes mellitus type 1</p><p>Islet transplantation in Korea, Lee 1165–1170.</p><p>Diabetes mellitus, type 2</p><p>Decline in measured glomerular filtration rate is associated with simple renal cyst in Chinese patients with type 2 diabetes, Qiaoling 26–33.</p><p>Resistant starch and type 2 diabetes mellitus: Clinical perspective, Kim 395–401.</p><p>PIONEER REAL Japan: Primary results from a multicenter, prospective, real-world study of oral semaglutide in adults with type 2 diabetes in Japanese clinical practice, Yabe 1566–1577.</p><p>Diabetes patient</p><p>Associations of fasting plasma glucose with all-cause mortality and cardiovascular events in older Chinese diabetes patients: A population-based cohort study, Wang 1129–1139.</p><p>Diabetes therapy-related quality of life</p><p>Association between variation in hemoglobin A1c levels and diabetes therapy-related quality of life in patients with diabetes, Imai 1042–1046.</p><p>Diabetic cardiomyopathy</p><p><i>Polygonatum sibiricum</i> (Huang Jing) polysaccharide reduces diabetic cardiomyopathy through increasing cyclic guanosine monophosphate-protein kinase G signaling in diabetic mice, Lei 823–834.</p><p>Regulatory T cells protect against diabetic cardiomyopathy in <i>db/db</i> mice, Zhang 1191–1201.</p><p>Diabetic complications</p><p>The role of vascular adhesion protein-1 in diabetes and diabetic complications, Yen 982–989.</p><p>Diabetic education</p><p>Implementation rate of diabetic self-management education and support for Japanese people with diabetes using the National Database, Ihana-Sugiyama 861–866.</p><p>Diabetic foot</p><p>What characteristics are most important in stratifying patients into groups with different risk of diabetic foot ulceration?, Naemi 1094–1104.</p><p>Cardiac electrophysiology, structure and diastolic function in patients with diabetic foot versus those without diabetic foot, Bai 1276–1286.</p><p>Diabetic foot ulcer recurrence</p><p>Plantar pressure measurement in diabetic foot disease: A scoping review, Lockhart 990–999.</p><p>Diabetic ketoacidosis</p><p>Fulminant type 1 diabetes, an underrecognized and unique subtype of type 1 diabetes: A case series from Singapore, Tan 786–789.</p><p>Diabetic kidney disease</p><p>Social deprivation and diabetic kidney disease: A European view, Casey 541–556.</p><p>Nutrient quality in dietary therapy for diabetes and diabetic kidney disease, Tsuruta 973–981.</p><p>Relationship between circulating thrombospondin-1 messenger ribonucleic acid and microribonucleic acid-194 levels in Chinese patients with type 2 diabetic kidney disease: The outcomes of a case–control study, Ma 1248–1258.</p><p>Young-onset type 2 diabetes mellitus enhances proteinuria, but not glomerular filtration rate decline: A Japanese cohort study, Saito 1444–1456.</p><p>Interpretable machine learning models based on shear-wave elastography radiomics for predicting cardiovascular disease in diabetic kidney disease patients, Dai 1637–1650.</p><p>Angiopoietin-like 4 is a potential biomarker for diabetic kidney disease in type 2 diabetes patients, Wang 1763–1772.</p><p>Diabetic macular edema</p><p>Sodium–glucose cotransporter 2 inhibitor therapy reduces the administration frequency of steroid injection in patients with diabetic macular edema: A cohort study using the Japanese health insurance claims database, Ishibashi 1231–1238.</p><p>Diabetic nephropathy</p><p>Identification and validation of voltage-dependent anion channel 1-related genes and immune cell infiltration in diabetic nephropathy, Lin 87–105.</p><p>Sympathetic skin response for early detection of type 2 diabetic peripheral neuropathy and nephropathy, Liu 106–112.</p><p>Circ_0068087 knockdown attenuates high-glucose-induced human tubular epithelial cell injury in a microribonucleic acid/progestin and adipoQ receptor 3-dependent manner in diabetic nephropathy, Liu 159–171.</p><p>METTL3/YTHDF2 m6A axis mediates the progression of diabetic nephropathy through epigenetically suppressing PINK1 and mitophagy, Wang 288–299.</p><p><i>Cordyceps cicadae</i> polysaccharides attenuate diabetic nephropathy via the miR-30a-3p/TRIM16 axis, Zheng 300–314.</p><p>Immunoglobulin heavy constant gamma 1 silencing decreases tonicity-responsive enhancer-binding protein expression to alleviate diabetic nephropathy, Hu 572–583.</p><p>Diabetic neuropathy</p><p>Circulating netrin-1 levels are reduced and related to corneal nerve fiber loss in patients with diabetic neuropathy, Mondal 1068–1074.</p><p>Diminished levels of insulin-like growth factor-1 may be a risk factor for peripheral neuropathy in type 2 diabetes patients, Zhong 1259–1265.</p><p>Sheffield One-Stop Service: A potential model to improve the screening uptake of diabetic peripheral neuropathy and other microvascular complications of diabetes, Sloan 1355–1362.</p><p>Targeting PI3K/AKT and MEK/ERK pathways for synergic effects on improving features of peripheral diabetic neuropathy, Pham 1537–1544.</p><p>Diabetic peripheral neuropathy</p><p>Identification and validation of voltage-dependent anion channel 1-related genes and immune cell infiltration in diabetic nephropathy, Lin 87–105.</p><p>Sympathetic skin response for early detection of type 2 diabetic peripheral neuropathy and nephropathy, Liu 106–112.</p><p>Diabetic polyneuropathies</p><p>Simplified electrophysiological approach combining a point-of-care nerve conduction device and an electrocardiogram produces an accurate diagnosis of diabetic polyneuropathy, Hayashi 736–742.</p><p>Diabetic retinopathy</p><p>Association between area under the C-peptide curve during an oral glucose tolerance test and diabetic retinopathy in type 2 diabetes patients, Zhang 315–325.</p><p>Serum vitamin D is substantially reduced and predicts flares in diabetic retinopathy patients, Zhuang 867–873.</p><p>Characterization of the visually impaired patients with diabetes mellitus in Japan, Sugihara 882–891.</p><p>Causal association between cystatin C and diabetic retinopathy: A two-sample Mendelian randomization study, Ruan 1626–1636.</p><p>Diabetic striatopathy</p><p>Diabetic striatopathy: Hyperglycemic chorea/ballism successfully treated with L-dopa, Tsukaguchi 1524–1527.</p><p>Diabetics with critical limb ischemia</p><p>Microvascular permeability and texture analysis of bone marrow in diabetic rabbits with critical limb ischemia based on dynamic contrast-enhanced magnetic resonance imaging, Yang 584–593.</p><p>Diabetic symmetric sensorimotor polyneuropathy</p><p>Prevalence and characteristics of diabetic symmetric sensorimotor polyneuropathy in Japanese patients with type 2 diabetes: The Japan Diabetes Complication and its Prevention Prospective study (JDCP study 10), Kamiya 247–253</p><p>Diet</p><p>Resistant starch and type 2 diabetes mellitus: Clinical perspective, Kim 395–401.</p><p>Dietary intervention</p><p>Application of the integrated data platform combined with dietary management for adults with diabetes: A prospective randomized controlled trial, Liu 1548–1555.</p><p>Dietary therapy</p><p>Nutrient quality in dietary therapy for diabetes and diabetic kidney disease, Tsuruta 973–981.</p><p>Digital platform</p><p>Application of the integrated data platform combined with dietary management for adults with diabetes: A prospective randomized controlled trial, Liu 1548–1555.</p><p>Doxorubicin</p><p>Mitochondrial ALDH2 improves β-cell survival and function against doxorubicin-induced apoptosis by targeting CK2 signaling, Karunakaran 684–692.</p><p>DPNCheck</p><p>Simplified electrophysiological approach combining a point-of-care nerve conduction device and an electrocardiogram produces an accurate diagnosis of diabetic polyneuropathy, Hayashi 736–742.</p><p>East Asians</p><p>Low-carbohydrate diets in East Asians with type 2 diabetes: A systematic review and meta-analysis of randomized controlled trials, Hironaka 1753–1762.</p><p>Eating behavior</p><p>An exploratory study of factors in disordered eating behavior in diabetes self-management in Japan, Tsukamoto-Kawashima 874–881.</p><p>Eating behaviors</p><p>Eating behaviors and incidence of type 2 diabetes in Japanese people: The population-based Panasonic cohort study 15, Toyokuni 1017–1025.</p><p>Editorial</p><p>Common metabolite for microangiopathy in Japanese and European populations, Shojima 523–524.</p><p>The Ulaanbaatar agreement: Revising diabetes terminology in Asia to combat stigma, Seino 1533–1536.</p><p>The roles of output clock genes in regulating glucose metabolism, Taguchi 1707–1710.</p><p>Elderly</p><p>Sulfonylurea prescription patterns in elderly patients with type 2 diabetes mellitus: A comprehensive analysis of real-world data from pharmacies in Japan, Yamazaki 1604–1613.</p><p>Embryonic lethal abnormal visual-like protein 1</p><p>Tanshinone IIA suppresses ferroptosis to attenuate renal podocyte injury in diabetic nephropathy through the embryonic lethal abnormal visual-like protein 1 and acyl-coenzyme A synthetase long-chain family member 4 signaling pathway, Zhu 1003–1016.</p><p>Empagliflozin</p><p>Improvements of myocardial strain and work in diabetes patients with normal ejection fraction after empagliflozin treatment, Cheng 851–860.</p><p>EPAC</p><p>Epac2 activation mediates glucagon-induced glucogenesis in primary rat hepatocytes, Shiozaki-Takagi 429–436.</p><p>Epigenetic change</p><p>Glucose metabolism partially regulates β-cell function through epigenomic changes, Kim 649–655.</p><p>Epilepsy</p><p>Type 1 diabetes and the risk of epilepsy: A meta-analysis, Wu 364–373.</p><p>Estimated glomerular filtration rate</p><p>Risk factors for chronic kidney disease progression over 20 years for primary prevention in Japanese individuals at a preventive medicine research center: Focus on the influence of plasma glucose levels, Minami 1434–1443.</p><p>Angiopoietin-like 4 is a potential biomarker for diabetic kidney disease in type 2 diabetes patients, Wang 1763–1772.</p><p>Ethnicity</p><p>Lipid profile in women of different ethnicity with gestational diabetes: Relationship with fetal growth, Dalfrá 355–363.</p><p>Executive function</p><p>Global cognition and executive functions of older adults with type 1 diabetes mellitus without dementia, Nagasawa 922–930.</p><p>Fasting plasma glucose</p><p>Inverted U-shaped associations between serumuric acid and fasting - plasma glucose level in non-diabetic, pre-diabetic, and diabetic adults: A population-based study in China, Shi 483–490.</p><p>Associations of fasting plasma glucose with all-cause mortality and cardiovascular events in older Chinese diabetes patients: A population-based cohort study, Wang 1129–1139.</p><p>Fenofibrate</p><p>Haptoglobin phenotype and levels in type 2 diabetes and effects of fenofibrate, Januszewski 1663–1668.</p><p>Flash glucose monitoring</p><p>Fresh autologous blood transfusion.</p><p>Exploration of the mechanism of reinfusion of fresh autologous blood in type 2 diabetes mice to induce macrophage polarization and inhibit erythrocyte damage, Hu 70–77.</p><p>Foot ulcer</p><p>What characteristics are most important in stratifying patients into groups with different risk of diabetic foot ulceration?, Naemi 1094–1104.</p><p>Frailty</p><p>Management of older adults with diabetes mellitus: Perspective from geriatric medicine, Umegaki 1347–1354.</p><p>Fulminant type 1 diabetes</p><p>Fulminant type 1 diabetes, an underrecognized and unique subtype of type 1 diabetes: A case series from Singapore, Tan 786–789.</p><p>GAD antibody</p><p>New diagnostic criteria (2023) for slowly progressive type 1 diabetes (SPIDDM): Report from Committee on Type 1 Diabetes of the Japan Diabetes Society (English version), Shimada 254–257.</p><p>Gastrectomy</p><p>Theragnostic utility of continuous glucose monitoring in post-gastrectomy hypoglycemia, Son 1696–1699.</p><p>Gastrointestinal diseases</p><p>Association between gastrointestinal symptoms and insomnia in patients with type 2 diabetes: The KAMOGAWA-DM cohort study, Minamida 946–952.</p><p>Gene editing</p><p>Long-term efficacy of encapsulated xenogeneic islet transplantation: Impact of encapsulation techniques and donor genetic traits, Park 693–703.</p><p>Generalized lipodystrophy</p><p>Corticosteroid-triggered acute skeletal muscle loss in lipodystrophy: A case report, Sasako 782–785.</p><p>Genetic insulin resistance syndrome</p><p>A multicenter, open-label, single-arm trial of the long-term safety of empagliflozin treatment for refractory diabetes mellitus with insulin resistance (EMPIRE-02), Hirota 1211–1219.</p><p>Genetics and pathogenesis</p><p>Identification of eight genomic protective alleles for mitochondrial diabetes by Kinship-graph convolutional network, Wang 52–62.</p><p>Genome-wide association studies</p><p>Perspectives on genetic studies of type 2 diabetes from the genome-wide association studies era to precision medicine, Imamura 410–422.</p><p>Gestational diabetes</p><p>The role of lipid dysregulation in gestational diabetes mellitus: Early prediction and postpartum prognosis, Zhang 15–25.</p><p>Maternal birth weight as an indicator of early and late gestational diabetes mellitus: The Japan Environment and Children's Study, Tagami 751–761.</p><p>Gestational diabetes mellitus</p><p>Body composition and risk of gestational diabetes mellitus: A univariable and multivariable Mendelian randomization study, Gao 346–354.</p><p>Lipid profile in women of different ethnicity with gestational diabetes: Relationship with fetal growth, Dalfrá 355–363.</p><p>Comparing the screening methods for gestational diabetes mellitus before and during the COVID-19 pandemic: A systematic review, Sun 500–516.</p><p>Health impacts of new-onset diabetes in women post-gestational diabetes mellitus: Insights from Hong Kong's territory-wide data, Zhang 772–781.</p><p>Second-trimester triglyceride-glucose index to predict adverse outcomes in women with gestational diabetes mellitus: A retrospective multicenter cohort study, Bai 1489–1499.</p><p>Problems in screening for gestational diabetes mellitus by measurement of casual blood glucose levels at 24–28 gestational weeks, Tomimoto 1797–1802.</p><p>Multiple positive points during the 75 g oral glucose tolerance test are good predictors for early insulin therapy in gestational diabetes mellitus diagnosed before 24 gestational weeks, Kasuga 1803–1808.</p><p>Gestational weight gain</p><p>Association between infant birth weight and gestational weight gain in Japanese women with diabetes mellitus, Fujikawa Shingu 906–913.</p><p>Glomerular filtration rate</p><p>Decline in measured glomerular filtration rate is associated with simple renal cyst in Chinese patients with type 2 diabetes, Qiaoling 26–33.</p><p>Glucagon</p><p>Epac2 activation mediates glucagon-induced glucogenesis in primary rat hepatocytes, Shiozaki-Takagi 429–436.</p><p>Imeglimin enhances glucagon secretion through an indirect mechanism and improves fatty liver in high-fat, high-sucrose diet-fed mice, Kikuchi 1177–1190.</p><p>Glucagon-like peptide-1</p><p>Imeglimin enhances glucagon secretion through an indirect mechanism and improves fatty liver in high-fat, high-sucrose diet-fed mice, Kikuchi 1177–1190.</p><p>Glucagon-like peptide 1 receptor agonist</p><p>Efficacy and tolerability of oral semaglutide in Japanese patients with type 2 diabetes mellitus: Analysis report from diabetes specialist clinics, Inokuchi 1202–1210.</p><p>Glucogenic action</p><p>Epac2 activation mediates glucagon-induced glucogenesis in primary rat hepatocytes, Shiozaki-Takagi 429–436.</p><p>Glucokinase</p><p>Effects of glucokinase haploinsufficiency on the pancreatic β-cell mass and function of long-term high-fat, high-sucrose diet-fed mice, Shigesawa 1732–1742.</p><p>Glucose</p><p>Post-load glucose is a stronger predictor of adverse pregnancy outcomes than first-trimester HbA1c in women without gestational diabetes, Rajabi 914–921.</p><p>Glucose metabolism</p><p>Glucose metabolism partially regulates β-cell function through epigenomic changes, Kim 649–655.</p><p>Glucose-stimulated insulin secretion</p><p>Effects of glucokinase haploinsufficiency on the pancreatic β-cell mass and function of long-term high-fat, high-sucrose diet-fed mice, Shigesawa 1732–1742.</p><p>Glutamic acid decarboxylase.</p><p>Prediction of future insulin-deficiency in glutamic acid decarboxylase autoantibody enzyme-linked immunosorbent assay-positive patients with slowly progressive type 1 diabetes, Kawasaki 835–842.</p><p>Glycated albumin</p><p>Association between glycated albumin and adverse outcomes in patients with heart failure, Chen 1457–1463.</p><p>Glycated hemoglobin</p><p>Association between glycated albumin and adverse outcomes in patients with heart failure, Chen 1457–1463.</p><p>Low-carbohydrate diets in East Asians with type 2 diabetes: A systematic review and meta-analysis of randomized controlled trials, Hironaka 1753–1762.</p><p>Glycemia risk index</p><p>Association between glycemia risk index and arterial stiffness in type 2 diabetes, Cai 614–622.</p><p>Glycemic control</p><p>Influence of disease course and comprehensive management on blood glucose level in children and adolescents with type 2 diabetes mellitus, Wu 1026–1033.</p><p>Medical database analysis of the association between kidney function and achievement of glycemic control in older Japanese adults with type 2 diabetes who started with oral antidiabetic drugs, Suzuki 1057–1067.</p><p>Patient-reported outcomes and treatment adherence in type 2 diabetes using natural language processing: Wave 8 of the Observational International Diabetes Management Practices Study, Chan 1306–1316.</p><p>Glycemic metrics in Japanese isCGM users—Analysis by diabetes type and therapy, Ogawa 1483–1488.</p><p>Glycemic management</p><p>The association between alcohol drinking and glycemic management among people with type 2 diabetes in China, Ye 237–244.</p><p>Safety and effectiveness of tofogliflozin in Japanese people with type 2 diabetes: A multicenter prospective observational study in routine clinical practice, Yamada 1585–1595.</p><p>Glycemic variability</p><p>Glycemic variability: Measurement, target, impact on complications of diabetes and does it really matter? Mo 5–14.</p><p>Glycemic variability is associated with sural nerve conduction velocity in outpatients with type 2 diabetes: Usefulness of a new point-of-care device for nerve conduction studies, Morita 1075–1083.</p><p>Glycosylated hemoglobin</p><p>Association between glycated hemoglobin and risk of all-cause mortality in community patients with type 2 diabetes: A prospective cohort study, He 939–945.</p><p>Growth</p><p>Overnutrition in the early postnatal period influences lifetime metabolic risk: Evidence for impact on pancreatic β-cell mass and function, Burton 263–274.</p><p>Handgrip strength</p><p>The impact of handgrip strength and waist circumference on glycemic control: Prospective, observational study using outpatient clinical data in Japanese patients with type 2 diabetes mellitus, Nakanishi 892–898.</p><p>Haptoglobin</p><p>Haptoglobin phenotype and levels in type 2 diabetes and effects of fenofibrate, Januszewski 1663–1668.</p><p>HbA1c</p><p>Effect of hemoglobin A1c management levels on coronary physiology evaluated by quantitative flow ratio in patients who underwent percutaneous coronary intervention, Chen 336–345.</p><p>HbA1c degradation</p><p>Evaluation of the transition program at the University Hospital of Reims from 2015 to 2020, Chibane 1519–1523.</p><p>HbA1c trajectory</p><p>Mandatory monthly outpatient visits could improve therapeutic inertia in patients with poorly controlled type 2 diabetes, Tsai 227–236.</p><p>HbA1c variability</p><p>Prognostic value of longitudinal HbA1c variability in predicting the development of diabetic sensorimotor polyneuropathy among patients with type 2 diabetes mellitus: A prospective cohort observational study, Lai 326–335.</p><p>Health care costs</p><p>Healthcare resource utilization and healthcare costs in patients with type 2 diabetes mellitus initiating sodium-glucose cotransporter 2 inhibitors vs dipeptidyl peptidase-4 inhibitors in Japan: A real-world administrative database analysis, Kashiwagi 374–387.</p><p>Healthcare quality assessment</p><p>Associations between income/employment status and diabetes care processes, health behaviors, and health outcomes in Japan: A cross-sectional study using claims data linked to a questionnaire survey, Yamaoka 1684–1695.</p><p>Health resources</p><p>Healthcare resource utilization and healthcare costs in patients with type 2 diabetes mellitus initiating sodium-glucose cotransporter 2 inhibitors vs dipeptidyl peptidase-4 inhibitors in Japan: A real-world administrative database analysis, Kashiwagi 374–387.</p><p>Healthy volunteers</p><p>Delayed dinnertime impairs glucose tolerance in healthy young adults, Nakamura 172–176.</p><p>Heart failure</p><p>Association between glycated albumin and adverse outcomes in patients with heart failure, Chen 1457–1463.</p><p>Heart rate variability</p><p>Associations of age-adjusted coefficient of variation of R-R intervals with autonomic and peripheral nerve function in non-elderly persons with diabetes, Sugimoto 186–196.</p><p>Cardiac electrophysiology, structure and diastolic function in patients with diabetic foot versus those without diabetic foot, Bai 1276–1286.</p><p>Improvement of heart rate variability after metabolic bariatric surgery in Korean subjects with obesity, Jang 1773–1780.</p><p>Hematocrit</p><p>Impact of hematocrit levels on the accuracy of specific blood glucose meters: A hospital-based study, Pham 1472–1482.</p><p>Hemoglobin A1c</p><p>Post-load glucose is a stronger predictor of adverse pregnancy outcomes than first-trimester HbA1c in women without gestational diabetes, Rajabi 914–921.</p><p>Henagliflozin</p><p>Sodium–glucose cotransporter 2 inhibition through henagliflozin ameliorates cognitive impairment in patients with type 2 diabetes, Zhang 1596–1603.</p><p>Hepatocyte nuclear factor 1B</p><p>Hepatocyte nuclear factor 1B deletion, but not intragenic mutation, might be more susceptible to hypomagnesemia, Wang 121–130.</p><p>High-density lipoprotein cholesterol</p><p>Association between serum uric acid-to-high-density lipoprotein cholesterol ratio and insulin resistance in patients with type 2 diabetes mellitus, Zhou 113–120.</p><p>hs-CRP</p><p>High sensitivity C-reactive protein and prediabetes progression and regression in middle-aged and older adults: A prospective cohort study, Cheng 78–86.</p><p>Hyperlipidemia</p><p>Optimizing lipid control in Taiwanese diabetic patients: A collaborative consensus by the Diabetes Association of the Republic of China (Taiwan) and the Taiwanese Association of Diabetes Educators, Shen 1151–1160.</p><p>Hypoglycemia</p><p>Recurrent hypoglycemia induced by clopidogrel: A case report and mini review, Du 275–281.</p><p>Development and validation of a prediction model for self-reported hypoglycemia risk in patients with type 2 diabetes: A longitudinal cohort study, Xu 468–482.</p><p>Islet transplantation in Korea, Lee 1165–1170.</p><p>Theragnostic utility of continuous glucose monitoring in post-gastrectomy hypoglycemia, Son 1696–1699.</p><p>Hypomagnesemia</p><p>Hepatocyte nuclear factor 1B deletion, but not intragenic mutation, might be more susceptible to hypomagnesemia, Wang 121–130.</p><p>Ideal cardiovascular health</p><p>The association between metabolic syndrome and insulin resistance with risk of cardiovascular events in different states of cardiovascular health status, Hosseinpour-Niazi 208–218.</p><p>IDegLira</p><p>Comparison of efficacy and safety of insulin degludec/liraglutide and insulin glargine U-100/lixisenatide in individuals with type 2 diabetes mellitus using professional continuous glucose monitoring, Kawaguchi 598–607.</p><p>IGHG1</p><p>Immunoglobulin heavy constant gamma 1 silencing decreases tonicity-responsive enhancer-binding protein expression to alleviate diabetic nephropathy, Hu 572–583.</p><p>IGlarLixi</p><p>Comparison of efficacy and safety of insulin degludec/liraglutide and insulin glargine U-100/lixisenatide in individuals with type 2 diabetes mellitus using professional continuous glucose monitoring, Kawaguchi 598–607.</p><p>Imeglimin</p><p>Imeglimin enhances glucagon secretion through an indirect mechanism and improves fatty liver in high-fat, high-sucrose diet-fed mice, Kikuchi 1177–1190.</p><p>Factors contributing to the clinical effectiveness of imeglimin monotherapy in Japanese patients with type 2 diabetes mellitus, Hagi 1239–1247.</p><p>Inflammation</p><p>Regulatory T cells protect against diabetic cardiomyopathy in <i>db/db</i> mice, Zhang 1191–1201.</p><p>Influence factors</p><p>Prevalence, awareness, treatment and control of type 2 diabetes in southeast China: A population-based study, Hu 1034–1041.</p><p>Injection</p><p>Adherence and treatment discontinuation of oral semaglutide and once-weekly semaglutide injection at 12-month follow-up: Japanese real-world data, Horii 1578–1584.</p><p>Insulin</p><p>Targeting PI3K/AKT and MEK/ERK pathways for synergic effects on improving features of peripheral diabetic neuropathy, Pham 1537–1544.</p><p>Multiple positive points during the 75 g oral glucose tolerance test are good predictors for early insulin therapy in gestational diabetes mellitus diagnosed before 24 gestational weeks, Kasuga 1803–1808.</p><p>Insulin autoimmune syndrome</p><p>Recurrent hypoglycemia induced by clopidogrel: A case report and mini review, Du 275–281.</p><p>Insulin infusion systems</p><p>Effects of hybrid closed-loop system on glycemic control and psychological aspects in persons with type 1 diabetes treated with sensor-augmented pump: A prospective single-center observational study, Akiyama 219–226.</p><p>Insulin-like growth factor-1</p><p>Diminished levels of insulin-like growth factor-1 may be a risk factor for peripheral neuropathy in type 2 diabetes patients, Zhong 1259–1265.</p><p>Insulin resistance</p><p>The association between metabolic syndrome and insulin resistance with risk of cardiovascular events in different states of cardiovascular health status, Hosseinpour-Niazi 208–218.</p><p>Association between serum uric acid-to-high-density lipoprotein cholesterol ratio and insulin resistance in an American population: A population-based analysis, Zhou 762–771.</p><p>Insulin secretion</p><p>Short-term recovery of insulin secretion in response to a meal is associated with future glycemic control in type 2 diabetes patients, Enkaku 437–448.</p><p>Pancreatic beta-cell mass and function and therapeutic implications of using antidiabetic medications in type 2 diabetes, Moon 669–683.</p><p>Insulin secretory capacity</p><p>Association of xanthine oxidoreductase inhibitor use with insulin secretory capacity inpatients with type 2 diabetes, Kitamura 1500–1509.</p><p>Insulin sensitivity</p><p>Interactive calculator to estimate insulin sensitivity in type 1 diabetes, Januszewski 594–597.</p><p>Intermittent fasting</p><p>Effect of intermittent fasting 16:8 and 14:10 compared with control-group on weight reduction and metabolic outcomes in obesity with type 2 diabetes patients: A randomized controlled trial, Sukkriang 1297–1305.</p><p>Intermittently scanned continuous glucose monitoring</p><p>Patient-reported outcomes and treatment adherence in type 2 diabetes using natural language processing: Wave 8 of the Observational International Diabetes Management Practices Study, Chan 1306–1316.</p><p>Internet of things</p><p>Internet of things-based approach for glycemic control in people with type 2 diabetes: A randomized controlled trial, Bouchi 1287–1296.</p><p>Intestine</p><p>Diabetes treatment by conversion of gut epithelial cells to insulin-producing cells, Accili 797–804.</p><p>Islets of Langerhans transplantation</p><p>Long-term efficacy of encapsulated xenogeneic islet transplantation: Impact of encapsulation techniques and donor genetic traits, Park 693–703.</p><p>Islet transplantation in Korea, Lee 1165–1170.</p><p>JDCP study</p><p>Prevalence and characteristics of diabetic symmetric sensorimotor polyneuropathy in Japanese patients with type 2 diabetes: The Japan Diabetes Complication and its Prevention Prospective study (JDCP study 10), Kamiya 247–253.</p><p>Kidney complications</p><p>Health impacts of new-onset diabetes in women post-gestational diabetes mellitus: Insights from Hong Kong's territory-wide data, Zhang 772–781.</p><p>Kidney function</p><p>Association analysis between serum asprosin and metabolic characteristics, Complications in type 2 diabetic patients with different durations, Ma 1781–1787.</p><p>Large-scale claims database</p><p>Factor affecting severe atherothrombotic cerebral infarction in patients with type 2 diabetes mellitus: Large-scale claim database analysis of Japan, Horii 1651–1662.</p><p>Latent autoimmune diabetes in adults</p><p>New diagnostic criteria (2023) for slowly progressive type 1 diabetes (SPIDDM): Report from Committee on Type 1 Diabetes of the Japan Diabetes Society (English version), Shimada 254–257.</p><p>L-dopa</p><p>Diabetic striatopathy: Hyperglycemic chorea/ballism successfully treated with L-dopa, Tsukaguchi 1524–1527.</p><p>Left ventricular diastolic dysfunction</p><p>The correlation between serum asprosin and left ventricular diastolic dysfunction in elderly patients with type 2 diabetes mellitus in the community, Liang 608–613.</p><p>Cardiac electrophysiology, structure and diastolic function in patients with diabetic foot versus those without diabetic foot, Bai 1276–1286.</p><p>Letter to the Editor</p><p>Longitudinal association of sedentary time with diabetes mellitus and markers of glucose metabolism in middle-aged and older adults: The Hisayama Study, Tsuda 245–246.</p><p>Comment on the article titled “Association of the triglyceride-glucose index with subclinical left ventricular dysfunction in type 2 diabetes mellitus patients: A retrospective cross-sectional study”, Naharci 517–518.</p><p>Comment on a recent article titled ‘Hepatocyte nuclear factor 1B deletion, but not intragenic mutation, might be more susceptible to hypomagnesemia’, Clissold 790.</p><p>Long-term safety of alginate-poly-L-ornithine microcapsules, enveloping human islet allografts, into nonimmunosuppressed patients with type 1 diabetes mellitus, Calafiore 1700–1701.</p><p>Maturity-onset diabetes of the young: A proposal for updated nomenclature, Tosur 1818–1819.</p><p>Coexistence of high visceral fat area and sarcopenia and atherosclerotic markers in older patients with diabetes: Is there an association?, Saleh 1820.</p><p>Lifestyle interventions</p><p>Postpartum life interventions to prevent type 2 diabetes in women with gestational diabetes: A systematic review and meta-analysis, Wang 1115–1128.</p><p>Lipid</p><p>Estimated small dense low-density lipoprotein cholesterol and nonalcoholic fatty liver disease in nonobese populations, Huang 491–499.</p><p>Lipid metabolism</p><p>The role of lipid dysregulation in gestational diabetes mellitus: Early prediction and postpartum prognosis, Zhang 15–25.</p><p>Lipid profile</p><p>Lipid profile in women of different ethnicity with gestational diabetes: Relationship with fetal growth, Dalfrá 355–363.</p><p>Lipoatrophic diabetes</p><p>A multicenter, open-label, single-arm trial of the long-term safety of empagliflozin treatment for refractory diabetes mellitus with insulin resistance (EMPIRE-02), Hirota 1211–1219.</p><p>Liver steatosis</p><p>Metabolic dysfunction-associated steatotic liver disease: A superior predictor for incident type 2 diabetes over traditional criteria—NAGALA study, Sakai 1788–1796.</p><p>Liver transplantation</p><p>Risk factors and prediction score for new-onset diabetes mellitus after liver transplantation, Bai 1105–1114.</p><p>Low birthweight</p><p>Interaction effect between low birthweight and resistin gene rs1862513 variant on insulin resistance and type 2 diabetes mellitus in adulthood: Toon Genome Study, Yoshida 725–735.</p><p>Low-carbohydrate diet</p><p>Efficacy of long-term low-carbohydrate diets for patients with type 2 diabetes: A systematic review and meta-analysis, Ichikawa 1410–1421.</p><p>Low-carbohydrate diets in East Asians with type 2 diabetes: A systematic review and meta-analysis of randomized controlled trials, Hironaka 1753–1762.</p><p>Low-density lipoprotein cholesterol</p><p>Effect of sodium–glucose cotransporter 2 inhibitors on serum low-density lipoprotein cholesterol in Japanese patients with type 2 diabetes mellitus, Imada 843–850.</p><p>Lysosome</p><p>Role of β-cell autophagy in β-cell physiology and the development of diabetes, Yasasilka 656–668.</p><p>Machine learning</p><p>Identification of eight genomic protective alleles for mitochondrial diabetes by Kinship-graph convolutional network, Wang 52–62.</p><p>Performance of different machine learning algorithms in identifying undiagnosed diabetes based on nonlaboratory parameters and the influence of muscle strength: A cross-sectional study, Xu 743–750.</p><p>Interpretable machine learning models based on shear-wave elastography radiomics for predicting cardiovascular disease in diabetic kidney disease patients, Dai 1637–1650.</p><p>Macrophages</p><p>Exploration of the mechanism of reinfusion of fresh autologous blood in type 2 diabetes mice to induce macrophage polarization and inhibit erythrocyte damage, Hu 70–77.</p><p>Malignant neoplasms</p><p>Causes of death in Japanese patients with diabetes based on the results of a survey of 68,555 cases during 2011–2020: Committee report on causes of death in diabetes mellitus, Japan Diabetes Society (English version), Nakamura 1821–1837.</p><p>Marfan syndrome</p><p>Coexistence of type 2 diabetes mellitus, arginine vasopressin deficiency, and Marfan syndrome: A case report, Le 964–967.</p><p>Maternally inherited diabetes and deafness</p><p>Identification of eight genomic protective alleles for mitochondrial diabetes by Kinship-graph convolutional network, Wang 52–62.</p><p>Maturity-onset diabetes of the young</p><p>Hepatocyte nuclear factor 1B deletion, but not intragenic mutation, might be more susceptible to hypomagnesemia, Wang 121–130.</p><p>Mean blood glucose</p><p>Between blood glucose and mortality in critically ill patients: Retrospective analysis of the MIMIC-IV database, Li 931–938.</p><p>Mendelian randomization</p><p>Body composition and risk of gestational diabetes mellitus: A univariable and multivariable Mendelian randomization study, Gao 346–354.</p><p>Causal association between cystatin C and diabetic retinopathy: A two-sample Mendelian randomization study, Ruan 1626–1636.</p><p>Meta-analysis</p><p>Type 1 diabetes and the risk of epilepsy: A meta-analysis, Wu 364–373.</p><p>Postpartum life interventions to prevent type 2 diabetes in women with gestational diabetes: A systematic review and meta-analysis, Wang 1115–1128.</p><p>Efficacy of long-term low-carbohydrate diets for patients with type 2 diabetes: A systematic review and meta-analysis, Ichikawa 1410–1421.</p><p>Metabolic bariatric surgery</p><p>Improvement of heart rate variability after metabolic bariatric surgery in Korean subjects with obesity, Jang 1773–1780.</p><p>Metabolic dysfunction-associated fatty liver diseases</p><p>Elevated small dense low-density lipoprotein cholesterol to high-density lipoprotein cholesterol ratio is associated with an increased risk of metabolic dysfunction-associated fatty liver disease in Chinese patients with type 2 diabetes mellitus, Yang 634–642.</p><p>Metabolic dysfunction-associated steatotic liver disease</p><p>Long-term effects of ipragliflozin and pioglitazone on metabolic dysfunction-associated steatotic liver disease in patients with type 2 diabetes: 5 year observational follow-up of a randomized, 24 week, active-controlled trial, Ito 1220–1230.</p><p>Metabolic outcomes</p><p>Effect of intermittent fasting 16:8 and 14:10 compared with control-group on weight reduction and metabolic outcomes in obesity with type 2 diabetes patients: A randomized controlled trial, Sukkriang 1297–1305.</p><p>Metabolic syndrome</p><p>The association between metabolic syndrome and insulin resistance with risk of cardiovascular events in different states of cardiovascular health status, Hosseinpour-Niazi 208–218.</p><p>METTL3</p><p>METTL3/YTHDF2 m6A axis mediates the progression of diabetic nephropathy through epigenetically suppressing PINK1 and mitophagy, Wang 288–299.</p><p>Microalbuminuria</p><p>Identification and validation of voltage-dependent anion channel 1-related genes and immune cell infiltration in diabetic nephropathy, Lin 87–105.</p><p>Sympathetic skin response for early detection of type 2 diabetic peripheral neuropathy and nephropathy, Liu 106–112.</p><p>MicroRNAs</p><p>Investigating the altered expression of miR-486-5p and miR-novel-chr1_40444 in dysglycemia in a South African population, Weale 1377–1389.</p><p>microRNA-194</p><p>Relationship between circulating thrombospondin-1 messenger ribonucleic acid and microribonucleic acid-194 levels in Chinese patients with type 2 diabetic kidney disease: The outcomes of a case–control study, Ma 1248–1258.</p><p>miR-30a-3p</p><p><i>Cordyceps cicadae</i> polysaccharides attenuate diabetic nephropathy via the miR-30a-3p/TRIM16 axis, Zheng 300–314.</p><p>miR-488-3p</p><p>MiR-488-3p facilitates wound healing throughCYP1B1-mediated Wnt/β-catenin signaling pathway by targeting MeCP2, Zuo 145–158.</p><p>MiRNA let7d-5p</p><p>High glucose promotes atherosclerosis by regulating miRNA let7d-5p level, Wang 711–724.</p><p>Mitiglinide/voglibose fixed-dose combination tablet</p><p>Comparative effects of fixed-dose mitiglinide/voglibose combination and glimepiride on vascular endothelial function and glycemic variability in patients with type 2 diabetes: A randomized controlled trial, Tanaka 449–458.</p><p>Molecular diagnosis</p><p>Genetic variant profiling of neonatal diabetes mellitus in Iranian patients: Unveiling 58 distinct variants in 14 genes, Mianesaz 1390–1402.</p><p>Mood</p><p>An exploratory study of factors in disordered eating behavior in diabetes self-management in Japan, Tsukamoto-Kawashima 874–881.</p><p>Mortality</p><p>Between blood glucose and mortality in critically ill patients: Retrospective analysis of the MIMIC-IV database, Li 931–938.</p><p>Mortality rate</p><p>Type 1 and type 2 diabetes mortality burden: Predictions for 2030 based on Bayesian age-period-cohort analysis of China and global mortality burden from 1990 to 2019, Dong 623–633.</p><p>Mortality risk</p><p>Association between glycated hemoglobin and risk of all-cause mortality in community patients with type 2 diabetes: A prospective cohort study, He 939–945.</p><p>Multimorbidity</p><p>Management of older adults with diabetes mellitus: Perspective from geriatric medicine, Umegaki 1347–1354.</p><p>Muscle strength</p><p>Performance of different machine learning algorithms in identifying undiagnosed diabetes based on nonlaboratory parameters and the influence of muscle strength: A cross-sectional study, Xu 743–750.</p><p>Myocardial function</p><p>Improvements of myocardial strain and work in diabetes patients with normal ejection fraction after empagliflozin treatment, Cheng 851–860.</p><p>Neonatal</p><p>Neonatal diabetes mellitus around the world: Update 2024, Barbetti 1711–1724.</p><p>Neonatal diabetes</p><p>Genetic variant profiling of neonatal diabetes mellitus in Iranian patients: Unveiling 58 distinct variants in 14 genes, Mianesaz 1390–1402.</p><p>Neovascular glaucoma</p><p>Characterization of the visually impaired patients with diabetes mellitus in Japan, Sugihara 882–891.</p><p>Nerve conduction</p><p>Associations of age-adjusted coefficient of variation of R-R intervals with autonomic and peripheral nerve function in non-elderly persons with diabetes, Sugimoto 186–196.</p><p>Nerve conduction studies</p><p>Identification and validation of voltage-dependent anion channel 1-related genes and immune cell infiltration in diabetic nephropathy, Lin 87–105.</p><p>Sympathetic skin response for early detection of type 2 diabetic peripheral neuropathy and nephropathy, Liu 106–112.</p><p>Diminished levels of insulin-like growth factor-1 may be a risk factor for peripheral neuropathy in type 2 diabetes patients, Zhong 1259–1265.</p><p>Netrin-1</p><p>Circulating netrin-1 levels are reduced and related to corneal nerve fiber loss in patients with diabetic neuropathy, Mondal 1068–1074.</p><p>New-onset diabetes mellitus</p><p>Risk factors and prediction score for new-onset diabetes mellitus after liver transplantation, Bai 1105–1114.</p><p>Nitrosamines</p><p>Assessment of cancer risk associated with 7-nitroso-3-(trifluoromethyl)-5,6,7,8-tetrahydro[1,2,4] triazolo-[4,3-a]pyrazine-contaminated sitagliptin use: A retrospective cohort study, Sugiyama 1556–1565.</p><p>Nocturia</p><p>Multicenter, open-label, randomized controlled superiority trial for availability to reduce nocturnal urination frequency: The TOP-STAR study, Nakajima 1809–1817.</p><p>Nomograms</p><p>A novel predictive model for optimizing diabetes screening in older adults, Lin 1403–1409.</p><p>Nonalcoholic fatty liver disease</p><p>Estimated small dense low-density lipoprotein cholesterol and nonalcoholic fatty liver disease in nonobese populations, Huang 491–499.</p><p>Nonalcoholic fatty liver disease</p><p>Long-term effects of ipragliflozin and pioglitazone on metabolic dysfunction-associated steatotic liver disease in patients with type 2 diabetes: 5 year observational follow-up of a randomized, 24 week, active-controlled trial, Ito 1220–1230.</p><p>Metabolic dysfunction-associated steatotic liver disease: A superior predictor for incident type 2 diabetes over traditional criteria – NAGALA study, Sakai 1788–1796.</p><p>Novel variants</p><p>Genetic variant profiling of neonatal diabetes mellitus in Iranian patients: Unveiling 58 distinct variants in 14 genes, Mianesaz 1390–1402.</p><p>Nutrition</p><p>Overnutrition in the early postnatal period influences lifetime metabolic risk: Evidence for impact on pancreatic β-cell mass and function, Burton 263–274.</p><p>Nutrient quality in dietary therapy for diabetes and diabetic kidney disease, Tsuruta 973–981.</p><p>Obesity</p><p>Overnutrition in the early postnatal period influences lifetime metabolic risk: Evidence for impact on pancreatic β-cell mass and function, Burton 263–274.</p><p>A case of type 2 diabetes mellitus with weight gain and worsening of glycemic management after tezepelumab administration for severe bronchial asthma, Umamoto 388–390.</p><p>Association between serum uric acid-to-high-density lipoprotein cholesterol ratio and insulin resistance in an American population: A population-based analysis, Zhou 762–771.</p><p>Observational studies</p><p>Type 1 diabetes and the risk of epilepsy: A meta-analysis, Wu 364–373.</p><p>Occupational health</p><p>Relationship between diabetes treatment status and occupational accidents, Ogasawara 899–905.</p><p>Older adults</p><p>Medical database analysis of the association between kidney function and achievement of glycemic control in older Japanese adults with type 2 diabetes who started with oral antidiabetic drugs, Suzuki 1057–1067.</p><p>Online calculator</p><p>Interactive calculator to estimate insulin sensitivity in type 1 diabetes, Januszewski 594–597.</p><p>Opportunistic case finding</p><p>External validation of the Hong Kong Chinese nonlaboratory risk models and scoring algorithm for case finding of prediabetes and diabetes mellitus in primary care, Cheng 1317–1325.</p><p>Oral</p><p>Adherence and treatment discontinuation of oral semaglutide and once-weekly semaglutide injection at 12 month follow-up: Japanese real-world data, Horii 1578–1584.</p><p>Oral antidiabetic drugs</p><p>Prevalence of adherence to oral antidiabetic drugs in patients with type 2 diabetes: A systematic review and meta-analysis, Boonpattharatthiti 1614–1625.</p><p>Oral cancer</p><p>Impact of diabetes on the prognosis of patients with oral and oropharyngeal cancer: A meta-analysis, Xu 1140–1150.</p><p>Oral glucose tolerance test</p><p>Multiple positive points during the 75 g oral glucose tolerance test are good predictors for early insulin therapy in gestational diabetes mellitus diagnosed before 24 gestational weeks, Kasuga 1803–1808.</p><p>Oral semaglutide</p><p>Efficacy and tolerability of oral semaglutide in Japanese patients with type 2 diabetes mellitus: Analysis report from diabetes specialist clinics, Inokuchi 1202–1210.</p><p>PIONEER REAL Japan: Primary results from a multicenter, prospective, real-world study of oral semaglutide in adults with type 2 diabetes in Japanese clinical practice, Yabe 1566–1577.</p><p>Orthostatic hypotension</p><p>Associations of age-adjusted coefficient of variation of R-R intervals with autonomic and peripheral nerve function in non-elderly persons with diabetes, Sugimoto 186–196.</p><p>Outcome</p><p>Post-load glucose is a stronger predictor of adverse pregnancy outcomes than first-trimester HbA1c in women without gestational diabetes, Rajabi 914–921.</p><p>Oxidative stress</p><p>Oxidative stress suppresses PHB2-mediated mitophagy in β-cells via the Nrf2/PHB2 pathway, Liu 559–571.</p><p>Pancreatic β-cell</p><p>Pancreatic beta-cell mass and function and therapeutic implications of using antidiabetic medications in type 2 diabetes, Moon 669–683.</p><p>Pancreatic β-cells</p><p>Mitochondrial ALDH2 improves β-cell survival and function against doxorubicin-induced apoptosis by targeting CK2 signaling, Karunakaran 684–692.</p><p>Parkin</p><p>METTL3/YTHDF2 m6A axis mediates the progression of diabetic nephropathy through epigenetically suppressing PINK1 and mitophagy, Wang 288–299.</p><p>Patient-reported outcomes</p><p>Patient-reported outcomes and treatment adherence in type 2 diabetes using natural language processing: Wave 8 of the Observational International Diabetes Management Practices Study, Chan 1306–1316.</p><p>People with type 2 diabetes</p><p>The association between alcohol drinking and glycemic management among people with type 2 diabetes in China, Ye 237–244.</p><p>Percutaneous coronary intervention</p><p>Effect of hemoglobin A1c management levels on coronary physiology evaluated by quantitative flow ratio in patients who underwent percutaneous coronary intervention, Chen 336–345.</p><p>Peripheral nerve function</p><p>Glycemic variability is associated with sural nerve conduction velocity in outpatients with type 2 diabetes: Usefulness of a new point-of-care device for nerve conduction studies, Morita 1075–1083.</p><p>Permeability</p><p>Microvascular permeability and texture analysis of bone marrow in diabetic rabbits with critical limb ischemia based on dynamic contrast-enhanced magnetic resonance imaging, Yang 584–593.</p><p>Pharmacoepidemiology</p><p>Assessment of cancer risk associated with 7-nitroso-3-(trifluoromethyl)-5,6,7,8-tetrahydro[1,2,4] triazolo-[4,3-a]pyrazine-contaminated sitagliptin use: A retrospective cohort study, Sugiyama 1556–1565.</p><p>Pharmacotherapy</p><p>A consensus statement from the Japan Diabetes Society: A proposed algorithm for pharmacotherapy in people with type 2diabetes – 2nd edition (English version), Bouchi 1326–1342.</p><p>Pharmacovigilance</p><p>A real-world disproportionality analysis of semaglutide: Post-marketing pharmacovigilance data, Du 1422–1433.</p><p>Plantar pressure</p><p>Plantar pressure measurement in diabetic foot disease: A scoping review, Lockhart 990–999.</p><p>Plasma glucose</p><p>Risk factors for chronic kidney disease progression over 20 years for primary prevention in Japanese individuals at a preventive medicine research center: Focus on the influence of plasma glucose levels, Minami 1434–1443.</p><p>Polygenic risk scores</p><p>Perspectives on genetic studies of type 2 diabetes from the genome-wide association studies era to precision medicine, Imamura 410–422.</p><p><i>Polygonatum sibiricum</i> polysaccharide</p><p><i>Polygonatum sibiricum</i> (Huang Jing) polysaccharide reduces diabetic cardiomyopathy through increasing cyclic guanosine monophosphate-protein kinase G signaling in diabetic mice, Lei 823–834.</p><p>Polypharmacy</p><p>Management of older adults with diabetes mellitus: Perspective from geriatric medicine, Umegaki 1347–1354.</p><p>Population attributable fraction</p><p>Health impacts of new-onset diabetes in women post-gestational diabetes mellitus: Insights from Hong Kong's territory-wide data, Zhang 772–781.</p><p>Post-load plasma glucose</p><p>Linking extent of return to fasting state after oral glucose tolerance test to future risk of prediabetes and type 2 diabetes: Insights from the TLGS, Masrouri 1743–1752.</p><p>Postnatal</p><p>Overnutrition in the early postnatal period influences lifetime metabolic risk: Evidence for impact on pancreatic β-cell mass and function, Burton 263–274.</p><p>Postprandial period</p><p>Delayed dinnertime impairs glucose tolerance in healthy young adults, Nakamura 172–176.</p><p>Prediabetes</p><p>Characteristics of individuals who developed type 2 diabetes from prediabetes despite undergoing interventions, and evaluation of the performance of urinary myo-inositol as a risk factor for developing diabetes, Yamagata 177–185.</p><p>External validation of the Hong Kong Chinese nonlaboratory risk models and scoring algorithm for case finding of prediabetes and diabetes mellitus in primary care, Cheng 1317–1325.</p><p>Prediabetes progression</p><p>High sensitivity C-reactive protein and prediabetes progression and regression in middle-aged and older adults: A prospective cohort study, Cheng 78–86.</p><p>Prediabetes regression</p><p>High sensitivity C-reactive protein and prediabetes progression and regression in middle-aged and older adults: A prospective cohort study, Cheng 78–86.</p><p>Prediction</p><p>Prediction of future insulin-deficiency in glutamic acid decarboxylase autoantibody enzyme-linked immunosorbent assay-positive patients with slowly progressive type 1 diabetes, Kawasaki 835–842.</p><p>Post-load glucose is a stronger predictor of adverse pregnancy outcomes than first-trimester HbA1c in women without gestational diabetes, Rajabi 914–921.</p><p>Risk factors and prediction score for new-onset diabetes mellitus after liver transplantation, Bai 1105–1114.</p><p>Prediction model</p><p>Development and validation of a prediction model for self-reported hypoglycemia risk in patients with type 2 diabetes: A longitudinal cohort study, Xu 468–482.</p><p>Prediction of onset of diabetes</p><p>Characteristics of individuals who developed type 2 diabetes from prediabetes despite undergoing interventions, and evaluation of the performance of urinary myo-inositol as a risk factor for developing diabetes, Yamagata 177–185.</p><p>Pregnancy</p><p>Post-load glucose is a stronger predictor of adverse pregnancy outcomes than first-trimester HbA1c in women without gestational diabetes, Rajabi 914–921.</p><p>Pregnancy outcome</p><p>Second-trimester triglyceride-glucose index to predict adverse outcomes in women with gestational diabetes mellitus: A retrospective multicenter cohort study, Bai 1489–1499.</p><p>Prenatal</p><p>Overnutrition in the early postnatal period influences lifetime metabolic risk: Evidence for impact on pancreatic β-cell mass and function, Burton 263–274.</p><p>Progestin and adipoQ receptor 3</p><p>Circ_0068087 knockdown attenuates high-glucose-induced human tubular epithelial cell injury in a microribonucleic acid/progestin and adipoQ receptor 3-dependent manner in diabetic nephropathy, Liu 159–171.</p><p>Prohibitin2</p><p>Oxidative stress suppresses PHB2-mediated mitophagy in β-cells via the Nrf2/PHB2 pathway, Liu 559–571.</p><p>Prospective studies</p><p>PIONEER REAL Japan: Baseline characteristics of a multicenter, prospective, real-world study of oral semaglutide in adults with type 2 diabetes in clinical practice in Japan, Suzuki 1047–1056.</p><p>PIONEER REAL Japan: Primary results from a multicenter, prospective, real-world study of oral semaglutide in adults with type 2 diabetes in Japanese clinical practice, Yabe 1566–1577.</p><p>Protein catabolism</p><p>Corticosteroid-triggered acute skeletal muscle loss in lipodystrophy: A case report, Sasako 782–785.</p><p>Proteinuria</p><p>Young-onset type 2 diabetes mellitus enhances proteinuria, but not glomerular filtration rate decline: A Japanese cohort study, Saito 1444–1456.</p><p>Public health</p><p>Health impacts of new-onset diabetes in women post-gestational diabetes mellitus: Insights from Hong Kong's territory-wide data, Zhang 772–781.</p><p>Quantitative flow ratio</p><p>Effect of hemoglobin A1c management levels on coronary physiology evaluated by quantitative flow ratio in patients who underwent percutaneous coronary intervention, Chen 336–345.</p><p>Reactive hyperemia index</p><p>Comparative effects of fixed-dose mitiglinide/voglibose combination and glimepiride on vascular endothelial function and glycemic variability in patients with type 2 diabetes: A randomized controlled trial, Tanaka 449–458.</p><p>Reactive oxygen species</p><p><i>Polygonatum sibiricum</i> (Huang Jing) polysaccharide reduces diabetic cardiomyopathy through increasing cyclic guanosine monophosphate-protein kinase G signaling in diabetic mice, Lei 823–834.</p><p>Real-world data</p><p>Risk stratification for cardiovascular disease based on prior coronary artery disease, cerebrovascular disease and type 2 diabetes mellitus, Oe 1464–1471.</p><p>Sulfonylurea prescription patterns in elderly patients with type 2 diabetes mellitus: A comprehensive analysis of real-world data from pharmacies in Japan, Yamazaki 1604–1613.</p><p>Real-world evidence</p><p>Patient-reported outcomes and treatment adherence in type 2 diabetes using natural language processing: Wave 8 of the Observational International Diabetes Management Practices Study, Chan 1306–1316.</p><p>Regulatory T cells</p><p>Regulatory T cells protect against diabetic cardiomyopathy in <i>db/db</i> mice, Zhang 1191–1201.</p><p>Remnant cholesterol</p><p>Remnant cholesterol, but not other traditional lipids or lipid ratios, is independently and positively related to future diabetes risk in Chinese general population: A 3 year cohort study, Li 1084–1093.</p><p>Remote pressure measurement</p><p>Plantar pressure measurement in diabetic foot disease: A scoping review, Lockhart 990–999.</p><p>Renal cyst</p><p>Decline in measured glomerular filtration rate is associated with simple renal cyst in Chinese patients with type 2 diabetes, Qiaoling 26–33.</p><p>Resistant starch</p><p>Resistant starch and type 2 diabetes mellitus: Clinical perspective, Kim 395–401.</p><p>Resistin</p><p>Interaction effect between low birthweight and resistin gene rs1862513 variant on insulin resistance and type 2 diabetes mellitus in adulthood: Toon Genome Study, Yoshida 725–735.</p><p>Ribosomal protein S26</p><p>Association of RPS26 gene polymorphism with different types of diabetes in Chinese individuals, Song 34–43.</p><p>Risk</p><p>Post-load glucose is a stronger predictor of adverse pregnancy outcomes than first-trimester HbA1c in women without gestational diabetes, Rajabi 914–921.</p><p>Risk prediction models</p><p>External validation of the Hong Kong Chinese nonlaboratory risk models and scoring algorithm for case finding of prediabetes and diabetes mellitus in primary care, Cheng 1317–1325.</p><p>Salt restriction</p><p>Multicenter, open-label, randomized controlled superiority trial for availability to reduce nocturnal urination frequency: The TOP-STAR study, Nakajima 1809–1817.</p><p>Sarcopenic obesity</p><p>Coexistence of high visceral fat area and sarcopenia is associated with atherosclerotic markers in old-old patients with diabetes: A cross-sectional study, Sato 1510–1518.</p><p>Screening</p><p>Sheffield One-Stop Service: A potential model to improve the screening uptake of diabetic peripheral neuropathy and other microvascular complications of diabetes, Sloan 1355–1362.</p><p>Screening methods</p><p>Comparing the screening methods for gestational diabetes mellitus before and during the COVID-19 pandemic: A systematic review, Sun 500–516.</p><p>Self-management</p><p>Implementation rate of diabetic self-management education and support for Japanese people with diabetes using the National Database, Ihana-Sugiyama 861–866.</p><p>Semaglutide</p><p>PIONEER REAL Japan: Baseline characteristics of a multicenter, prospective, real-world study of oral semaglutide in adults with type 2 diabetes in clinical practice in Japan, Suzuki 1047–1056.</p><p>A real-world disproportionality analysis of semaglutide: Post-marketing pharmacovigilance data, Du 1422–1433.</p><p>Adherence and treatment discontinuation of oral semaglutide and once-weekly semaglutide injection at 12 month follow-up: Japanese real-world data, Horii 1578–1584.</p><p>Semicarbazide-sensitive amine oxidase</p><p>The role of vascular adhesion protein-1 in diabetes and diabetic complications, Yen 982–989.</p><p>Serum amyloid A</p><p>Association of serum amyloid A and prognosis in people with diabetes and COVID-19: A retrospective cohort study, Qu 44–51.</p><p>Serum uric acid</p><p>Inverted U-shaped associations between serumuric acid and fasting - plasma glucose level in non-diabetic, pre-diabetic, and diabetic adults: A population-based study in China, Shi 483–490.</p><p>Severe atherothrombotic brain infarction</p><p>Factor affecting severe atherothrombotic cerebral infarction in patients with type 2 diabetes mellitus: Large-scale claim database analysis of Japan, Horii 1651–1662.</p><p>SGLT2 inhibitor</p><p>A multicenter, open-label, single-arm trial of the long-term safety of empagliflozin treatment for refractory diabetes mellitus with insulin resistance (EMPIRE-02), Hirota 1211–1219.</p><p>Multicenter, open-label, randomized controlled superiority trial for availability to reduce nocturnal urination frequency: The TOP-STAR study, Nakajima 1809–1817.</p><p>Sitagliptin phosphate</p><p>Assessment of cancer risk associated with 7-nitroso-3-(trifluoromethyl)-5,6,7,8-tetrahydro[1,2,4] triazolo-[4,3-a]pyrazine-contaminated sitagliptin use: A retrospective cohort study, Sugiyama 1556–1565.</p><p>Slowly progressive type 1 diabetes</p><p>New diagnostic criteria (2023) for slowly progressive type 1 diabetes (SPIDDM): Report from Committee on Type 1 Diabetes of the Japan Diabetes Society (English version), Shimada 254–257.</p><p>Prediction of future insulin-deficiency in glutamic acid decarboxylase autoantibody enzyme-linked immunosorbent assay-positive patients with slowly progressive type 1 diabetes, Kawasaki 835–842.</p><p>Small dense low-density lipoprotein cholesterol</p><p>Elevated small dense low-density lipoprotein cholesterol to high-density lipoprotein cholesterol ratio is associated with an increased risk of metabolic dysfunction-associated fatty liver disease in Chinese patients with type 2 diabetes mellitus, Yang 634–642.</p><p>Social deprivation</p><p>Social deprivation and diabetic kidney disease: A European view, Casey 541–556.</p><p>Socioeconomic status</p><p>Associations between income/employment status and diabetes care processes, health behaviors, and health outcomes in Japan: A cross-sectional study using claims data linked to a questionnaire survey, Yamaoka 1684–1695.</p><p>Sodium–glucose cotransporter 2 inhibitor</p><p>Effect of sodium–glucose cotransporter 2 inhibitors on serum low-density lipoprotein cholesterol in Japanese patients with type 2 diabetes mellitus, Imada 843–850.</p><p>Sodium–glucose cotransporter 2 inhibitor therapy reduces the administration frequency of steroid injection in patients with diabetic macular edema: A cohort study using the Japanese health insurance claims database, Ishibashi 1231–1238.</p><p>Sodium–glucose cotransporter 2 inhibitors</p><p>Healthcare resource utilization and healthcare costs in patients with type 2 diabetes mellitus initiating sodium-glucose cotransporter 2inhibitors vs dipeptidyl peptidase-4 inhibitors in Japan: A real-world administrative database analysis, Kashiwagi 374–387.</p><p>Small dense low-density lipoprotein cholesterol</p><p>Estimated small dense low-density lipoprotein cholesterol and nonalcoholic fatty liver disease in nonobese populations, Huang 491–499.</p><p>Long-term effects of ipragliflozin and pioglitazone on metabolic dysfunction-associated steatotic liver disease in patients with type 2 diabetes: 5 year observational follow-up of a randomized, 24 week, active-controlled trial, Ito 1220–1230.</p><p>South Africa</p><p>Investigating the altered expression of miR-486-5p and miR-novel-chr1_40444 in dysglycemia in a South African population, Weale 1377–1389.</p><p>Statin</p><p>Optimizing lipid control in Taiwanese diabetic patients: A collaborative consensus by the Diabetes Association of the Republic of China (Taiwan) and the Taiwanese Association of Diabetes Educators, Shen 1151–1160.</p><p>Steroid injection</p><p>Sodium–glucose cotransporter 2 inhibitor therapy reduces the administration frequency of steroid injection in patients with diabetic macular edema: A cohort study using the Japanese health insurance claims database, Ishibashi 1231–1238.</p><p>Steroid myopathy</p><p>Corticosteroid-triggered acute skeletal muscle loss in lipodystrophy: A case report, Sasako 782–785.</p><p>Stratification</p><p>What characteristics are most important in stratifying patients into groups with different risk of diabetic foot ulceration?, Naemi 1094–1104.</p><p>Sulfonylurea</p><p>Sulfonylurea prescription patterns in elderly patients with type 2 diabetes mellitus: A comprehensive analysis of real-world data from pharmacies in Japan, Yamazaki 1604–1613.</p><p>Survival</p><p>Impact of diabetes on the prognosis of patients with oral and oropharyngeal cancer: A meta-analysis, Xu 1140–1150.</p><p>Sympathetic skin response</p><p>Sympathetic skin response for early detection of type 2 diabetic peripheral neuropathy and nephropathy, Liu 106–112.</p><p>Systematic Coronary Risk Evaluation 2-Diabetes risk</p><p>Predictive value of Systematic Coronary Risk Evaluation 2-Diabetes risk model and arterial stiffness for cardiovascular events in the Asian population with type 2 diabetes mellitus, Suwannasom 1266–1275.</p><p>Tanshinone IIA</p><p>Tanshinone IIA suppresses ferroptosis to attenuate renal podocyte injury in diabetic nephropathy through the embryonic lethal abnormal visual-like protein 1 and acyl-coenzyme A synthetase long-chain family member 4 signaling pathway, Zhu 1003–1016.</p><p>Tehran Lipid and Glucose Study</p><p>Linking extent of return to fasting state after oral glucose tolerance test to future risk of prediabetes and type 2 diabetes: Insights from the TLGS, Masrouri 1743–1752.</p><p>Texture analysis</p><p>Microvascular permeability and texture analysis of bone marrow in diabetic rabbits with critical limb ischemia based on dynamic contrast-enhanced magnetic resonance imaging, Yang 584–593.</p><p>Tezepelumab</p><p>A case of type 2 diabetes mellitus with weight gain and worsening of glycemic management after tezepelumab administration for severe bronchial asthma, Umamoto 388–390.</p><p>Therapeutic inertia</p><p>Mandatory monthly outpatient visits could improve therapeutic inertia in patients with poorly controlled type 2 diabetes, Tsai 227–236.</p><p>The Simple Diagnostic Criteria for Diabetic Polyneuropathy</p><p>Prevalence and characteristics of diabetic symmetric sensorimotor polyneuropathy in Japanese patients with type 2 diabetes: The Japan Diabetes Complication and its Prevention Prospective study (JDCP study 10), Kamiya 247–253.</p><p>Thrombospondin-1</p><p>Relationship between elevated circulatingthrombospondin-1 levels and vascular complications in diabetes mellitus, Guo 197–207.</p><p>Relationship between circulating thrombospondin-1 messenger ribonucleic acid and microribonucleic acid-194 levels in Chinese patients with type 2 diabetic kidney disease: The outcomes of a case–control study, Ma 1248–1258.</p><p>Tolerability</p><p>Efficacy and tolerability of oral semaglutide in Japanese patients with type 2 diabetes mellitus: Analysis report from diabetes specialist clinics, Inokuchi 1202–1210.</p><p>Transition</p><p>Evaluation of the transition program at the University Hospital of Reims from 2015 to 2020, Chibane 1519–1523.</p><p>Treatment</p><p>Prevalence, awareness, treatment and control of type 2 diabetes in southeast China: A population-based study, Hu 1034–1041.</p><p>Treatment – Education</p><p>Patient-reported outcomes and treatment adherence in type 2 diabetes using natural language processing: Wave 8 of the Observational International Diabetes Management Practices Study, Chan 1306–1316.</p><p>Treatment response</p><p>Factors contributing to the clinical effectiveness of imeglimin monotherapy in Japanese patients with type 2 diabetes mellitus, Hagi 1239–1247.</p><p>Triglyceride-glucose index</p><p>Second-trimester triglyceride-glucose index to predict adverse outcomes in women with gestational diabetes mellitus: A retrospective multicenter cohort study, Bai 1489–1499.</p><p>TXNIP/NLRP3 inflammasome</p><p>Calpeptin improves the cognitive function in Alzheimer's disease-like complications of diabetes mellitus rats by regulating TXNIP/NLRP3 inflammasome, Qiao 1365–1376.</p><p>Type 1 diabetes</p><p>Interactive calculator to estimate insulin sensitivity in type 1 diabetes, Januszewski 594–597.</p><p>Global cognition and executive functions of older adults with type 1 diabetes mellitus without dementia, Nagasawa 922–930.</p><p>Evaluation of the transition program at the University Hospital of Reims from 2015 to 2020, Chibane 1519–1523.</p><p>Type 1 diabetes mellitus</p><p>Type 1 diabetes, COVID-19 vaccines and short-term safety: Subgroup analysis from the global COVAD study, Chatterjee 131–138.</p><p>Effects of hybrid closed-loop system on glycemic control and psychological aspects in persons with type 1 diabetes treated with sensor-augmented pump: A prospective single-center observational study, Akiyama 219–226.</p><p>Type 2</p><p>Prevalence, awareness, treatment and control of type 2 diabetes in southeast China: A population-based study, Hu 1034–1041.</p><p>Type 2 diabetes</p><p>Exploration of the mechanism of reinfusion of fresh autologous blood in type 2 diabetes mice to induce macrophage polarization and inhibit erythrocyte damage, Hu 70–77.</p><p>Mandatory monthly outpatient visits could improve therapeutic inertia in patients with poorly controlled type 2 diabetes, Tsai 227–236.</p><p>Changing landscape of diabetes in Asia – What are the unmet needs?, Luk 402–409.</p><p>Perspectives on genetic studies of type 2 diabetes from the genome-wide association studies era to precision medicine, Imamura 410–422.</p><p>Short-term recovery of insulin secretion in response to a meal is associated with future glycemic control in type 2 diabetes patients, Enkaku 437–448.</p><p>Coexistence of type 2 diabetes mellitus, arginine vasopressin deficiency, and Marfan syndrome: A case report, Le 964–967.</p><p>Eating behaviors and incidence of type 2 diabetes in Japanese people: The population-based Panasonic cohort study 15, Toyokuni 1017–1025.</p><p>PIONEER REAL Japan: Baseline characteristics of a multicenter, prospective, real-world study of oral semaglutide in adults with type 2 diabetes in clinical practice in Japan, Suzuki 1047–1056.</p><p>Internet of things-based approach for glycemic control in people with type 2 diabetes: A randomized controlled trial, Bouchi 1287–1296.</p><p>Patient-reported outcomes and treatment adherence in type 2 diabetes using natural language processing: Wave 8 of the Observational International Diabetes Management Practices Study, Chan 1306–1316.</p><p>A consensus statement from the Japan Diabetes Society: A proposed algorithm for pharmacotherapy in people with type 2diabetes – 2nd edition (English version), Bouchi 1326–1342.</p><p>Investigating the altered expression of miR-486-5p and miR-novel-chr1_40444 in dysglycemia in a South African population, Weale 1377–1389.</p><p>Efficacy of long-term low-carbohydrate diets for patients with type 2 diabetes: A systematic review and meta-analysis, Ichikawa 1410–1421.</p><p>Association of xanthine oxidoreductase inhibitor use with insulin secretory capacity inpatients with type 2 diabetes, Kitamura 1500–1509.</p><p>Application of the integrated data platform combined with dietary management for adults with diabetes: A prospective randomized controlled trial, Liu 1548–1555.</p><p>Safety and effectiveness of tofogliflozin in Japanese people with type 2 diabetes: A multicenter prospective observational study in routine clinical practice, Yamada 1585–1595.</p><p>Sodium–glucose cotransporter 2 inhibition through henagliflozin ameliorates cognitive impairment in patients with type 2 diabetes, Zhang 1596–1603.</p><p>Factor affecting severe atherothrombotic cerebral infarction in patients with type 2 diabetes mellitus: Large-scale claim database analysis of Japan, Horii 1651–1662.</p><p>Haptoglobin phenotype and levels in type 2 diabetes and effects of fenofibrate, Januszewski 1663–1668.</p><p>Type 2 diabetes mellitus</p><p>Oxidative stress suppresses PHB2-mediated mitophagy in β-cells via the Nrf2/PHB2 pathway, Liu 559–571.</p><p>The correlation between serum asprosin and left ventricular diastolic dysfunction in elderly patients with type 2 diabetes mellitus in the community, Liang 608–613.</p><p>Elevated small dense low-density lipoprotein cholesterol to high-density lipoprotein cholesterol ratio is associated with an increased risk of metabolic dysfunction-associated fatty liver disease in Chinese patients with type 2 diabetes mellitus, Yang 634–642.</p><p>High glucose promotes atherosclerosis by regulating miRNA let7d-5p level, Wang 711–724.</p><p>Effect of sodium–glucose cotransporter 2 inhibitors on serum low-density lipoprotein cholesterol in Japanese patients with type 2diabetes mellitus, Imada 843–850.</p><p>Serum vitamin D is substantially reduced and predicts flares in diabetic retinopathy patients, Zhuang 867–873.</p><p>Association between glycated hemoglobin and risk of all-cause mortality in community patients with type 2 diabetes: A prospective cohort study, He 939–945.</p><p>Influence of disease course and comprehensive management on blood glucose level in children and adolescents with type 2 diabetes mellitus, Wu 1026–1033.</p><p>Factors contributing to the clinical effectiveness of imeglimin monotherapy in Japanese patients with type 2 diabetes mellitus, Hagi 1239–1247.</p><p>Risk stratification for cardiovascular disease based on prior coronary artery disease, cerebrovascular disease and type 2 diabetes mellitus, Oe 1464–1471.</p><p>Linking extent of return to fasting state after oral glucose tolerance test to future risk of prediabetes and type 2 diabetes: Insights from the TLGS, Masrouri 1743–1752.</p><p>Metabolic dysfunction-associated steatotic liver disease: A superior predictor for incident type 2 diabetes over traditional criteria – NAGALA study, Sakai 1788–1796.</p><p>Type 2 diabetes susceptibility genes</p><p>Interaction effect between low birthweight and resistin gene rs1862513 variant on insulin resistance and type 2 diabetes mellitus in adulthood: Toon Genome Study, Yoshida 725–735.</p><p>Update</p><p>Effectiveness and safety of sodium–glucose cotransporter 2 inhibitors in Asian populations, Ha 285–287.</p><p>Interplay of cardiovascular health and diabetes: Insights into weight management and risk reduction, Hsu 707–710.</p><p>Advances in diagnostic methods for early-stage diabetic polyneuropathy, Naruse 820–822.</p><p>An update of contemporary insulin therapy, Tsai 1000–1002.</p><p>Clinical lessons for diabetes treatment from the COVID-19 pandemic, Hamamoto 1363–1364.</p><p>Clinical challenges in early pregnancy in Japan: An update on gestational diabetes, Sugiyama 1729–1731.</p><p>Uric acid</p><p>Association between serum uric acid-to-high-density lipoprotein cholesterol ratio and insulin resistance in patients with type 2 diabetes mellitus, Zhou 113–120.</p><p>Association between serum uric acid-to-high-density lipoprotein cholesterol ratio and insulin resistance in an American population: A population-based analysis, Zhou 762–771.</p><p>Uric acid-to-high-density lipoprotein cholesterol ratio</p><p>Association between serum uric acid-to-high-density lipoprotein cholesterol ratio and insulin resistance in patients with type 2 diabetes mellitus, Zhou 113–120.</p><p>Urinary myo-inositol</p><p>Characteristics of individuals who developed type 2 diabetes from prediabetes despite undergoing interventions, and evaluation of the performance of urinary myo-inositol as a risk factor for developing diabetes, Yamagata 177–185.</p><p>Vaccine</p><p>Type 1 diabetes, COVID-19 vaccines and short-term safety: Subgroup analysis from the global COVAD study, Chatterjee 131–138.</p><p>Variation in hemoglobin A1c</p><p>Association between variation in hemoglobin A1c levels and diabetes therapy-related quality of life in patients with diabetes, Imai 1042–1046.</p><p>Vascular adhesion protein-1</p><p>The role of vascular adhesion protein-1 in diabetes and diabetic complications, Yen 982–989.</p><p>Visceral fat area</p><p>Coexistence of high visceral fat area and sarcopenia is associated with atherosclerotic markers in old-old patients with diabetes: A cross-sectional study, Sato 1510–1518.</p><p>Vitamin D</p><p>Serum vitamin D is substantially reduced and predicts flares in diabetic retinopathy patients, Zhuang 867–873.</p><p>Waist circumference</p><p>The impact of handgrip strength and waist circumference on glycemic control: Prospective, observational study using outpatient clinical data in Japanese patients with type 2 diabetes mellitus, Nakanishi 892–898.</p><p>Weight loss</p><p>Safety and effectiveness of tofogliflozin in Japanese people with type 2 diabetes: A multicenter prospective observational study in routine clinical practice, Yamada 1585–1595.</p><p>Weight reduction</p><p>Effect of intermittent fasting 16:8 and 14:10 compared with control-group on weight reduction and metabolic outcomes in obesity with type 2 diabetes patients: A randomized controlled trial, Sukkriang 1297–1305.</p><p>Wound healing</p><p>MiR-488-3p facilitates wound healing throughCYP1B1-mediated Wnt/β-catenin signaling pathway by targeting MeCP2, Zuo 145–158.</p><p>XOR inhibitor</p><p>Association of xanthine oxidoreductase inhibitor use with insulin secretory capacity inpatients with type 2 diabetes, Kitamura 1500–1509.</p><p>Young-onset diabetes</p><p>Changing landscape of diabetes in Asia – What are the unmet needs?, Luk 402–409.</p><p>Young-onset type 2 diabetes mellitus enhances proteinuria, but not glomerular filtration rate decline: A Japanese cohort study, Saito 1444–1456.</p>","PeriodicalId":51250,"journal":{"name":"Journal of Diabetes Investigation","volume":"15 12","pages":"1841-1861"},"PeriodicalIF":3.1000,"publicationDate":"2024-12-04","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://onlinelibrary.wiley.com/doi/epdf/10.1111/jdi.14374","citationCount":"0","resultStr":"{\"title\":\"Volume 15\",\"authors\":\"\",\"doi\":\"10.1111/jdi.14374\",\"DOIUrl\":null,\"url\":null,\"abstract\":\"<p>50-g Oral glucose challenge test</p><p>Problems in screening for gestational diabetes mellitus by measurement of casual blood glucose levels at 24–28 gestational weeks, Tomimoto 1797–1802.</p><p>β-Cell dysfunction</p><p>Glucose metabolism partially regulates β-cell function through epigenomic changes, Kim 649–655.</p><p>β-Cells</p><p>Role of β-cell autophagy in β-cell physiology and the development of diabetes, Yasasilka 656–668.</p><p>β-Cell mass</p><p>Effects of glucokinase haploinsufficiency on the pancreatic β-cell mass and function of long-term high-fat, high-sucrose diet-fed mice, Shigesawa 1732–1742.</p><p>Accuracy</p><p>Impact of hematocrit levels on the accuracy of specific blood glucose meters: A hospital-based study, Pham 1472–1482.</p><p>Acyl-coenzyme A synthetase long-chain family member 4</p><p>Tanshinone IIA suppresses ferroptosis to attenuate renal podocyte injury in diabetic nephropathy through the embryonic lethal abnormal visual-like protein 1 and acyl-coenzyme A synthetase long-chain family member 4 signaling pathway, Zhu 1003–1016.</p><p>Adherence</p><p>Modification effect of receipt of diabetes care on the association between COVID-19 infection and HbA1c level during the first year of the coronavirus pandemic using a nationwide population-based database, Okada 953–963.</p><p>Prevalence of adherence to oral antidiabetic drugs in patients with type 2 diabetes: A systematic review and meta-analysis, Boonpattharatthiti 1614–1625.</p><p>Aging</p><p>Association of biomarkers and Barthel Index with occurrence of age-related adverse health outcomes in individuals with diabetes, Umamoto 1675–1683.</p><p>Alcohol drinking</p><p>The association between alcohol drinking and glycemic management among people with type 2 diabetes in China, Ye 237–244.</p><p>Aldehyde dehydrogenase 2</p><p>Mitochondrial ALDH2 improves β-cell survival and function against doxorubicin-induced apoptosis by targeting CK2 signaling, Karunakaran 684–692.</p><p>Algorithm</p><p>A consensus statement from the Japan Diabetes Society: A proposed algorithm for pharmacotherapy in people with type 2 diabetes—2nd edition (English version), Bouchi 1326–1342.</p><p>Alzheimer's disease-like complications of DM</p><p>Calpeptin improves the cognitive function in Alzheimer's disease-like complications of diabetes mellitus rats by regulating TXNIP/NLRP3 inflammasome, Qiao 1365–1376.</p><p>Angiopoietin-like 4</p><p>Angiopoietin-like 4 is a potential biomarker for diabetic kidney disease in type 2 diabetes patients, Wang 1763–1772.</p><p>Antidiabetic drugs</p><p>Cancer biology in diabetes update: Focusing on antidiabetic drugs, Kawakita 525–540.</p><p>Pancreatic beta-cell mass and function and therapeutic implications of using antidiabetic medications in type 2 diabetes, Moon 669–683.</p><p>Anti-inflammatory activity</p><p>High-density lipoprotein in diabetes: Structural and functional relevance, Lui 805–816.</p><p>Anti-oxidative activity</p><p>High-density lipoprotein in diabetes: Structural and functional relevance, Lui 805–816.</p><p>Area under the C-peptide curve</p><p>Association between area under the C-peptide curve during an oral glucose tolerance test and diabetic retinopathy in type 2 diabetes patients, Zhang 315–325.</p><p>Arginine vasopressin deficiency</p><p>Coexistence of type 2 diabetes mellitus, arginine vasopressin deficiency, and Marfan syndrome: A case report, Le 964–967.</p><p>Arterial stiffness</p><p>Association between glycemia risk index and arterial stiffness in type 2 diabetes, Cai 614–622.</p><p>Asia</p><p>Changing landscape of diabetes in Asia – What are the unmet needs?, Luk 402–409.</p><p>Aspirin</p><p>Low-dose aspirin for prevention of cardiovascular mortality in patients with type 2 diabetes and chronic kidney disease: A real-world nationwide cohort study, Lin 459–467.</p><p>Asprosin</p><p>The correlation between serum asprosin and left ventricular diastolic dysfunction in elderly patients with type 2 diabetes mellitus in the community, Liang 608–613.</p><p>Association analysis between serum asprosin and metabolic characteristics, Complications in type 2 diabetic patients with different durations, Ma 1781–1787.</p><p>Asthma</p><p>A case of type 2 diabetes mellitus with weight gain and worsening of glycemic management after tezepelumab administration for severe bronchial asthma, Umamoto 388–390.</p><p>Atherosclerosis</p><p>High glucose promotes atherosclerosis by regulating miRNA let7d-5p level, Wang 711–724.</p><p>Coexistence of high visceral fat area and sarcopenia is associated with atherosclerotic markers in old-old patients with diabetes: A cross-sectional study, Sato 1510–1518.</p><p>Autoimmunity</p><p>Diabetes treatment by conversion of gut epithelial cells to insulin-producing cells, Accili 797–804.</p><p>Autophagy</p><p>Role of β-cell autophagy in β-cell physiology and the development of diabetes, Yasasilka 656–668.</p><p>Average age at death</p><p>Causes of death in Japanese patients with diabetes based on the results of a survey of 68,555 cases during 2011–2020: Committee report on causes of death in diabetes mellitus, Japan Diabetes Society (English version), Nakamura 1821–1837.</p><p>Average real variability</p><p>Prognostic value of longitudinal HbA1c variability in predicting the development of diabetic sensorimotor polyneuropathy among patients with type 2 diabetes mellitus: A prospective cohort observational study, Lai 326–335.</p><p>Behavioral change</p><p>Internet of things-based approach for glycemic control in people with type 2 diabetes: A randomized controlled trial, Bouchi 1287–1296.</p><p>Beta-cell function</p><p>Association between area under the C-peptide curve during an oral glucose tolerance test and diabetic retinopathy in type 2 diabetes patients, Zhang 315–325.</p><p>Bioinformatics</p><p>Identification and validation of voltage-dependent anion channel 1-related genes and immune cell infiltration in diabetic nephropathy, Lin 87–105.</p><p>Bioinformatics analysis</p><p>Immunoglobulin heavy constant gamma 1 silencing decreases tonicity-responsive enhancer-binding protein expression to alleviate diabetic nephropathy, Hu 572–583.</p><p>Biomarker</p><p>Association of biomarkers and Barthel Index with occurrence of age-related adverse health outcomes in individuals with diabetes, Umamoto 1675–1683.</p><p>Biomarkers</p><p>The role of lipid dysregulation in gestational diabetes mellitus: Early prediction and postpartum prognosis, Zhang 15–25.</p><p>Identification and validation of voltage-dependent anion channel 1-related genes and immune cell infiltration in diabetic nephropathy, Lin 87–105.</p><p>Birth weight</p><p>Maternal birth weight as an indicator of early and late gestational diabetes mellitus: The Japan Environment and Children's Study, Tagami 751–761.</p><p>Association between infant birth weight and gestational weight gain in Japanese women with diabetes mellitus, Fujikawa Shingu 906–913.</p><p>Blind</p><p>Characterization of the visually impaired patients with diabetes mellitus in Japan, Sugihara 882–891.</p><p>Blood glucose</p><p>Delayed dinnertime impairs glucose tolerance in healthy young adults, Nakamura 172–176.</p><p>Effects of hybrid closed-loop system on glycemic control and psychological aspects in persons with type 1 diabetes treated with sensor-augmented pump: A prospective single-center observational study, Akiyama 219–226.</p><p>A novel predictive model for optimizing diabetes screening in older adults, Lin 1403–1409.</p><p>Blood glucose monitors</p><p>Impact of hematocrit levels on the accuracy of specific blood glucose meters: A hospital-based study, Pham 1472–1482.</p><p>Body composition</p><p>Body composition and risk of gestational diabetes mellitus: A univariable and multivariable Mendelian randomization study, Gao 346–354.</p><p>Body mass index</p><p>Eating behaviors and incidence of type 2 diabetes in Japanese people: The population-based Panasonic cohort study 15, Toyokuni 1017–1025.</p><p>Calpain-2</p><p>Calpeptin improves the cognitive function in Alzheimer's disease-like complications of diabetes mellitus rats by regulating TXNIP/NLRP3 inflammasome, Qiao 1365–1376.</p><p>Cancer</p><p>Cancer biology in diabetes update: Focusing on antidiabetic drugs, Kawakita 525–540.</p><p>Cardio-ankle vascular index</p><p>Systematic Coronary Risk Evaluation 2-Diabetes risk.</p><p>Predictive value of Systematic Coronary Risk Evaluation 2-Diabetes risk model and arterial stiffness for cardiovascular events in the Asian population with type 2 diabetes mellitus, Suwannasom 1266–1275.</p><p>Cardiovascular autonomic neuropathy</p><p>Improvement of heart rate variability after metabolic bariatric surgery in Korean subjects with obesity, Jang 1773–1780.</p><p>Cardiovascular disease</p><p>Health impacts of new-onset diabetes in women post-gestational diabetes mellitus: Insights from Hong Kong's territory-wide data, Zhang 772–781.</p><p>Associations of fasting plasma glucose with all-cause mortality and cardiovascular events in older Chinese diabetes patients: A population-based cohort study, Wang 1129–1139.</p><p>Interpretable machine learning models based on shear-wave elastography radiomics for predicting cardiovascular disease in diabetic kidney disease patients, Dai 1637–1650.</p><p>Cardiovascular diseases</p><p>Risk stratification for cardiovascular disease based on prior coronary artery disease, cerebrovascular disease and type 2 diabetes mellitus, Oe 1464–1471.</p><p>Casual blood glucose</p><p>Problems in screening for gestational diabetes mellitus by measurement of casual blood glucose levels at 24–28 gestational weeks, Tomimoto 1797–1802.</p><p>Cause of death</p><p>Causes of death in Japanese patients with diabetes based on the results of a survey of 68,555 cases during 2011–2020: Committee report on causes of death in diabetes mellitus, Japan Diabetes Society (English version), Nakamura 1821–1837.</p><p>CCP</p><p><i>Cordyceps cicadae</i> polysaccharides attenuate diabetic nephropathy via the miR-30a-3p/TRIM16 axis, Zheng 300–314.</p><p>Cell encapsulation</p><p>Long-term efficacy of encapsulated xenogeneic islet transplantation: Impact of encapsulation techniques and donor genetic traits, Park 693–703.</p><p>Cesarean</p><p>Post-load glucose is a stronger predictor of adverse pregnancy outcomes than first-trimester HbA1c in women without gestational diabetes, Rajabi 914–921.</p><p>Children</p><p>Influence of disease course and comprehensive management on blood glucose level in children and adolescents with type 2 diabetes mellitus, Wu 1026–1033.</p><p>Children and adolescents</p><p>Clinical significance of coefficient of variation in continuous glucose monitoring for glycemic management in children and adolescents with type 1 diabetes, Urakami 1669–1674.</p><p>China</p><p>Type 1 and type 2 diabetes mortality burden: Predictions for 2030 based on Bayesian age-period-cohort analysis of China and global mortality burden from 1990 to 2019, Dong 623–633.</p><p>Chinese Han population</p><p>Association of RPS26 gene polymorphism with different types of diabetes in Chinese individuals, Song 34–43.</p><p>Cholesterol efflux</p><p>High-density lipoprotein in diabetes: Structural and functional relevance, Lui 805–816.</p><p>Chorea</p><p>Diabetic striatopathy: Hyperglycemic chorea/ballism successfully treated with L-dopa, Tsukaguchi 1524–1527.</p><p>Chronic kidney disease</p><p>Low-dose aspirin for prevention of cardiovascular mortality in patients with type 2 diabetes and chronic kidney disease: A real-world nationwide cohort study, Lin 459–467.</p><p>Chronic kidney disease progression</p><p>Risk factors for chronic kidney disease progression over 20 years for primary prevention in Japanese individuals at a preventive medicine research center: Focus on the influence of plasma glucose levels, Minami 1434–1443.</p><p>Circ_0068087</p><p>Circ_0068087 knockdown attenuates high-glucose-induced human tubular epithelial cell injury in a microribonucleic acid/progestin and adipoQ receptor 3-dependent manner in diabetic nephropathy, Liu 159–171.</p><p>Claims analysis</p><p>Associations between income/employment status and diabetes care processes, health behaviors, and health outcomes in Japan: A cross-sectional study using claims data linked to a questionnaire survey, Yamaoka 1684–1695.</p><p>Claims data</p><p>Implementation rate of diabetic self-management education and support for Japanese people with diabetes using the National Database, Ihana-Sugiyama 861–866.</p><p>Clinical</p><p>Patient-reported outcomes and treatment adherence in type 2 diabetes using natural language processing: Wave 8 of the Observational International Diabetes Management Practices Study, Chan 1306–1316.</p><p>Clinical epidemiology</p><p>Modification effect of receipt of diabetes care on the association between COVID-19 infection and HbA1c level during the first year of the coronavirus pandemic using a nationwide population-based database, Okada 953–963.</p><p>Clopidogrel</p><p>Recurrent hypoglycemia induced by clopidogrel: A case report and mini review, Du 275–281.</p><p>Coefficient of variation</p><p>Clinical significance of coefficient of variation in continuous glucose monitoring for glycemic management in children and adolescents with type 1 diabetes, Urakami 1669–1674.</p><p>Coefficient of variation of R-R intervals</p><p>Simplified electrophysiological approach combining a point-of-care nerve conduction device and an electrocardiogram produces an accurate diagnosis of diabetic polyneuropathy, Hayashi 736–742.</p><p>Cognition</p><p>Global cognition and executive functions of older adults with type 1 diabetes mellitus without dementia, Nagasawa 922–930.</p><p>Cognitive impairment</p><p>Sodium–glucose cotransporter 2 inhibition through henagliflozin ameliorates cognitive impairment in patients with type 2 diabetes, Zhang 1596–1603.</p><p>Cohort study</p><p>Maternal birth weight as an indicator of early and late gestational diabetes mellitus: The Japan Environment and Children's Study, Tagami 751–761.</p><p>Remnant cholesterol, but not other traditional lipids or lipid ratios, is independently and positively related to future diabetes risk in Chinese general population: A 3 year cohort study, Li 1084–1093.</p><p>Combined approaches</p><p>Targeting PI3K/AKT and MEK/ERK pathways for synergic effects on improving features of peripheral diabetic neuropathy, Pham 1537–1544.</p><p>Commentary</p><p>Long-term safety and efficacy of SGLT2 inhibitor use in older east Asians with type 2 diabetes, Takahashi 63–66.</p><p>Pituitary gland agouti-related peptide cells: Novel player controlling glucose metabolism, Takahashi 67–69.</p><p>Dipeptidyl peptidase-4 inhibition targeting vascular senescence as a novel treatment for atherosclerosis, Yen 143–144.</p><p>Glucose-dependent insulinotropic polypeptide receptor systems in the hypothalamus and the brainstem regulate feeding and weight through distinct pathways, Yada 283–284.</p><p>Advancements and challenges in pancreatic islet transplantation: Insights from the Collaborative Islet Transplant Registry, Lee 423–425.</p><p>Deciphering the causal tapestry between cardiorespiratory fitness and type 2 diabetes mellitus, Ko 426–428.</p><p>Birthweight and risk of diabetes in later life, Sheu 557–558.</p><p>Effects of dipeptidyl peptidase-4 inhibition <i>in vivo</i>: Dipeptidyl peptidase-4 inhibitor/gut microbiome crosstalk suggests novel therapeutic options for diabetes management, Yasuda 704–706.</p><p>Gut microbiota dysbiosis as a novel pathogenic factor of diabetic peripheral neuropathy, Niimi 817–819.</p><p>Commentary on association of glycemic index and glycemic load with type 2 diabetes, cardiovascular disease, cancer, and all-cause mortality, Hsieh 1545–1547.</p><p>Regulation of glucose and energy metabolism through actions of glucagon-like peptide-1 and glucose-dependent insulinotropic polypeptide, Zenimaru 1725–1726.</p><p>Commentary on “Intra-islet a-cell Gs signaling promotes glucagon release”, Kitamura 1727–1728.</p><p>Complications of diabetes</p><p>Glycemic variability: Measurement, target, impact on complications of diabetes and does it really matter? Mo 5–14.</p><p>Continuous glucose monitoring</p><p>Glycemic variability: Measurement, target, impact on complications of diabetes and does it really matter? Mo 5–14.</p><p>Comparative effects of fixed-dose mitiglinide/voglibose combination and glimepiride on vascular endothelial function and glycemic variability in patients with type 2 diabetes: A randomized controlled trial, Tanaka 449–458.</p><p>Association between glycemia risk index and arterial stiffness in type 2 diabetes, Cai 614–622.</p><p>Glycemic variability is associated with sural nerve conduction velocity in outpatients with type 2 diabetes: Usefulness of a new point-of-care device for nerve conduction studies, Morita 1075–1083.</p><p>Possible etiological role of impaired endogenous double strand RNA editing in β-cells in type 1 diabetes, Imai 1171–1173.</p><p>A sneak peek into chronic glucose exposure and insulin secretion impairment through translatome, Helena 1174–1176.</p><p>Clinical significance of coefficient of variation in continuous glucose monitoring for glycemic management in children and adolescents with type 1 diabetes, Urakami 1669–1674.</p><p>Theragnostic utility of continuous glucose monitoring in post-gastrectomy hypoglycemia, Son 1696–1699.</p><p>Continuous subcutaneous insulin infusion</p><p>Fulminant type 1 diabetes, an underrecognized and unique subtype of type 1 diabetes: A case series from Singapore, Tan 786–789.</p><p>Corneal confocal microscopy</p><p>Circulating netrin-1 levels are reduced and related to corneal nerve fiber loss in patients with diabetic neuropathy, Mondal 1068–1074.</p><p>Cortisol</p><p>An exploratory study of factors in disordered eating behavior in diabetes self-management in Japan, Tsukamoto-Kawashima 874–881.</p><p>COVID-19</p><p>Association of serum amyloid A and prognosis in people with diabetes and COVID-19: A retrospective cohort study, Qu 44–51.</p><p>Type 1 diabetes, COVID-19 vaccines and short-term safety: Subgroup analysis from the global COVAD study, Chatterjee 131–138.</p><p>Modification effect of receipt of diabetes care on the association between COVID-19 infection and HbA1c level during the first year of the coronavirus pandemic using a nationwide population-based database, Okada 953–963.</p><p>COVID-19 pandemic</p><p>Comparing the screening methods for gestational diabetes mellitus before and during the COVID-19 pandemic: A systematic review, Sun 500–516.</p><p>C-peptide index</p><p>Short-term recovery of insulin secretion in response to a meal is associated with future glycemic control in type 2 diabetes patients, Enkaku 437–448.</p><p>Comparison of efficacy and safety of insulin degludec/liraglutide and insulin glargine U-100/lixisenatide in individuals with type 2 diabetes mellitus using professional continuous glucose monitoring, Kawaguchi 598–607.</p><p>Critically ill</p><p>Between blood glucose and mortality in critically ill patients: Retrospective analysis of the MIMIC-IV database, Li 931–938.</p><p>Cross-sectional studies</p><p>Association between gastrointestinal symptoms and insomnia in patients with type 2 diabetes: The KAMOGAWA-DM cohort study, Minamida 946–952.</p><p>Cross-sectional study</p><p>Relationship between diabetes treatment status and occupational accidents, Ogasawara 899–905.</p><p>CYP1B1</p><p>MiR-488-3p facilitates wound healing throughCYP1B1-mediated Wnt/β-catenin signaling pathway by targeting MeCP2, Zuo 145–158.</p><p>Cystatin C</p><p>Causal association between cystatin C and diabetic retinopathy: A two-sample Mendelian randomization study, Ruan 1626–1636.</p><p>Diabetes</p><p>Association of serum amyloid A and prognosis in people with diabetes and COVID-19: A retrospective cohort study, Qu 44–51.</p><p>Overnutrition in the early postnatal period influences lifetime metabolic risk: Evidence for impact on pancreatic β-cell mass and function, Burton 263–274.</p><p>Low-dose aspirin for prevention of cardiovascular mortality in patients with type 2 diabetes and chronic kidney disease: A real-world nationwide cohort study, Lin 459–467.</p><p>Inverted U-shaped associations between serumuric acid and fasting - plasma glucose level in non-diabetic, pre-diabetic, and diabetic adults: A population-based study in China, Shi 483–490.</p><p>Cancer biology in diabetes update: Focusing on antidiabetic drugs, Kawakita 525–540.</p><p>Type 1 and type 2 diabetes mortality burden: Predictions for 2030 based on Bayesian age-period-cohort analysis of China and global mortality burden from 1990 to 2019, Dong 623–633.</p><p>Performance of different machine learning algorithms in identifying undiagnosed diabetes based on nonlaboratory parameters and the influence of muscle strength: A cross-sectional study, Xu 743–750.</p><p>Diabetes treatment by conversion of gut epithelial cells to insulin-producing cells, Accili 797–804.</p><p>Relationship between diabetes treatment status and occupational accidents, Ogasawara 899–905.</p><p>Prevalence, awareness, treatment and control of type 2 diabetes in southeast China: A population-based study, Hu 1034–1041.</p><p>Remnant cholesterol, but not other traditional lipids or lipid ratios, is independently and positively related to future diabetes risk in Chinese general population: A 3 year cohort study, Li 1084–1093.</p><p>Impact of diabetes on the prognosis of patients with oral and oropharyngeal cancer: A meta-analysis, Xu 1140–1150.</p><p>Optimizing lipid control in Taiwanese diabetic patients: A collaborative consensus by the Diabetes Association of the Republic of China (Taiwan) and the Taiwanese Association of Diabetes Educators, Shen 1151–1160.</p><p>Prevalence of adherence to oral antidiabetic drugs in patients with type 2 diabetes: A systematic review and meta-analysis, Boonpattharatthiti 1614–1625.</p><p>Association of biomarkers and Barthel Index with occurrence of age-related adverse health outcomes in individuals with diabetes, Umamoto 1675–1683.</p><p>Diabetes complications</p><p>Relationship between elevated circulating thrombospondin-1 levels and vascular complications in diabetes mellitus, Guo 197–207.</p><p>Sheffield One-Stop Service: A potential model to improve the screening uptake of diabetic peripheral neuropathy and other microvascular complications of diabetes, Sloan 1355–1362.</p><p>Diabetes duration</p><p>Association analysis between serum asprosin and metabolic characteristics, Complications in type 2 diabetic patients with different durations, Ma 1781–1787.</p><p>Diabetes mellitus</p><p>Association of RPS26 gene polymorphism with different types of diabetes in Chinese individuals, Song 34–43.</p><p>Relationship between elevated circulating thrombospondin-1 levels and vascular complications in diabetes mellitus, Guo 197–207.</p><p>Development and validation of a prediction model for self-reported hypoglycemia risk in patients with type 2 diabetes: A longitudinal cohort study, Xu 468–482.</p><p>Social deprivation and diabetic kidney disease: A European view, Casey 541–556.</p><p>Improvements of myocardial strain and work in diabetes patients with normal ejection fraction after empagliflozin treatment, Cheng 851–860.</p><p>Association between infant birth weight and gestational weight gain in Japanese women with diabetes mellitus, Fujikawa Shingu 906–913.</p><p>Association between gastrointestinal symptoms and insomnia in patients with type 2 diabetes: The KAMOGAWA-DM cohort study, Minamida 946–952.</p><p>Association between variation in hemoglobin A1c levels and diabetes therapy-related quality of life in patients with diabetes, Imai 1042–1046.</p><p>Medical database analysis of the association between kidney function and achievement of glycemic control in older Japanese adults with type 2 diabetes who started with oral antidiabetic drugs, Suzuki 1057–1067.</p><p>Postpartum life interventions to prevent type 2 diabetes in women with gestational diabetes: A systematic review and meta-analysis, Wang 1115–1128.</p><p>Predictive value of Systematic Coronary Risk Evaluation 2-Diabetes risk model and arterial stiffness for cardiovascular events in the Asian population with type 2 diabetes mellitus, Suwannasom 1266–1275.</p><p>A novel predictive model for optimizing diabetes screening in older adults, Lin 1403–1409.</p><p>A real-world disproportionality analysis of semaglutide: Post-marketing pharmacovigilance data, Du 1422–1433.</p><p>Neonatal diabetes mellitus around the world: Update 2024, Barbetti 1711–1724.</p><p>Diabetes mellitus type 1</p><p>Islet transplantation in Korea, Lee 1165–1170.</p><p>Diabetes mellitus, type 2</p><p>Decline in measured glomerular filtration rate is associated with simple renal cyst in Chinese patients with type 2 diabetes, Qiaoling 26–33.</p><p>Resistant starch and type 2 diabetes mellitus: Clinical perspective, Kim 395–401.</p><p>PIONEER REAL Japan: Primary results from a multicenter, prospective, real-world study of oral semaglutide in adults with type 2 diabetes in Japanese clinical practice, Yabe 1566–1577.</p><p>Diabetes patient</p><p>Associations of fasting plasma glucose with all-cause mortality and cardiovascular events in older Chinese diabetes patients: A population-based cohort study, Wang 1129–1139.</p><p>Diabetes therapy-related quality of life</p><p>Association between variation in hemoglobin A1c levels and diabetes therapy-related quality of life in patients with diabetes, Imai 1042–1046.</p><p>Diabetic cardiomyopathy</p><p><i>Polygonatum sibiricum</i> (Huang Jing) polysaccharide reduces diabetic cardiomyopathy through increasing cyclic guanosine monophosphate-protein kinase G signaling in diabetic mice, Lei 823–834.</p><p>Regulatory T cells protect against diabetic cardiomyopathy in <i>db/db</i> mice, Zhang 1191–1201.</p><p>Diabetic complications</p><p>The role of vascular adhesion protein-1 in diabetes and diabetic complications, Yen 982–989.</p><p>Diabetic education</p><p>Implementation rate of diabetic self-management education and support for Japanese people with diabetes using the National Database, Ihana-Sugiyama 861–866.</p><p>Diabetic foot</p><p>What characteristics are most important in stratifying patients into groups with different risk of diabetic foot ulceration?, Naemi 1094–1104.</p><p>Cardiac electrophysiology, structure and diastolic function in patients with diabetic foot versus those without diabetic foot, Bai 1276–1286.</p><p>Diabetic foot ulcer recurrence</p><p>Plantar pressure measurement in diabetic foot disease: A scoping review, Lockhart 990–999.</p><p>Diabetic ketoacidosis</p><p>Fulminant type 1 diabetes, an underrecognized and unique subtype of type 1 diabetes: A case series from Singapore, Tan 786–789.</p><p>Diabetic kidney disease</p><p>Social deprivation and diabetic kidney disease: A European view, Casey 541–556.</p><p>Nutrient quality in dietary therapy for diabetes and diabetic kidney disease, Tsuruta 973–981.</p><p>Relationship between circulating thrombospondin-1 messenger ribonucleic acid and microribonucleic acid-194 levels in Chinese patients with type 2 diabetic kidney disease: The outcomes of a case–control study, Ma 1248–1258.</p><p>Young-onset type 2 diabetes mellitus enhances proteinuria, but not glomerular filtration rate decline: A Japanese cohort study, Saito 1444–1456.</p><p>Interpretable machine learning models based on shear-wave elastography radiomics for predicting cardiovascular disease in diabetic kidney disease patients, Dai 1637–1650.</p><p>Angiopoietin-like 4 is a potential biomarker for diabetic kidney disease in type 2 diabetes patients, Wang 1763–1772.</p><p>Diabetic macular edema</p><p>Sodium–glucose cotransporter 2 inhibitor therapy reduces the administration frequency of steroid injection in patients with diabetic macular edema: A cohort study using the Japanese health insurance claims database, Ishibashi 1231–1238.</p><p>Diabetic nephropathy</p><p>Identification and validation of voltage-dependent anion channel 1-related genes and immune cell infiltration in diabetic nephropathy, Lin 87–105.</p><p>Sympathetic skin response for early detection of type 2 diabetic peripheral neuropathy and nephropathy, Liu 106–112.</p><p>Circ_0068087 knockdown attenuates high-glucose-induced human tubular epithelial cell injury in a microribonucleic acid/progestin and adipoQ receptor 3-dependent manner in diabetic nephropathy, Liu 159–171.</p><p>METTL3/YTHDF2 m6A axis mediates the progression of diabetic nephropathy through epigenetically suppressing PINK1 and mitophagy, Wang 288–299.</p><p><i>Cordyceps cicadae</i> polysaccharides attenuate diabetic nephropathy via the miR-30a-3p/TRIM16 axis, Zheng 300–314.</p><p>Immunoglobulin heavy constant gamma 1 silencing decreases tonicity-responsive enhancer-binding protein expression to alleviate diabetic nephropathy, Hu 572–583.</p><p>Diabetic neuropathy</p><p>Circulating netrin-1 levels are reduced and related to corneal nerve fiber loss in patients with diabetic neuropathy, Mondal 1068–1074.</p><p>Diminished levels of insulin-like growth factor-1 may be a risk factor for peripheral neuropathy in type 2 diabetes patients, Zhong 1259–1265.</p><p>Sheffield One-Stop Service: A potential model to improve the screening uptake of diabetic peripheral neuropathy and other microvascular complications of diabetes, Sloan 1355–1362.</p><p>Targeting PI3K/AKT and MEK/ERK pathways for synergic effects on improving features of peripheral diabetic neuropathy, Pham 1537–1544.</p><p>Diabetic peripheral neuropathy</p><p>Identification and validation of voltage-dependent anion channel 1-related genes and immune cell infiltration in diabetic nephropathy, Lin 87–105.</p><p>Sympathetic skin response for early detection of type 2 diabetic peripheral neuropathy and nephropathy, Liu 106–112.</p><p>Diabetic polyneuropathies</p><p>Simplified electrophysiological approach combining a point-of-care nerve conduction device and an electrocardiogram produces an accurate diagnosis of diabetic polyneuropathy, Hayashi 736–742.</p><p>Diabetic retinopathy</p><p>Association between area under the C-peptide curve during an oral glucose tolerance test and diabetic retinopathy in type 2 diabetes patients, Zhang 315–325.</p><p>Serum vitamin D is substantially reduced and predicts flares in diabetic retinopathy patients, Zhuang 867–873.</p><p>Characterization of the visually impaired patients with diabetes mellitus in Japan, Sugihara 882–891.</p><p>Causal association between cystatin C and diabetic retinopathy: A two-sample Mendelian randomization study, Ruan 1626–1636.</p><p>Diabetic striatopathy</p><p>Diabetic striatopathy: Hyperglycemic chorea/ballism successfully treated with L-dopa, Tsukaguchi 1524–1527.</p><p>Diabetics with critical limb ischemia</p><p>Microvascular permeability and texture analysis of bone marrow in diabetic rabbits with critical limb ischemia based on dynamic contrast-enhanced magnetic resonance imaging, Yang 584–593.</p><p>Diabetic symmetric sensorimotor polyneuropathy</p><p>Prevalence and characteristics of diabetic symmetric sensorimotor polyneuropathy in Japanese patients with type 2 diabetes: The Japan Diabetes Complication and its Prevention Prospective study (JDCP study 10), Kamiya 247–253</p><p>Diet</p><p>Resistant starch and type 2 diabetes mellitus: Clinical perspective, Kim 395–401.</p><p>Dietary intervention</p><p>Application of the integrated data platform combined with dietary management for adults with diabetes: A prospective randomized controlled trial, Liu 1548–1555.</p><p>Dietary therapy</p><p>Nutrient quality in dietary therapy for diabetes and diabetic kidney disease, Tsuruta 973–981.</p><p>Digital platform</p><p>Application of the integrated data platform combined with dietary management for adults with diabetes: A prospective randomized controlled trial, Liu 1548–1555.</p><p>Doxorubicin</p><p>Mitochondrial ALDH2 improves β-cell survival and function against doxorubicin-induced apoptosis by targeting CK2 signaling, Karunakaran 684–692.</p><p>DPNCheck</p><p>Simplified electrophysiological approach combining a point-of-care nerve conduction device and an electrocardiogram produces an accurate diagnosis of diabetic polyneuropathy, Hayashi 736–742.</p><p>East Asians</p><p>Low-carbohydrate diets in East Asians with type 2 diabetes: A systematic review and meta-analysis of randomized controlled trials, Hironaka 1753–1762.</p><p>Eating behavior</p><p>An exploratory study of factors in disordered eating behavior in diabetes self-management in Japan, Tsukamoto-Kawashima 874–881.</p><p>Eating behaviors</p><p>Eating behaviors and incidence of type 2 diabetes in Japanese people: The population-based Panasonic cohort study 15, Toyokuni 1017–1025.</p><p>Editorial</p><p>Common metabolite for microangiopathy in Japanese and European populations, Shojima 523–524.</p><p>The Ulaanbaatar agreement: Revising diabetes terminology in Asia to combat stigma, Seino 1533–1536.</p><p>The roles of output clock genes in regulating glucose metabolism, Taguchi 1707–1710.</p><p>Elderly</p><p>Sulfonylurea prescription patterns in elderly patients with type 2 diabetes mellitus: A comprehensive analysis of real-world data from pharmacies in Japan, Yamazaki 1604–1613.</p><p>Embryonic lethal abnormal visual-like protein 1</p><p>Tanshinone IIA suppresses ferroptosis to attenuate renal podocyte injury in diabetic nephropathy through the embryonic lethal abnormal visual-like protein 1 and acyl-coenzyme A synthetase long-chain family member 4 signaling pathway, Zhu 1003–1016.</p><p>Empagliflozin</p><p>Improvements of myocardial strain and work in diabetes patients with normal ejection fraction after empagliflozin treatment, Cheng 851–860.</p><p>EPAC</p><p>Epac2 activation mediates glucagon-induced glucogenesis in primary rat hepatocytes, Shiozaki-Takagi 429–436.</p><p>Epigenetic change</p><p>Glucose metabolism partially regulates β-cell function through epigenomic changes, Kim 649–655.</p><p>Epilepsy</p><p>Type 1 diabetes and the risk of epilepsy: A meta-analysis, Wu 364–373.</p><p>Estimated glomerular filtration rate</p><p>Risk factors for chronic kidney disease progression over 20 years for primary prevention in Japanese individuals at a preventive medicine research center: Focus on the influence of plasma glucose levels, Minami 1434–1443.</p><p>Angiopoietin-like 4 is a potential biomarker for diabetic kidney disease in type 2 diabetes patients, Wang 1763–1772.</p><p>Ethnicity</p><p>Lipid profile in women of different ethnicity with gestational diabetes: Relationship with fetal growth, Dalfrá 355–363.</p><p>Executive function</p><p>Global cognition and executive functions of older adults with type 1 diabetes mellitus without dementia, Nagasawa 922–930.</p><p>Fasting plasma glucose</p><p>Inverted U-shaped associations between serumuric acid and fasting - plasma glucose level in non-diabetic, pre-diabetic, and diabetic adults: A population-based study in China, Shi 483–490.</p><p>Associations of fasting plasma glucose with all-cause mortality and cardiovascular events in older Chinese diabetes patients: A population-based cohort study, Wang 1129–1139.</p><p>Fenofibrate</p><p>Haptoglobin phenotype and levels in type 2 diabetes and effects of fenofibrate, Januszewski 1663–1668.</p><p>Flash glucose monitoring</p><p>Fresh autologous blood transfusion.</p><p>Exploration of the mechanism of reinfusion of fresh autologous blood in type 2 diabetes mice to induce macrophage polarization and inhibit erythrocyte damage, Hu 70–77.</p><p>Foot ulcer</p><p>What characteristics are most important in stratifying patients into groups with different risk of diabetic foot ulceration?, Naemi 1094–1104.</p><p>Frailty</p><p>Management of older adults with diabetes mellitus: Perspective from geriatric medicine, Umegaki 1347–1354.</p><p>Fulminant type 1 diabetes</p><p>Fulminant type 1 diabetes, an underrecognized and unique subtype of type 1 diabetes: A case series from Singapore, Tan 786–789.</p><p>GAD antibody</p><p>New diagnostic criteria (2023) for slowly progressive type 1 diabetes (SPIDDM): Report from Committee on Type 1 Diabetes of the Japan Diabetes Society (English version), Shimada 254–257.</p><p>Gastrectomy</p><p>Theragnostic utility of continuous glucose monitoring in post-gastrectomy hypoglycemia, Son 1696–1699.</p><p>Gastrointestinal diseases</p><p>Association between gastrointestinal symptoms and insomnia in patients with type 2 diabetes: The KAMOGAWA-DM cohort study, Minamida 946–952.</p><p>Gene editing</p><p>Long-term efficacy of encapsulated xenogeneic islet transplantation: Impact of encapsulation techniques and donor genetic traits, Park 693–703.</p><p>Generalized lipodystrophy</p><p>Corticosteroid-triggered acute skeletal muscle loss in lipodystrophy: A case report, Sasako 782–785.</p><p>Genetic insulin resistance syndrome</p><p>A multicenter, open-label, single-arm trial of the long-term safety of empagliflozin treatment for refractory diabetes mellitus with insulin resistance (EMPIRE-02), Hirota 1211–1219.</p><p>Genetics and pathogenesis</p><p>Identification of eight genomic protective alleles for mitochondrial diabetes by Kinship-graph convolutional network, Wang 52–62.</p><p>Genome-wide association studies</p><p>Perspectives on genetic studies of type 2 diabetes from the genome-wide association studies era to precision medicine, Imamura 410–422.</p><p>Gestational diabetes</p><p>The role of lipid dysregulation in gestational diabetes mellitus: Early prediction and postpartum prognosis, Zhang 15–25.</p><p>Maternal birth weight as an indicator of early and late gestational diabetes mellitus: The Japan Environment and Children's Study, Tagami 751–761.</p><p>Gestational diabetes mellitus</p><p>Body composition and risk of gestational diabetes mellitus: A univariable and multivariable Mendelian randomization study, Gao 346–354.</p><p>Lipid profile in women of different ethnicity with gestational diabetes: Relationship with fetal growth, Dalfrá 355–363.</p><p>Comparing the screening methods for gestational diabetes mellitus before and during the COVID-19 pandemic: A systematic review, Sun 500–516.</p><p>Health impacts of new-onset diabetes in women post-gestational diabetes mellitus: Insights from Hong Kong's territory-wide data, Zhang 772–781.</p><p>Second-trimester triglyceride-glucose index to predict adverse outcomes in women with gestational diabetes mellitus: A retrospective multicenter cohort study, Bai 1489–1499.</p><p>Problems in screening for gestational diabetes mellitus by measurement of casual blood glucose levels at 24–28 gestational weeks, Tomimoto 1797–1802.</p><p>Multiple positive points during the 75 g oral glucose tolerance test are good predictors for early insulin therapy in gestational diabetes mellitus diagnosed before 24 gestational weeks, Kasuga 1803–1808.</p><p>Gestational weight gain</p><p>Association between infant birth weight and gestational weight gain in Japanese women with diabetes mellitus, Fujikawa Shingu 906–913.</p><p>Glomerular filtration rate</p><p>Decline in measured glomerular filtration rate is associated with simple renal cyst in Chinese patients with type 2 diabetes, Qiaoling 26–33.</p><p>Glucagon</p><p>Epac2 activation mediates glucagon-induced glucogenesis in primary rat hepatocytes, Shiozaki-Takagi 429–436.</p><p>Imeglimin enhances glucagon secretion through an indirect mechanism and improves fatty liver in high-fat, high-sucrose diet-fed mice, Kikuchi 1177–1190.</p><p>Glucagon-like peptide-1</p><p>Imeglimin enhances glucagon secretion through an indirect mechanism and improves fatty liver in high-fat, high-sucrose diet-fed mice, Kikuchi 1177–1190.</p><p>Glucagon-like peptide 1 receptor agonist</p><p>Efficacy and tolerability of oral semaglutide in Japanese patients with type 2 diabetes mellitus: Analysis report from diabetes specialist clinics, Inokuchi 1202–1210.</p><p>Glucogenic action</p><p>Epac2 activation mediates glucagon-induced glucogenesis in primary rat hepatocytes, Shiozaki-Takagi 429–436.</p><p>Glucokinase</p><p>Effects of glucokinase haploinsufficiency on the pancreatic β-cell mass and function of long-term high-fat, high-sucrose diet-fed mice, Shigesawa 1732–1742.</p><p>Glucose</p><p>Post-load glucose is a stronger predictor of adverse pregnancy outcomes than first-trimester HbA1c in women without gestational diabetes, Rajabi 914–921.</p><p>Glucose metabolism</p><p>Glucose metabolism partially regulates β-cell function through epigenomic changes, Kim 649–655.</p><p>Glucose-stimulated insulin secretion</p><p>Effects of glucokinase haploinsufficiency on the pancreatic β-cell mass and function of long-term high-fat, high-sucrose diet-fed mice, Shigesawa 1732–1742.</p><p>Glutamic acid decarboxylase.</p><p>Prediction of future insulin-deficiency in glutamic acid decarboxylase autoantibody enzyme-linked immunosorbent assay-positive patients with slowly progressive type 1 diabetes, Kawasaki 835–842.</p><p>Glycated albumin</p><p>Association between glycated albumin and adverse outcomes in patients with heart failure, Chen 1457–1463.</p><p>Glycated hemoglobin</p><p>Association between glycated albumin and adverse outcomes in patients with heart failure, Chen 1457–1463.</p><p>Low-carbohydrate diets in East Asians with type 2 diabetes: A systematic review and meta-analysis of randomized controlled trials, Hironaka 1753–1762.</p><p>Glycemia risk index</p><p>Association between glycemia risk index and arterial stiffness in type 2 diabetes, Cai 614–622.</p><p>Glycemic control</p><p>Influence of disease course and comprehensive management on blood glucose level in children and adolescents with type 2 diabetes mellitus, Wu 1026–1033.</p><p>Medical database analysis of the association between kidney function and achievement of glycemic control in older Japanese adults with type 2 diabetes who started with oral antidiabetic drugs, Suzuki 1057–1067.</p><p>Patient-reported outcomes and treatment adherence in type 2 diabetes using natural language processing: Wave 8 of the Observational International Diabetes Management Practices Study, Chan 1306–1316.</p><p>Glycemic metrics in Japanese isCGM users—Analysis by diabetes type and therapy, Ogawa 1483–1488.</p><p>Glycemic management</p><p>The association between alcohol drinking and glycemic management among people with type 2 diabetes in China, Ye 237–244.</p><p>Safety and effectiveness of tofogliflozin in Japanese people with type 2 diabetes: A multicenter prospective observational study in routine clinical practice, Yamada 1585–1595.</p><p>Glycemic variability</p><p>Glycemic variability: Measurement, target, impact on complications of diabetes and does it really matter? Mo 5–14.</p><p>Glycemic variability is associated with sural nerve conduction velocity in outpatients with type 2 diabetes: Usefulness of a new point-of-care device for nerve conduction studies, Morita 1075–1083.</p><p>Glycosylated hemoglobin</p><p>Association between glycated hemoglobin and risk of all-cause mortality in community patients with type 2 diabetes: A prospective cohort study, He 939–945.</p><p>Growth</p><p>Overnutrition in the early postnatal period influences lifetime metabolic risk: Evidence for impact on pancreatic β-cell mass and function, Burton 263–274.</p><p>Handgrip strength</p><p>The impact of handgrip strength and waist circumference on glycemic control: Prospective, observational study using outpatient clinical data in Japanese patients with type 2 diabetes mellitus, Nakanishi 892–898.</p><p>Haptoglobin</p><p>Haptoglobin phenotype and levels in type 2 diabetes and effects of fenofibrate, Januszewski 1663–1668.</p><p>HbA1c</p><p>Effect of hemoglobin A1c management levels on coronary physiology evaluated by quantitative flow ratio in patients who underwent percutaneous coronary intervention, Chen 336–345.</p><p>HbA1c degradation</p><p>Evaluation of the transition program at the University Hospital of Reims from 2015 to 2020, Chibane 1519–1523.</p><p>HbA1c trajectory</p><p>Mandatory monthly outpatient visits could improve therapeutic inertia in patients with poorly controlled type 2 diabetes, Tsai 227–236.</p><p>HbA1c variability</p><p>Prognostic value of longitudinal HbA1c variability in predicting the development of diabetic sensorimotor polyneuropathy among patients with type 2 diabetes mellitus: A prospective cohort observational study, Lai 326–335.</p><p>Health care costs</p><p>Healthcare resource utilization and healthcare costs in patients with type 2 diabetes mellitus initiating sodium-glucose cotransporter 2 inhibitors vs dipeptidyl peptidase-4 inhibitors in Japan: A real-world administrative database analysis, Kashiwagi 374–387.</p><p>Healthcare quality assessment</p><p>Associations between income/employment status and diabetes care processes, health behaviors, and health outcomes in Japan: A cross-sectional study using claims data linked to a questionnaire survey, Yamaoka 1684–1695.</p><p>Health resources</p><p>Healthcare resource utilization and healthcare costs in patients with type 2 diabetes mellitus initiating sodium-glucose cotransporter 2 inhibitors vs dipeptidyl peptidase-4 inhibitors in Japan: A real-world administrative database analysis, Kashiwagi 374–387.</p><p>Healthy volunteers</p><p>Delayed dinnertime impairs glucose tolerance in healthy young adults, Nakamura 172–176.</p><p>Heart failure</p><p>Association between glycated albumin and adverse outcomes in patients with heart failure, Chen 1457–1463.</p><p>Heart rate variability</p><p>Associations of age-adjusted coefficient of variation of R-R intervals with autonomic and peripheral nerve function in non-elderly persons with diabetes, Sugimoto 186–196.</p><p>Cardiac electrophysiology, structure and diastolic function in patients with diabetic foot versus those without diabetic foot, Bai 1276–1286.</p><p>Improvement of heart rate variability after metabolic bariatric surgery in Korean subjects with obesity, Jang 1773–1780.</p><p>Hematocrit</p><p>Impact of hematocrit levels on the accuracy of specific blood glucose meters: A hospital-based study, Pham 1472–1482.</p><p>Hemoglobin A1c</p><p>Post-load glucose is a stronger predictor of adverse pregnancy outcomes than first-trimester HbA1c in women without gestational diabetes, Rajabi 914–921.</p><p>Henagliflozin</p><p>Sodium–glucose cotransporter 2 inhibition through henagliflozin ameliorates cognitive impairment in patients with type 2 diabetes, Zhang 1596–1603.</p><p>Hepatocyte nuclear factor 1B</p><p>Hepatocyte nuclear factor 1B deletion, but not intragenic mutation, might be more susceptible to hypomagnesemia, Wang 121–130.</p><p>High-density lipoprotein cholesterol</p><p>Association between serum uric acid-to-high-density lipoprotein cholesterol ratio and insulin resistance in patients with type 2 diabetes mellitus, Zhou 113–120.</p><p>hs-CRP</p><p>High sensitivity C-reactive protein and prediabetes progression and regression in middle-aged and older adults: A prospective cohort study, Cheng 78–86.</p><p>Hyperlipidemia</p><p>Optimizing lipid control in Taiwanese diabetic patients: A collaborative consensus by the Diabetes Association of the Republic of China (Taiwan) and the Taiwanese Association of Diabetes Educators, Shen 1151–1160.</p><p>Hypoglycemia</p><p>Recurrent hypoglycemia induced by clopidogrel: A case report and mini review, Du 275–281.</p><p>Development and validation of a prediction model for self-reported hypoglycemia risk in patients with type 2 diabetes: A longitudinal cohort study, Xu 468–482.</p><p>Islet transplantation in Korea, Lee 1165–1170.</p><p>Theragnostic utility of continuous glucose monitoring in post-gastrectomy hypoglycemia, Son 1696–1699.</p><p>Hypomagnesemia</p><p>Hepatocyte nuclear factor 1B deletion, but not intragenic mutation, might be more susceptible to hypomagnesemia, Wang 121–130.</p><p>Ideal cardiovascular health</p><p>The association between metabolic syndrome and insulin resistance with risk of cardiovascular events in different states of cardiovascular health status, Hosseinpour-Niazi 208–218.</p><p>IDegLira</p><p>Comparison of efficacy and safety of insulin degludec/liraglutide and insulin glargine U-100/lixisenatide in individuals with type 2 diabetes mellitus using professional continuous glucose monitoring, Kawaguchi 598–607.</p><p>IGHG1</p><p>Immunoglobulin heavy constant gamma 1 silencing decreases tonicity-responsive enhancer-binding protein expression to alleviate diabetic nephropathy, Hu 572–583.</p><p>IGlarLixi</p><p>Comparison of efficacy and safety of insulin degludec/liraglutide and insulin glargine U-100/lixisenatide in individuals with type 2 diabetes mellitus using professional continuous glucose monitoring, Kawaguchi 598–607.</p><p>Imeglimin</p><p>Imeglimin enhances glucagon secretion through an indirect mechanism and improves fatty liver in high-fat, high-sucrose diet-fed mice, Kikuchi 1177–1190.</p><p>Factors contributing to the clinical effectiveness of imeglimin monotherapy in Japanese patients with type 2 diabetes mellitus, Hagi 1239–1247.</p><p>Inflammation</p><p>Regulatory T cells protect against diabetic cardiomyopathy in <i>db/db</i> mice, Zhang 1191–1201.</p><p>Influence factors</p><p>Prevalence, awareness, treatment and control of type 2 diabetes in southeast China: A population-based study, Hu 1034–1041.</p><p>Injection</p><p>Adherence and treatment discontinuation of oral semaglutide and once-weekly semaglutide injection at 12-month follow-up: Japanese real-world data, Horii 1578–1584.</p><p>Insulin</p><p>Targeting PI3K/AKT and MEK/ERK pathways for synergic effects on improving features of peripheral diabetic neuropathy, Pham 1537–1544.</p><p>Multiple positive points during the 75 g oral glucose tolerance test are good predictors for early insulin therapy in gestational diabetes mellitus diagnosed before 24 gestational weeks, Kasuga 1803–1808.</p><p>Insulin autoimmune syndrome</p><p>Recurrent hypoglycemia induced by clopidogrel: A case report and mini review, Du 275–281.</p><p>Insulin infusion systems</p><p>Effects of hybrid closed-loop system on glycemic control and psychological aspects in persons with type 1 diabetes treated with sensor-augmented pump: A prospective single-center observational study, Akiyama 219–226.</p><p>Insulin-like growth factor-1</p><p>Diminished levels of insulin-like growth factor-1 may be a risk factor for peripheral neuropathy in type 2 diabetes patients, Zhong 1259–1265.</p><p>Insulin resistance</p><p>The association between metabolic syndrome and insulin resistance with risk of cardiovascular events in different states of cardiovascular health status, Hosseinpour-Niazi 208–218.</p><p>Association between serum uric acid-to-high-density lipoprotein cholesterol ratio and insulin resistance in an American population: A population-based analysis, Zhou 762–771.</p><p>Insulin secretion</p><p>Short-term recovery of insulin secretion in response to a meal is associated with future glycemic control in type 2 diabetes patients, Enkaku 437–448.</p><p>Pancreatic beta-cell mass and function and therapeutic implications of using antidiabetic medications in type 2 diabetes, Moon 669–683.</p><p>Insulin secretory capacity</p><p>Association of xanthine oxidoreductase inhibitor use with insulin secretory capacity inpatients with type 2 diabetes, Kitamura 1500–1509.</p><p>Insulin sensitivity</p><p>Interactive calculator to estimate insulin sensitivity in type 1 diabetes, Januszewski 594–597.</p><p>Intermittent fasting</p><p>Effect of intermittent fasting 16:8 and 14:10 compared with control-group on weight reduction and metabolic outcomes in obesity with type 2 diabetes patients: A randomized controlled trial, Sukkriang 1297–1305.</p><p>Intermittently scanned continuous glucose monitoring</p><p>Patient-reported outcomes and treatment adherence in type 2 diabetes using natural language processing: Wave 8 of the Observational International Diabetes Management Practices Study, Chan 1306–1316.</p><p>Internet of things</p><p>Internet of things-based approach for glycemic control in people with type 2 diabetes: A randomized controlled trial, Bouchi 1287–1296.</p><p>Intestine</p><p>Diabetes treatment by conversion of gut epithelial cells to insulin-producing cells, Accili 797–804.</p><p>Islets of Langerhans transplantation</p><p>Long-term efficacy of encapsulated xenogeneic islet transplantation: Impact of encapsulation techniques and donor genetic traits, Park 693–703.</p><p>Islet transplantation in Korea, Lee 1165–1170.</p><p>JDCP study</p><p>Prevalence and characteristics of diabetic symmetric sensorimotor polyneuropathy in Japanese patients with type 2 diabetes: The Japan Diabetes Complication and its Prevention Prospective study (JDCP study 10), Kamiya 247–253.</p><p>Kidney complications</p><p>Health impacts of new-onset diabetes in women post-gestational diabetes mellitus: Insights from Hong Kong's territory-wide data, Zhang 772–781.</p><p>Kidney function</p><p>Association analysis between serum asprosin and metabolic characteristics, Complications in type 2 diabetic patients with different durations, Ma 1781–1787.</p><p>Large-scale claims database</p><p>Factor affecting severe atherothrombotic cerebral infarction in patients with type 2 diabetes mellitus: Large-scale claim database analysis of Japan, Horii 1651–1662.</p><p>Latent autoimmune diabetes in adults</p><p>New diagnostic criteria (2023) for slowly progressive type 1 diabetes (SPIDDM): Report from Committee on Type 1 Diabetes of the Japan Diabetes Society (English version), Shimada 254–257.</p><p>L-dopa</p><p>Diabetic striatopathy: Hyperglycemic chorea/ballism successfully treated with L-dopa, Tsukaguchi 1524–1527.</p><p>Left ventricular diastolic dysfunction</p><p>The correlation between serum asprosin and left ventricular diastolic dysfunction in elderly patients with type 2 diabetes mellitus in the community, Liang 608–613.</p><p>Cardiac electrophysiology, structure and diastolic function in patients with diabetic foot versus those without diabetic foot, Bai 1276–1286.</p><p>Letter to the Editor</p><p>Longitudinal association of sedentary time with diabetes mellitus and markers of glucose metabolism in middle-aged and older adults: The Hisayama Study, Tsuda 245–246.</p><p>Comment on the article titled “Association of the triglyceride-glucose index with subclinical left ventricular dysfunction in type 2 diabetes mellitus patients: A retrospective cross-sectional study”, Naharci 517–518.</p><p>Comment on a recent article titled ‘Hepatocyte nuclear factor 1B deletion, but not intragenic mutation, might be more susceptible to hypomagnesemia’, Clissold 790.</p><p>Long-term safety of alginate-poly-L-ornithine microcapsules, enveloping human islet allografts, into nonimmunosuppressed patients with type 1 diabetes mellitus, Calafiore 1700–1701.</p><p>Maturity-onset diabetes of the young: A proposal for updated nomenclature, Tosur 1818–1819.</p><p>Coexistence of high visceral fat area and sarcopenia and atherosclerotic markers in older patients with diabetes: Is there an association?, Saleh 1820.</p><p>Lifestyle interventions</p><p>Postpartum life interventions to prevent type 2 diabetes in women with gestational diabetes: A systematic review and meta-analysis, Wang 1115–1128.</p><p>Lipid</p><p>Estimated small dense low-density lipoprotein cholesterol and nonalcoholic fatty liver disease in nonobese populations, Huang 491–499.</p><p>Lipid metabolism</p><p>The role of lipid dysregulation in gestational diabetes mellitus: Early prediction and postpartum prognosis, Zhang 15–25.</p><p>Lipid profile</p><p>Lipid profile in women of different ethnicity with gestational diabetes: Relationship with fetal growth, Dalfrá 355–363.</p><p>Lipoatrophic diabetes</p><p>A multicenter, open-label, single-arm trial of the long-term safety of empagliflozin treatment for refractory diabetes mellitus with insulin resistance (EMPIRE-02), Hirota 1211–1219.</p><p>Liver steatosis</p><p>Metabolic dysfunction-associated steatotic liver disease: A superior predictor for incident type 2 diabetes over traditional criteria—NAGALA study, Sakai 1788–1796.</p><p>Liver transplantation</p><p>Risk factors and prediction score for new-onset diabetes mellitus after liver transplantation, Bai 1105–1114.</p><p>Low birthweight</p><p>Interaction effect between low birthweight and resistin gene rs1862513 variant on insulin resistance and type 2 diabetes mellitus in adulthood: Toon Genome Study, Yoshida 725–735.</p><p>Low-carbohydrate diet</p><p>Efficacy of long-term low-carbohydrate diets for patients with type 2 diabetes: A systematic review and meta-analysis, Ichikawa 1410–1421.</p><p>Low-carbohydrate diets in East Asians with type 2 diabetes: A systematic review and meta-analysis of randomized controlled trials, Hironaka 1753–1762.</p><p>Low-density lipoprotein cholesterol</p><p>Effect of sodium–glucose cotransporter 2 inhibitors on serum low-density lipoprotein cholesterol in Japanese patients with type 2 diabetes mellitus, Imada 843–850.</p><p>Lysosome</p><p>Role of β-cell autophagy in β-cell physiology and the development of diabetes, Yasasilka 656–668.</p><p>Machine learning</p><p>Identification of eight genomic protective alleles for mitochondrial diabetes by Kinship-graph convolutional network, Wang 52–62.</p><p>Performance of different machine learning algorithms in identifying undiagnosed diabetes based on nonlaboratory parameters and the influence of muscle strength: A cross-sectional study, Xu 743–750.</p><p>Interpretable machine learning models based on shear-wave elastography radiomics for predicting cardiovascular disease in diabetic kidney disease patients, Dai 1637–1650.</p><p>Macrophages</p><p>Exploration of the mechanism of reinfusion of fresh autologous blood in type 2 diabetes mice to induce macrophage polarization and inhibit erythrocyte damage, Hu 70–77.</p><p>Malignant neoplasms</p><p>Causes of death in Japanese patients with diabetes based on the results of a survey of 68,555 cases during 2011–2020: Committee report on causes of death in diabetes mellitus, Japan Diabetes Society (English version), Nakamura 1821–1837.</p><p>Marfan syndrome</p><p>Coexistence of type 2 diabetes mellitus, arginine vasopressin deficiency, and Marfan syndrome: A case report, Le 964–967.</p><p>Maternally inherited diabetes and deafness</p><p>Identification of eight genomic protective alleles for mitochondrial diabetes by Kinship-graph convolutional network, Wang 52–62.</p><p>Maturity-onset diabetes of the young</p><p>Hepatocyte nuclear factor 1B deletion, but not intragenic mutation, might be more susceptible to hypomagnesemia, Wang 121–130.</p><p>Mean blood glucose</p><p>Between blood glucose and mortality in critically ill patients: Retrospective analysis of the MIMIC-IV database, Li 931–938.</p><p>Mendelian randomization</p><p>Body composition and risk of gestational diabetes mellitus: A univariable and multivariable Mendelian randomization study, Gao 346–354.</p><p>Causal association between cystatin C and diabetic retinopathy: A two-sample Mendelian randomization study, Ruan 1626–1636.</p><p>Meta-analysis</p><p>Type 1 diabetes and the risk of epilepsy: A meta-analysis, Wu 364–373.</p><p>Postpartum life interventions to prevent type 2 diabetes in women with gestational diabetes: A systematic review and meta-analysis, Wang 1115–1128.</p><p>Efficacy of long-term low-carbohydrate diets for patients with type 2 diabetes: A systematic review and meta-analysis, Ichikawa 1410–1421.</p><p>Metabolic bariatric surgery</p><p>Improvement of heart rate variability after metabolic bariatric surgery in Korean subjects with obesity, Jang 1773–1780.</p><p>Metabolic dysfunction-associated fatty liver diseases</p><p>Elevated small dense low-density lipoprotein cholesterol to high-density lipoprotein cholesterol ratio is associated with an increased risk of metabolic dysfunction-associated fatty liver disease in Chinese patients with type 2 diabetes mellitus, Yang 634–642.</p><p>Metabolic dysfunction-associated steatotic liver disease</p><p>Long-term effects of ipragliflozin and pioglitazone on metabolic dysfunction-associated steatotic liver disease in patients with type 2 diabetes: 5 year observational follow-up of a randomized, 24 week, active-controlled trial, Ito 1220–1230.</p><p>Metabolic outcomes</p><p>Effect of intermittent fasting 16:8 and 14:10 compared with control-group on weight reduction and metabolic outcomes in obesity with type 2 diabetes patients: A randomized controlled trial, Sukkriang 1297–1305.</p><p>Metabolic syndrome</p><p>The association between metabolic syndrome and insulin resistance with risk of cardiovascular events in different states of cardiovascular health status, Hosseinpour-Niazi 208–218.</p><p>METTL3</p><p>METTL3/YTHDF2 m6A axis mediates the progression of diabetic nephropathy through epigenetically suppressing PINK1 and mitophagy, Wang 288–299.</p><p>Microalbuminuria</p><p>Identification and validation of voltage-dependent anion channel 1-related genes and immune cell infiltration in diabetic nephropathy, Lin 87–105.</p><p>Sympathetic skin response for early detection of type 2 diabetic peripheral neuropathy and nephropathy, Liu 106–112.</p><p>MicroRNAs</p><p>Investigating the altered expression of miR-486-5p and miR-novel-chr1_40444 in dysglycemia in a South African population, Weale 1377–1389.</p><p>microRNA-194</p><p>Relationship between circulating thrombospondin-1 messenger ribonucleic acid and microribonucleic acid-194 levels in Chinese patients with type 2 diabetic kidney disease: The outcomes of a case–control study, Ma 1248–1258.</p><p>miR-30a-3p</p><p><i>Cordyceps cicadae</i> polysaccharides attenuate diabetic nephropathy via the miR-30a-3p/TRIM16 axis, Zheng 300–314.</p><p>miR-488-3p</p><p>MiR-488-3p facilitates wound healing throughCYP1B1-mediated Wnt/β-catenin signaling pathway by targeting MeCP2, Zuo 145–158.</p><p>MiRNA let7d-5p</p><p>High glucose promotes atherosclerosis by regulating miRNA let7d-5p level, Wang 711–724.</p><p>Mitiglinide/voglibose fixed-dose combination tablet</p><p>Comparative effects of fixed-dose mitiglinide/voglibose combination and glimepiride on vascular endothelial function and glycemic variability in patients with type 2 diabetes: A randomized controlled trial, Tanaka 449–458.</p><p>Molecular diagnosis</p><p>Genetic variant profiling of neonatal diabetes mellitus in Iranian patients: Unveiling 58 distinct variants in 14 genes, Mianesaz 1390–1402.</p><p>Mood</p><p>An exploratory study of factors in disordered eating behavior in diabetes self-management in Japan, Tsukamoto-Kawashima 874–881.</p><p>Mortality</p><p>Between blood glucose and mortality in critically ill patients: Retrospective analysis of the MIMIC-IV database, Li 931–938.</p><p>Mortality rate</p><p>Type 1 and type 2 diabetes mortality burden: Predictions for 2030 based on Bayesian age-period-cohort analysis of China and global mortality burden from 1990 to 2019, Dong 623–633.</p><p>Mortality risk</p><p>Association between glycated hemoglobin and risk of all-cause mortality in community patients with type 2 diabetes: A prospective cohort study, He 939–945.</p><p>Multimorbidity</p><p>Management of older adults with diabetes mellitus: Perspective from geriatric medicine, Umegaki 1347–1354.</p><p>Muscle strength</p><p>Performance of different machine learning algorithms in identifying undiagnosed diabetes based on nonlaboratory parameters and the influence of muscle strength: A cross-sectional study, Xu 743–750.</p><p>Myocardial function</p><p>Improvements of myocardial strain and work in diabetes patients with normal ejection fraction after empagliflozin treatment, Cheng 851–860.</p><p>Neonatal</p><p>Neonatal diabetes mellitus around the world: Update 2024, Barbetti 1711–1724.</p><p>Neonatal diabetes</p><p>Genetic variant profiling of neonatal diabetes mellitus in Iranian patients: Unveiling 58 distinct variants in 14 genes, Mianesaz 1390–1402.</p><p>Neovascular glaucoma</p><p>Characterization of the visually impaired patients with diabetes mellitus in Japan, Sugihara 882–891.</p><p>Nerve conduction</p><p>Associations of age-adjusted coefficient of variation of R-R intervals with autonomic and peripheral nerve function in non-elderly persons with diabetes, Sugimoto 186–196.</p><p>Nerve conduction studies</p><p>Identification and validation of voltage-dependent anion channel 1-related genes and immune cell infiltration in diabetic nephropathy, Lin 87–105.</p><p>Sympathetic skin response for early detection of type 2 diabetic peripheral neuropathy and nephropathy, Liu 106–112.</p><p>Diminished levels of insulin-like growth factor-1 may be a risk factor for peripheral neuropathy in type 2 diabetes patients, Zhong 1259–1265.</p><p>Netrin-1</p><p>Circulating netrin-1 levels are reduced and related to corneal nerve fiber loss in patients with diabetic neuropathy, Mondal 1068–1074.</p><p>New-onset diabetes mellitus</p><p>Risk factors and prediction score for new-onset diabetes mellitus after liver transplantation, Bai 1105–1114.</p><p>Nitrosamines</p><p>Assessment of cancer risk associated with 7-nitroso-3-(trifluoromethyl)-5,6,7,8-tetrahydro[1,2,4] triazolo-[4,3-a]pyrazine-contaminated sitagliptin use: A retrospective cohort study, Sugiyama 1556–1565.</p><p>Nocturia</p><p>Multicenter, open-label, randomized controlled superiority trial for availability to reduce nocturnal urination frequency: The TOP-STAR study, Nakajima 1809–1817.</p><p>Nomograms</p><p>A novel predictive model for optimizing diabetes screening in older adults, Lin 1403–1409.</p><p>Nonalcoholic fatty liver disease</p><p>Estimated small dense low-density lipoprotein cholesterol and nonalcoholic fatty liver disease in nonobese populations, Huang 491–499.</p><p>Nonalcoholic fatty liver disease</p><p>Long-term effects of ipragliflozin and pioglitazone on metabolic dysfunction-associated steatotic liver disease in patients with type 2 diabetes: 5 year observational follow-up of a randomized, 24 week, active-controlled trial, Ito 1220–1230.</p><p>Metabolic dysfunction-associated steatotic liver disease: A superior predictor for incident type 2 diabetes over traditional criteria – NAGALA study, Sakai 1788–1796.</p><p>Novel variants</p><p>Genetic variant profiling of neonatal diabetes mellitus in Iranian patients: Unveiling 58 distinct variants in 14 genes, Mianesaz 1390–1402.</p><p>Nutrition</p><p>Overnutrition in the early postnatal period influences lifetime metabolic risk: Evidence for impact on pancreatic β-cell mass and function, Burton 263–274.</p><p>Nutrient quality in dietary therapy for diabetes and diabetic kidney disease, Tsuruta 973–981.</p><p>Obesity</p><p>Overnutrition in the early postnatal period influences lifetime metabolic risk: Evidence for impact on pancreatic β-cell mass and function, Burton 263–274.</p><p>A case of type 2 diabetes mellitus with weight gain and worsening of glycemic management after tezepelumab administration for severe bronchial asthma, Umamoto 388–390.</p><p>Association between serum uric acid-to-high-density lipoprotein cholesterol ratio and insulin resistance in an American population: A population-based analysis, Zhou 762–771.</p><p>Observational studies</p><p>Type 1 diabetes and the risk of epilepsy: A meta-analysis, Wu 364–373.</p><p>Occupational health</p><p>Relationship between diabetes treatment status and occupational accidents, Ogasawara 899–905.</p><p>Older adults</p><p>Medical database analysis of the association between kidney function and achievement of glycemic control in older Japanese adults with type 2 diabetes who started with oral antidiabetic drugs, Suzuki 1057–1067.</p><p>Online calculator</p><p>Interactive calculator to estimate insulin sensitivity in type 1 diabetes, Januszewski 594–597.</p><p>Opportunistic case finding</p><p>External validation of the Hong Kong Chinese nonlaboratory risk models and scoring algorithm for case finding of prediabetes and diabetes mellitus in primary care, Cheng 1317–1325.</p><p>Oral</p><p>Adherence and treatment discontinuation of oral semaglutide and once-weekly semaglutide injection at 12 month follow-up: Japanese real-world data, Horii 1578–1584.</p><p>Oral antidiabetic drugs</p><p>Prevalence of adherence to oral antidiabetic drugs in patients with type 2 diabetes: A systematic review and meta-analysis, Boonpattharatthiti 1614–1625.</p><p>Oral cancer</p><p>Impact of diabetes on the prognosis of patients with oral and oropharyngeal cancer: A meta-analysis, Xu 1140–1150.</p><p>Oral glucose tolerance test</p><p>Multiple positive points during the 75 g oral glucose tolerance test are good predictors for early insulin therapy in gestational diabetes mellitus diagnosed before 24 gestational weeks, Kasuga 1803–1808.</p><p>Oral semaglutide</p><p>Efficacy and tolerability of oral semaglutide in Japanese patients with type 2 diabetes mellitus: Analysis report from diabetes specialist clinics, Inokuchi 1202–1210.</p><p>PIONEER REAL Japan: Primary results from a multicenter, prospective, real-world study of oral semaglutide in adults with type 2 diabetes in Japanese clinical practice, Yabe 1566–1577.</p><p>Orthostatic hypotension</p><p>Associations of age-adjusted coefficient of variation of R-R intervals with autonomic and peripheral nerve function in non-elderly persons with diabetes, Sugimoto 186–196.</p><p>Outcome</p><p>Post-load glucose is a stronger predictor of adverse pregnancy outcomes than first-trimester HbA1c in women without gestational diabetes, Rajabi 914–921.</p><p>Oxidative stress</p><p>Oxidative stress suppresses PHB2-mediated mitophagy in β-cells via the Nrf2/PHB2 pathway, Liu 559–571.</p><p>Pancreatic β-cell</p><p>Pancreatic beta-cell mass and function and therapeutic implications of using antidiabetic medications in type 2 diabetes, Moon 669–683.</p><p>Pancreatic β-cells</p><p>Mitochondrial ALDH2 improves β-cell survival and function against doxorubicin-induced apoptosis by targeting CK2 signaling, Karunakaran 684–692.</p><p>Parkin</p><p>METTL3/YTHDF2 m6A axis mediates the progression of diabetic nephropathy through epigenetically suppressing PINK1 and mitophagy, Wang 288–299.</p><p>Patient-reported outcomes</p><p>Patient-reported outcomes and treatment adherence in type 2 diabetes using natural language processing: Wave 8 of the Observational International Diabetes Management Practices Study, Chan 1306–1316.</p><p>People with type 2 diabetes</p><p>The association between alcohol drinking and glycemic management among people with type 2 diabetes in China, Ye 237–244.</p><p>Percutaneous coronary intervention</p><p>Effect of hemoglobin A1c management levels on coronary physiology evaluated by quantitative flow ratio in patients who underwent percutaneous coronary intervention, Chen 336–345.</p><p>Peripheral nerve function</p><p>Glycemic variability is associated with sural nerve conduction velocity in outpatients with type 2 diabetes: Usefulness of a new point-of-care device for nerve conduction studies, Morita 1075–1083.</p><p>Permeability</p><p>Microvascular permeability and texture analysis of bone marrow in diabetic rabbits with critical limb ischemia based on dynamic contrast-enhanced magnetic resonance imaging, Yang 584–593.</p><p>Pharmacoepidemiology</p><p>Assessment of cancer risk associated with 7-nitroso-3-(trifluoromethyl)-5,6,7,8-tetrahydro[1,2,4] triazolo-[4,3-a]pyrazine-contaminated sitagliptin use: A retrospective cohort study, Sugiyama 1556–1565.</p><p>Pharmacotherapy</p><p>A consensus statement from the Japan Diabetes Society: A proposed algorithm for pharmacotherapy in people with type 2diabetes – 2nd edition (English version), Bouchi 1326–1342.</p><p>Pharmacovigilance</p><p>A real-world disproportionality analysis of semaglutide: Post-marketing pharmacovigilance data, Du 1422–1433.</p><p>Plantar pressure</p><p>Plantar pressure measurement in diabetic foot disease: A scoping review, Lockhart 990–999.</p><p>Plasma glucose</p><p>Risk factors for chronic kidney disease progression over 20 years for primary prevention in Japanese individuals at a preventive medicine research center: Focus on the influence of plasma glucose levels, Minami 1434–1443.</p><p>Polygenic risk scores</p><p>Perspectives on genetic studies of type 2 diabetes from the genome-wide association studies era to precision medicine, Imamura 410–422.</p><p><i>Polygonatum sibiricum</i> polysaccharide</p><p><i>Polygonatum sibiricum</i> (Huang Jing) polysaccharide reduces diabetic cardiomyopathy through increasing cyclic guanosine monophosphate-protein kinase G signaling in diabetic mice, Lei 823–834.</p><p>Polypharmacy</p><p>Management of older adults with diabetes mellitus: Perspective from geriatric medicine, Umegaki 1347–1354.</p><p>Population attributable fraction</p><p>Health impacts of new-onset diabetes in women post-gestational diabetes mellitus: Insights from Hong Kong's territory-wide data, Zhang 772–781.</p><p>Post-load plasma glucose</p><p>Linking extent of return to fasting state after oral glucose tolerance test to future risk of prediabetes and type 2 diabetes: Insights from the TLGS, Masrouri 1743–1752.</p><p>Postnatal</p><p>Overnutrition in the early postnatal period influences lifetime metabolic risk: Evidence for impact on pancreatic β-cell mass and function, Burton 263–274.</p><p>Postprandial period</p><p>Delayed dinnertime impairs glucose tolerance in healthy young adults, Nakamura 172–176.</p><p>Prediabetes</p><p>Characteristics of individuals who developed type 2 diabetes from prediabetes despite undergoing interventions, and evaluation of the performance of urinary myo-inositol as a risk factor for developing diabetes, Yamagata 177–185.</p><p>External validation of the Hong Kong Chinese nonlaboratory risk models and scoring algorithm for case finding of prediabetes and diabetes mellitus in primary care, Cheng 1317–1325.</p><p>Prediabetes progression</p><p>High sensitivity C-reactive protein and prediabetes progression and regression in middle-aged and older adults: A prospective cohort study, Cheng 78–86.</p><p>Prediabetes regression</p><p>High sensitivity C-reactive protein and prediabetes progression and regression in middle-aged and older adults: A prospective cohort study, Cheng 78–86.</p><p>Prediction</p><p>Prediction of future insulin-deficiency in glutamic acid decarboxylase autoantibody enzyme-linked immunosorbent assay-positive patients with slowly progressive type 1 diabetes, Kawasaki 835–842.</p><p>Post-load glucose is a stronger predictor of adverse pregnancy outcomes than first-trimester HbA1c in women without gestational diabetes, Rajabi 914–921.</p><p>Risk factors and prediction score for new-onset diabetes mellitus after liver transplantation, Bai 1105–1114.</p><p>Prediction model</p><p>Development and validation of a prediction model for self-reported hypoglycemia risk in patients with type 2 diabetes: A longitudinal cohort study, Xu 468–482.</p><p>Prediction of onset of diabetes</p><p>Characteristics of individuals who developed type 2 diabetes from prediabetes despite undergoing interventions, and evaluation of the performance of urinary myo-inositol as a risk factor for developing diabetes, Yamagata 177–185.</p><p>Pregnancy</p><p>Post-load glucose is a stronger predictor of adverse pregnancy outcomes than first-trimester HbA1c in women without gestational diabetes, Rajabi 914–921.</p><p>Pregnancy outcome</p><p>Second-trimester triglyceride-glucose index to predict adverse outcomes in women with gestational diabetes mellitus: A retrospective multicenter cohort study, Bai 1489–1499.</p><p>Prenatal</p><p>Overnutrition in the early postnatal period influences lifetime metabolic risk: Evidence for impact on pancreatic β-cell mass and function, Burton 263–274.</p><p>Progestin and adipoQ receptor 3</p><p>Circ_0068087 knockdown attenuates high-glucose-induced human tubular epithelial cell injury in a microribonucleic acid/progestin and adipoQ receptor 3-dependent manner in diabetic nephropathy, Liu 159–171.</p><p>Prohibitin2</p><p>Oxidative stress suppresses PHB2-mediated mitophagy in β-cells via the Nrf2/PHB2 pathway, Liu 559–571.</p><p>Prospective studies</p><p>PIONEER REAL Japan: Baseline characteristics of a multicenter, prospective, real-world study of oral semaglutide in adults with type 2 diabetes in clinical practice in Japan, Suzuki 1047–1056.</p><p>PIONEER REAL Japan: Primary results from a multicenter, prospective, real-world study of oral semaglutide in adults with type 2 diabetes in Japanese clinical practice, Yabe 1566–1577.</p><p>Protein catabolism</p><p>Corticosteroid-triggered acute skeletal muscle loss in lipodystrophy: A case report, Sasako 782–785.</p><p>Proteinuria</p><p>Young-onset type 2 diabetes mellitus enhances proteinuria, but not glomerular filtration rate decline: A Japanese cohort study, Saito 1444–1456.</p><p>Public health</p><p>Health impacts of new-onset diabetes in women post-gestational diabetes mellitus: Insights from Hong Kong's territory-wide data, Zhang 772–781.</p><p>Quantitative flow ratio</p><p>Effect of hemoglobin A1c management levels on coronary physiology evaluated by quantitative flow ratio in patients who underwent percutaneous coronary intervention, Chen 336–345.</p><p>Reactive hyperemia index</p><p>Comparative effects of fixed-dose mitiglinide/voglibose combination and glimepiride on vascular endothelial function and glycemic variability in patients with type 2 diabetes: A randomized controlled trial, Tanaka 449–458.</p><p>Reactive oxygen species</p><p><i>Polygonatum sibiricum</i> (Huang Jing) polysaccharide reduces diabetic cardiomyopathy through increasing cyclic guanosine monophosphate-protein kinase G signaling in diabetic mice, Lei 823–834.</p><p>Real-world data</p><p>Risk stratification for cardiovascular disease based on prior coronary artery disease, cerebrovascular disease and type 2 diabetes mellitus, Oe 1464–1471.</p><p>Sulfonylurea prescription patterns in elderly patients with type 2 diabetes mellitus: A comprehensive analysis of real-world data from pharmacies in Japan, Yamazaki 1604–1613.</p><p>Real-world evidence</p><p>Patient-reported outcomes and treatment adherence in type 2 diabetes using natural language processing: Wave 8 of the Observational International Diabetes Management Practices Study, Chan 1306–1316.</p><p>Regulatory T cells</p><p>Regulatory T cells protect against diabetic cardiomyopathy in <i>db/db</i> mice, Zhang 1191–1201.</p><p>Remnant cholesterol</p><p>Remnant cholesterol, but not other traditional lipids or lipid ratios, is independently and positively related to future diabetes risk in Chinese general population: A 3 year cohort study, Li 1084–1093.</p><p>Remote pressure measurement</p><p>Plantar pressure measurement in diabetic foot disease: A scoping review, Lockhart 990–999.</p><p>Renal cyst</p><p>Decline in measured glomerular filtration rate is associated with simple renal cyst in Chinese patients with type 2 diabetes, Qiaoling 26–33.</p><p>Resistant starch</p><p>Resistant starch and type 2 diabetes mellitus: Clinical perspective, Kim 395–401.</p><p>Resistin</p><p>Interaction effect between low birthweight and resistin gene rs1862513 variant on insulin resistance and type 2 diabetes mellitus in adulthood: Toon Genome Study, Yoshida 725–735.</p><p>Ribosomal protein S26</p><p>Association of RPS26 gene polymorphism with different types of diabetes in Chinese individuals, Song 34–43.</p><p>Risk</p><p>Post-load glucose is a stronger predictor of adverse pregnancy outcomes than first-trimester HbA1c in women without gestational diabetes, Rajabi 914–921.</p><p>Risk prediction models</p><p>External validation of the Hong Kong Chinese nonlaboratory risk models and scoring algorithm for case finding of prediabetes and diabetes mellitus in primary care, Cheng 1317–1325.</p><p>Salt restriction</p><p>Multicenter, open-label, randomized controlled superiority trial for availability to reduce nocturnal urination frequency: The TOP-STAR study, Nakajima 1809–1817.</p><p>Sarcopenic obesity</p><p>Coexistence of high visceral fat area and sarcopenia is associated with atherosclerotic markers in old-old patients with diabetes: A cross-sectional study, Sato 1510–1518.</p><p>Screening</p><p>Sheffield One-Stop Service: A potential model to improve the screening uptake of diabetic peripheral neuropathy and other microvascular complications of diabetes, Sloan 1355–1362.</p><p>Screening methods</p><p>Comparing the screening methods for gestational diabetes mellitus before and during the COVID-19 pandemic: A systematic review, Sun 500–516.</p><p>Self-management</p><p>Implementation rate of diabetic self-management education and support for Japanese people with diabetes using the National Database, Ihana-Sugiyama 861–866.</p><p>Semaglutide</p><p>PIONEER REAL Japan: Baseline characteristics of a multicenter, prospective, real-world study of oral semaglutide in adults with type 2 diabetes in clinical practice in Japan, Suzuki 1047–1056.</p><p>A real-world disproportionality analysis of semaglutide: Post-marketing pharmacovigilance data, Du 1422–1433.</p><p>Adherence and treatment discontinuation of oral semaglutide and once-weekly semaglutide injection at 12 month follow-up: Japanese real-world data, Horii 1578–1584.</p><p>Semicarbazide-sensitive amine oxidase</p><p>The role of vascular adhesion protein-1 in diabetes and diabetic complications, Yen 982–989.</p><p>Serum amyloid A</p><p>Association of serum amyloid A and prognosis in people with diabetes and COVID-19: A retrospective cohort study, Qu 44–51.</p><p>Serum uric acid</p><p>Inverted U-shaped associations between serumuric acid and fasting - plasma glucose level in non-diabetic, pre-diabetic, and diabetic adults: A population-based study in China, Shi 483–490.</p><p>Severe atherothrombotic brain infarction</p><p>Factor affecting severe atherothrombotic cerebral infarction in patients with type 2 diabetes mellitus: Large-scale claim database analysis of Japan, Horii 1651–1662.</p><p>SGLT2 inhibitor</p><p>A multicenter, open-label, single-arm trial of the long-term safety of empagliflozin treatment for refractory diabetes mellitus with insulin resistance (EMPIRE-02), Hirota 1211–1219.</p><p>Multicenter, open-label, randomized controlled superiority trial for availability to reduce nocturnal urination frequency: The TOP-STAR study, Nakajima 1809–1817.</p><p>Sitagliptin phosphate</p><p>Assessment of cancer risk associated with 7-nitroso-3-(trifluoromethyl)-5,6,7,8-tetrahydro[1,2,4] triazolo-[4,3-a]pyrazine-contaminated sitagliptin use: A retrospective cohort study, Sugiyama 1556–1565.</p><p>Slowly progressive type 1 diabetes</p><p>New diagnostic criteria (2023) for slowly progressive type 1 diabetes (SPIDDM): Report from Committee on Type 1 Diabetes of the Japan Diabetes Society (English version), Shimada 254–257.</p><p>Prediction of future insulin-deficiency in glutamic acid decarboxylase autoantibody enzyme-linked immunosorbent assay-positive patients with slowly progressive type 1 diabetes, Kawasaki 835–842.</p><p>Small dense low-density lipoprotein cholesterol</p><p>Elevated small dense low-density lipoprotein cholesterol to high-density lipoprotein cholesterol ratio is associated with an increased risk of metabolic dysfunction-associated fatty liver disease in Chinese patients with type 2 diabetes mellitus, Yang 634–642.</p><p>Social deprivation</p><p>Social deprivation and diabetic kidney disease: A European view, Casey 541–556.</p><p>Socioeconomic status</p><p>Associations between income/employment status and diabetes care processes, health behaviors, and health outcomes in Japan: A cross-sectional study using claims data linked to a questionnaire survey, Yamaoka 1684–1695.</p><p>Sodium–glucose cotransporter 2 inhibitor</p><p>Effect of sodium–glucose cotransporter 2 inhibitors on serum low-density lipoprotein cholesterol in Japanese patients with type 2 diabetes mellitus, Imada 843–850.</p><p>Sodium–glucose cotransporter 2 inhibitor therapy reduces the administration frequency of steroid injection in patients with diabetic macular edema: A cohort study using the Japanese health insurance claims database, Ishibashi 1231–1238.</p><p>Sodium–glucose cotransporter 2 inhibitors</p><p>Healthcare resource utilization and healthcare costs in patients with type 2 diabetes mellitus initiating sodium-glucose cotransporter 2inhibitors vs dipeptidyl peptidase-4 inhibitors in Japan: A real-world administrative database analysis, Kashiwagi 374–387.</p><p>Small dense low-density lipoprotein cholesterol</p><p>Estimated small dense low-density lipoprotein cholesterol and nonalcoholic fatty liver disease in nonobese populations, Huang 491–499.</p><p>Long-term effects of ipragliflozin and pioglitazone on metabolic dysfunction-associated steatotic liver disease in patients with type 2 diabetes: 5 year observational follow-up of a randomized, 24 week, active-controlled trial, Ito 1220–1230.</p><p>South Africa</p><p>Investigating the altered expression of miR-486-5p and miR-novel-chr1_40444 in dysglycemia in a South African population, Weale 1377–1389.</p><p>Statin</p><p>Optimizing lipid control in Taiwanese diabetic patients: A collaborative consensus by the Diabetes Association of the Republic of China (Taiwan) and the Taiwanese Association of Diabetes Educators, Shen 1151–1160.</p><p>Steroid injection</p><p>Sodium–glucose cotransporter 2 inhibitor therapy reduces the administration frequency of steroid injection in patients with diabetic macular edema: A cohort study using the Japanese health insurance claims database, Ishibashi 1231–1238.</p><p>Steroid myopathy</p><p>Corticosteroid-triggered acute skeletal muscle loss in lipodystrophy: A case report, Sasako 782–785.</p><p>Stratification</p><p>What characteristics are most important in stratifying patients into groups with different risk of diabetic foot ulceration?, Naemi 1094–1104.</p><p>Sulfonylurea</p><p>Sulfonylurea prescription patterns in elderly patients with type 2 diabetes mellitus: A comprehensive analysis of real-world data from pharmacies in Japan, Yamazaki 1604–1613.</p><p>Survival</p><p>Impact of diabetes on the prognosis of patients with oral and oropharyngeal cancer: A meta-analysis, Xu 1140–1150.</p><p>Sympathetic skin response</p><p>Sympathetic skin response for early detection of type 2 diabetic peripheral neuropathy and nephropathy, Liu 106–112.</p><p>Systematic Coronary Risk Evaluation 2-Diabetes risk</p><p>Predictive value of Systematic Coronary Risk Evaluation 2-Diabetes risk model and arterial stiffness for cardiovascular events in the Asian population with type 2 diabetes mellitus, Suwannasom 1266–1275.</p><p>Tanshinone IIA</p><p>Tanshinone IIA suppresses ferroptosis to attenuate renal podocyte injury in diabetic nephropathy through the embryonic lethal abnormal visual-like protein 1 and acyl-coenzyme A synthetase long-chain family member 4 signaling pathway, Zhu 1003–1016.</p><p>Tehran Lipid and Glucose Study</p><p>Linking extent of return to fasting state after oral glucose tolerance test to future risk of prediabetes and type 2 diabetes: Insights from the TLGS, Masrouri 1743–1752.</p><p>Texture analysis</p><p>Microvascular permeability and texture analysis of bone marrow in diabetic rabbits with critical limb ischemia based on dynamic contrast-enhanced magnetic resonance imaging, Yang 584–593.</p><p>Tezepelumab</p><p>A case of type 2 diabetes mellitus with weight gain and worsening of glycemic management after tezepelumab administration for severe bronchial asthma, Umamoto 388–390.</p><p>Therapeutic inertia</p><p>Mandatory monthly outpatient visits could improve therapeutic inertia in patients with poorly controlled type 2 diabetes, Tsai 227–236.</p><p>The Simple Diagnostic Criteria for Diabetic Polyneuropathy</p><p>Prevalence and characteristics of diabetic symmetric sensorimotor polyneuropathy in Japanese patients with type 2 diabetes: The Japan Diabetes Complication and its Prevention Prospective study (JDCP study 10), Kamiya 247–253.</p><p>Thrombospondin-1</p><p>Relationship between elevated circulatingthrombospondin-1 levels and vascular complications in diabetes mellitus, Guo 197–207.</p><p>Relationship between circulating thrombospondin-1 messenger ribonucleic acid and microribonucleic acid-194 levels in Chinese patients with type 2 diabetic kidney disease: The outcomes of a case–control study, Ma 1248–1258.</p><p>Tolerability</p><p>Efficacy and tolerability of oral semaglutide in Japanese patients with type 2 diabetes mellitus: Analysis report from diabetes specialist clinics, Inokuchi 1202–1210.</p><p>Transition</p><p>Evaluation of the transition program at the University Hospital of Reims from 2015 to 2020, Chibane 1519–1523.</p><p>Treatment</p><p>Prevalence, awareness, treatment and control of type 2 diabetes in southeast China: A population-based study, Hu 1034–1041.</p><p>Treatment – Education</p><p>Patient-reported outcomes and treatment adherence in type 2 diabetes using natural language processing: Wave 8 of the Observational International Diabetes Management Practices Study, Chan 1306–1316.</p><p>Treatment response</p><p>Factors contributing to the clinical effectiveness of imeglimin monotherapy in Japanese patients with type 2 diabetes mellitus, Hagi 1239–1247.</p><p>Triglyceride-glucose index</p><p>Second-trimester triglyceride-glucose index to predict adverse outcomes in women with gestational diabetes mellitus: A retrospective multicenter cohort study, Bai 1489–1499.</p><p>TXNIP/NLRP3 inflammasome</p><p>Calpeptin improves the cognitive function in Alzheimer's disease-like complications of diabetes mellitus rats by regulating TXNIP/NLRP3 inflammasome, Qiao 1365–1376.</p><p>Type 1 diabetes</p><p>Interactive calculator to estimate insulin sensitivity in type 1 diabetes, Januszewski 594–597.</p><p>Global cognition and executive functions of older adults with type 1 diabetes mellitus without dementia, Nagasawa 922–930.</p><p>Evaluation of the transition program at the University Hospital of Reims from 2015 to 2020, Chibane 1519–1523.</p><p>Type 1 diabetes mellitus</p><p>Type 1 diabetes, COVID-19 vaccines and short-term safety: Subgroup analysis from the global COVAD study, Chatterjee 131–138.</p><p>Effects of hybrid closed-loop system on glycemic control and psychological aspects in persons with type 1 diabetes treated with sensor-augmented pump: A prospective single-center observational study, Akiyama 219–226.</p><p>Type 2</p><p>Prevalence, awareness, treatment and control of type 2 diabetes in southeast China: A population-based study, Hu 1034–1041.</p><p>Type 2 diabetes</p><p>Exploration of the mechanism of reinfusion of fresh autologous blood in type 2 diabetes mice to induce macrophage polarization and inhibit erythrocyte damage, Hu 70–77.</p><p>Mandatory monthly outpatient visits could improve therapeutic inertia in patients with poorly controlled type 2 diabetes, Tsai 227–236.</p><p>Changing landscape of diabetes in Asia – What are the unmet needs?, Luk 402–409.</p><p>Perspectives on genetic studies of type 2 diabetes from the genome-wide association studies era to precision medicine, Imamura 410–422.</p><p>Short-term recovery of insulin secretion in response to a meal is associated with future glycemic control in type 2 diabetes patients, Enkaku 437–448.</p><p>Coexistence of type 2 diabetes mellitus, arginine vasopressin deficiency, and Marfan syndrome: A case report, Le 964–967.</p><p>Eating behaviors and incidence of type 2 diabetes in Japanese people: The population-based Panasonic cohort study 15, Toyokuni 1017–1025.</p><p>PIONEER REAL Japan: Baseline characteristics of a multicenter, prospective, real-world study of oral semaglutide in adults with type 2 diabetes in clinical practice in Japan, Suzuki 1047–1056.</p><p>Internet of things-based approach for glycemic control in people with type 2 diabetes: A randomized controlled trial, Bouchi 1287–1296.</p><p>Patient-reported outcomes and treatment adherence in type 2 diabetes using natural language processing: Wave 8 of the Observational International Diabetes Management Practices Study, Chan 1306–1316.</p><p>A consensus statement from the Japan Diabetes Society: A proposed algorithm for pharmacotherapy in people with type 2diabetes – 2nd edition (English version), Bouchi 1326–1342.</p><p>Investigating the altered expression of miR-486-5p and miR-novel-chr1_40444 in dysglycemia in a South African population, Weale 1377–1389.</p><p>Efficacy of long-term low-carbohydrate diets for patients with type 2 diabetes: A systematic review and meta-analysis, Ichikawa 1410–1421.</p><p>Association of xanthine oxidoreductase inhibitor use with insulin secretory capacity inpatients with type 2 diabetes, Kitamura 1500–1509.</p><p>Application of the integrated data platform combined with dietary management for adults with diabetes: A prospective randomized controlled trial, Liu 1548–1555.</p><p>Safety and effectiveness of tofogliflozin in Japanese people with type 2 diabetes: A multicenter prospective observational study in routine clinical practice, Yamada 1585–1595.</p><p>Sodium–glucose cotransporter 2 inhibition through henagliflozin ameliorates cognitive impairment in patients with type 2 diabetes, Zhang 1596–1603.</p><p>Factor affecting severe atherothrombotic cerebral infarction in patients with type 2 diabetes mellitus: Large-scale claim database analysis of Japan, Horii 1651–1662.</p><p>Haptoglobin phenotype and levels in type 2 diabetes and effects of fenofibrate, Januszewski 1663–1668.</p><p>Type 2 diabetes mellitus</p><p>Oxidative stress suppresses PHB2-mediated mitophagy in β-cells via the Nrf2/PHB2 pathway, Liu 559–571.</p><p>The correlation between serum asprosin and left ventricular diastolic dysfunction in elderly patients with type 2 diabetes mellitus in the community, Liang 608–613.</p><p>Elevated small dense low-density lipoprotein cholesterol to high-density lipoprotein cholesterol ratio is associated with an increased risk of metabolic dysfunction-associated fatty liver disease in Chinese patients with type 2 diabetes mellitus, Yang 634–642.</p><p>High glucose promotes atherosclerosis by regulating miRNA let7d-5p level, Wang 711–724.</p><p>Effect of sodium–glucose cotransporter 2 inhibitors on serum low-density lipoprotein cholesterol in Japanese patients with type 2diabetes mellitus, Imada 843–850.</p><p>Serum vitamin D is substantially reduced and predicts flares in diabetic retinopathy patients, Zhuang 867–873.</p><p>Association between glycated hemoglobin and risk of all-cause mortality in community patients with type 2 diabetes: A prospective cohort study, He 939–945.</p><p>Influence of disease course and comprehensive management on blood glucose level in children and adolescents with type 2 diabetes mellitus, Wu 1026–1033.</p><p>Factors contributing to the clinical effectiveness of imeglimin monotherapy in Japanese patients with type 2 diabetes mellitus, Hagi 1239–1247.</p><p>Risk stratification for cardiovascular disease based on prior coronary artery disease, cerebrovascular disease and type 2 diabetes mellitus, Oe 1464–1471.</p><p>Linking extent of return to fasting state after oral glucose tolerance test to future risk of prediabetes and type 2 diabetes: Insights from the TLGS, Masrouri 1743–1752.</p><p>Metabolic dysfunction-associated steatotic liver disease: A superior predictor for incident type 2 diabetes over traditional criteria – NAGALA study, Sakai 1788–1796.</p><p>Type 2 diabetes susceptibility genes</p><p>Interaction effect between low birthweight and resistin gene rs1862513 variant on insulin resistance and type 2 diabetes mellitus in adulthood: Toon Genome Study, Yoshida 725–735.</p><p>Update</p><p>Effectiveness and safety of sodium–glucose cotransporter 2 inhibitors in Asian populations, Ha 285–287.</p><p>Interplay of cardiovascular health and diabetes: Insights into weight management and risk reduction, Hsu 707–710.</p><p>Advances in diagnostic methods for early-stage diabetic polyneuropathy, Naruse 820–822.</p><p>An update of contemporary insulin therapy, Tsai 1000–1002.</p><p>Clinical lessons for diabetes treatment from the COVID-19 pandemic, Hamamoto 1363–1364.</p><p>Clinical challenges in early pregnancy in Japan: An update on gestational diabetes, Sugiyama 1729–1731.</p><p>Uric acid</p><p>Association between serum uric acid-to-high-density lipoprotein cholesterol ratio and insulin resistance in patients with type 2 diabetes mellitus, Zhou 113–120.</p><p>Association between serum uric acid-to-high-density lipoprotein cholesterol ratio and insulin resistance in an American population: A population-based analysis, Zhou 762–771.</p><p>Uric acid-to-high-density lipoprotein cholesterol ratio</p><p>Association between serum uric acid-to-high-density lipoprotein cholesterol ratio and insulin resistance in patients with type 2 diabetes mellitus, Zhou 113–120.</p><p>Urinary myo-inositol</p><p>Characteristics of individuals who developed type 2 diabetes from prediabetes despite undergoing interventions, and evaluation of the performance of urinary myo-inositol as a risk factor for developing diabetes, Yamagata 177–185.</p><p>Vaccine</p><p>Type 1 diabetes, COVID-19 vaccines and short-term safety: Subgroup analysis from the global COVAD study, Chatterjee 131–138.</p><p>Variation in hemoglobin A1c</p><p>Association between variation in hemoglobin A1c levels and diabetes therapy-related quality of life in patients with diabetes, Imai 1042–1046.</p><p>Vascular adhesion protein-1</p><p>The role of vascular adhesion protein-1 in diabetes and diabetic complications, Yen 982–989.</p><p>Visceral fat area</p><p>Coexistence of high visceral fat area and sarcopenia is associated with atherosclerotic markers in old-old patients with diabetes: A cross-sectional study, Sato 1510–1518.</p><p>Vitamin D</p><p>Serum vitamin D is substantially reduced and predicts flares in diabetic retinopathy patients, Zhuang 867–873.</p><p>Waist circumference</p><p>The impact of handgrip strength and waist circumference on glycemic control: Prospective, observational study using outpatient clinical data in Japanese patients with type 2 diabetes mellitus, Nakanishi 892–898.</p><p>Weight loss</p><p>Safety and effectiveness of tofogliflozin in Japanese people with type 2 diabetes: A multicenter prospective observational study in routine clinical practice, Yamada 1585–1595.</p><p>Weight reduction</p><p>Effect of intermittent fasting 16:8 and 14:10 compared with control-group on weight reduction and metabolic outcomes in obesity with type 2 diabetes patients: A randomized controlled trial, Sukkriang 1297–1305.</p><p>Wound healing</p><p>MiR-488-3p facilitates wound healing throughCYP1B1-mediated Wnt/β-catenin signaling pathway by targeting MeCP2, Zuo 145–158.</p><p>XOR inhibitor</p><p>Association of xanthine oxidoreductase inhibitor use with insulin secretory capacity inpatients with type 2 diabetes, Kitamura 1500–1509.</p><p>Young-onset diabetes</p><p>Changing landscape of diabetes in Asia – What are the unmet needs?, Luk 402–409.</p><p>Young-onset type 2 diabetes mellitus enhances proteinuria, but not glomerular filtration rate decline: A Japanese cohort study, Saito 1444–1456.</p>\",\"PeriodicalId\":51250,\"journal\":{\"name\":\"Journal of Diabetes Investigation\",\"volume\":\"15 12\",\"pages\":\"1841-1861\"},\"PeriodicalIF\":3.1000,\"publicationDate\":\"2024-12-04\",\"publicationTypes\":\"Journal Article\",\"fieldsOfStudy\":null,\"isOpenAccess\":false,\"openAccessPdf\":\"https://onlinelibrary.wiley.com/doi/epdf/10.1111/jdi.14374\",\"citationCount\":\"0\",\"resultStr\":null,\"platform\":\"Semanticscholar\",\"paperid\":null,\"PeriodicalName\":\"Journal of Diabetes Investigation\",\"FirstCategoryId\":\"3\",\"ListUrlMain\":\"https://onlinelibrary.wiley.com/doi/10.1111/jdi.14374\",\"RegionNum\":3,\"RegionCategory\":\"医学\",\"ArticlePicture\":[],\"TitleCN\":null,\"AbstractTextCN\":null,\"PMCID\":null,\"EPubDate\":\"\",\"PubModel\":\"\",\"JCR\":\"Q2\",\"JCRName\":\"ENDOCRINOLOGY & METABOLISM\",\"Score\":null,\"Total\":0}","platform":"Semanticscholar","paperid":null,"PeriodicalName":"Journal of Diabetes Investigation","FirstCategoryId":"3","ListUrlMain":"https://onlinelibrary.wiley.com/doi/10.1111/jdi.14374","RegionNum":3,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"","PubModel":"","JCR":"Q2","JCRName":"ENDOCRINOLOGY & METABOLISM","Score":null,"Total":0}
引用次数: 0

摘要

妊娠24-28周随机血糖水平筛查妊娠糖尿病的问题，Tomimoto 1797-1802。β-细胞功能障碍葡萄糖代谢通过表观基因组改变部分调节β-细胞功能，Kim 649-655。β细胞自噬在β细胞生理和糖尿病发生中的作用，Yasasilka 656-668。β-细胞质量葡萄糖激酶单倍体不足对长期高脂高糖饮食小鼠胰腺β-细胞质量和功能的影响，Shigesawa 1732-1742。准确性红细胞压积水平对特定血糖仪准确性的影响：一项基于医院的研究，Pham 1472-1482。丹参酮IIA通过胚胎致死性异常视样蛋白1和酰基辅酶A合成酶长链家族成员4信号通路抑制铁下垂减轻糖尿病肾病肾足细胞损伤，Zhu 1003-1016。在冠状病毒大流行的第一年，接受糖尿病护理对COVID-19感染和HbA1c水平之间关系的影响，使用基于全国人口的数据库Okada 953-963。2型糖尿病患者口服降糖药依从性的患病率：一项系统回顾和荟萃分析，boonpathatharatthiti 1614-1625。生物标志物和Barthel指数与糖尿病患者年龄相关不良健康结局发生的关系，Umamoto 1675-1683。中国2型糖尿病患者饮酒与血糖控制之间的关系，叶237-244。醛脱氢酶2线粒体ALDH2通过靶向CK2信号通路改善β细胞存活和抗阿霉素诱导的凋亡功能，Karunakaran 684-692日本糖尿病学会的共识声明：2型糖尿病患者药物治疗的建议算法-第2版（英文版），Bouchi 1326-1342。DMCalpeptin通过调节TXNIP/NLRP3炎性体改善糖尿病大鼠阿尔茨海默病样并发症的认知功能，乔1365-1376。血管生成素样4是2型糖尿病患者糖尿病肾病的潜在生物标志物，Wang 1763-1772。糖尿病中的肿瘤生物学更新：聚焦于降糖药，Kawakita 525-540。2型糖尿病患者胰岛β细胞质量、功能及抗糖尿病药物的治疗意义。高密度脂蛋白在糖尿病中的抗炎活性：结构和功能的相关性，吕氏，805-816。高密度脂蛋白在糖尿病中的抗氧化活性：结构和功能的相关性。c肽曲线下面积：口服糖耐量试验中c肽曲线下面积与2型糖尿病视网膜病变的关系，Zhang 315-325。精氨酸加压素缺乏症2型糖尿病、精氨酸加压素缺乏症和马凡氏综合征共存：1例报告，Le 964-967。2型糖尿病患者血糖危险指数与动脉僵硬度的关系，蔡614-622。亚洲不断变化的糖尿病状况——有哪些未满足的需求？路加福音402-409。阿司匹林：低剂量阿司匹林预防2型糖尿病和慢性肾脏疾病患者心血管死亡：一项真实世界的全国队列研究，Lin 459-467。社区老年2型糖尿病患者血清asprosin与左室舒张功能障碍的相关性[j]， Liang 608-613。2型糖尿病不同病程患者血清asprosin与代谢特征及并发症的相关性分析，Ma 1781-1787。哮喘1例2型糖尿病患者在使用tezepelumab治疗严重支气管哮喘后体重增加和血糖管理恶化，Umamoto 388-390。高葡萄糖通过调节miRNA let7d-5p水平促进动脉粥样硬化，Wang 711-724。高内脏脂肪区和肌肉减少的共存与老年糖尿病患者的动脉粥样硬化标志物相关：一项横断面研究，Sato 1510-1518。肠道上皮细胞转化为胰岛素生成细胞治疗糖尿病，Accili 797-804。β细胞自噬在β细胞生理和糖尿病发生中的作用，Yasasilka 656-668。基于2011-2020年期间68,555例调查结果的日本糖尿病患者死亡原因：糖尿病死亡原因委员会报告，日本糖尿病学会（英文版），Nakamura 1821-1837。 氯吡格雷致复发性低血糖1例，文献回顾，[j]。2型糖尿病患者自我报告低血糖风险预测模型的建立和验证：一项纵向队列研究，Xu 468-482。胰岛移植在韩国的应用，Lee 1165-1170。连续血糖监测对胃切除术后低血糖的诊断价值，Son 1696-1699。低镁血症肝细胞核因子1B缺失，而非基因内突变，可能更容易发生低镁血症，Wang 121-130。不同心血管健康状态下代谢综合征和胰岛素抵抗与心血管事件风险的关系，Hosseinpour-Niazi 208-218。2型糖尿病患者使用专业连续血糖监测甘精胰岛素U-100/利昔那肽的疗效和安全性比较，Kawaguchi 598-607。免疫球蛋白重定γ 1沉默降低强直反应增强结合蛋白的表达以减轻糖尿病肾病，Hu 572-583。iglarlix1 2型糖尿病患者使用专业连续血糖监测胰岛素葡糖苷/利拉鲁肽与甘精胰岛素U-100/利利塞那肽的疗效和安全性比较，Kawaguchi 598-607。imegliminmeglimin通过间接机制促进胰高血糖素分泌，改善高脂肪、高蔗糖饮食喂养小鼠的脂肪肝，Kikuchi 1177-1190。影响日本2型糖尿病患者伊米霉素单药治疗临床疗效的因素，Hagi 1239-1247。炎症调节性T细胞对db/db小鼠糖尿病性心肌病的保护作用，Zhang 1191-1201。中国东南部地区2型糖尿病的患病率、认知、治疗和控制：一项基于人群的研究，胡1034-1041。注射：在12个月的随访中，口服西马鲁肽和每周一次西马鲁肽注射的依从性和治疗停药：日本真实世界数据，Horii 1578-1584。胰岛素靶向PI3K/AKT和MEK/ERK通路改善周围性糖尿病神经病变特征的协同作用，Pham 1537-1544。Kasuga 1803-1808: 75 g口服糖耐量试验中多个阳性点是妊娠24周前诊断的妊娠期糖尿病早期胰岛素治疗的良好预测指标。胰岛素自身免疫性综合征氯吡格雷致低血糖1例报告及回顾性分析，文献275-281。胰岛素输注系统混合闭环系统对传感器增强泵治疗1型糖尿病患者血糖控制和心理方面的影响：一项前瞻性单中心观察研究，Akiyama 219-226。胰岛素样生长因子-1水平降低可能是2型糖尿病患者周围神经病变的危险因素。胰岛素抵抗：代谢综合征和胰岛素抵抗与不同心血管健康状态下心血管事件风险的关系，Hosseinpour-Niazi 208-218。美国人群中血清尿酸与高密度脂蛋白胆固醇比值与胰岛素抵抗的关系：一项基于人群的分析，Zhou 762-771。胰岛素分泌进食后胰岛素分泌的短期恢复与2型糖尿病患者未来的血糖控制有关，Enkaku, 437-448。2型糖尿病患者胰岛β细胞质量、功能及抗糖尿病药物的治疗意义。胰岛素分泌能力：使用黄嘌呤氧化还原酶抑制剂与2型糖尿病患者胰岛素分泌能力的关系，Kitamura 1500-1509。胰岛素敏感性评估1型糖尿病胰岛素敏感性的交互式计算器，Januszewski 594-597。与对照组相比，间歇禁食16:8和14:10对肥胖合并2型糖尿病患者体重减轻和代谢结局的影响：一项随机对照试验，Sukkriang 1297-1305。间歇性扫描连续血糖监测2型糖尿病患者报告的结果和使用自然语言处理的治疗依从性：观察性国际糖尿病管理实践研究的第8波，1306-1316。物联网2型糖尿病患者血糖控制的物联网方法：Bouchi 1287-1296的随机对照试验。肠道上皮细胞转化为胰岛素生成细胞治疗糖尿病，Accili 797-804。包封异种胰岛移植的长期疗效：包封技术和供体遗传性状的影响，Park 693-703。胰岛移植在韩国的应用，Lee 1165-1170。 日本2型糖尿病患者糖尿病对称感觉运动多神经病变的患病率和特征：日本糖尿病并发症及其预防的前瞻性研究（JDCP研究10），Kamiya 247-253。肾脏并发症对妊娠后糖尿病妇女的健康影响：来自香港地区数据的见解，张772 - 781。2型糖尿病不同病程患者血清asprosin与代谢特征及并发症的相关性分析，Ma 1781-1787。2型糖尿病患者严重动脉粥样硬化性血栓性脑梗死的影响因素：日本大规模索赔数据库分析，Horii 1651-1662。缓慢进展型1型糖尿病（SPIDDM）的新诊断标准（2023）：日本糖尿病学会1型糖尿病委员会报告（英文版），Shimada 254-257。左旋多巴糖尿病纹状病：用左旋多巴成功治疗高血糖舞蹈病/肾小球病，Tsukaguchi 1524-1527。社区老年2型糖尿病患者血清asprosin与左室舒张功能障碍的相关性研究，Liang, 608-613。糖尿病足患者与非糖尿病足患者心脏电生理、结构和舒张功能的比较，白1276-1286。久坐时间与中老年人糖尿病和葡萄糖代谢标志物的纵向关联：Hisayama研究，Tsuda 245-246。对题为“甘油三酯-葡萄糖指数与2型糖尿病患者亚临床左心室功能障碍的关联：一项回顾性横断面研究”的文章的评论，Naharci 517-518。对最近一篇题为“肝细胞核因子1B缺失，但不是基因内突变，可能更容易发生低镁血症”的文章的评论，Clissold 790。海藻酸盐-聚l -鸟氨酸微胶囊包膜人胰岛异体移植物对非免疫抑制的1型糖尿病患者的长期安全性，Calafiore 1700-1701。年轻人的成熟型糖尿病：更新命名法的建议，Tosur 1818-1819。老年糖尿病患者高内脏脂肪区、肌肉减少和动脉粥样硬化标志物共存：是否存在关联？， Saleh 1820。生活方式干预：产后生活干预预防妊娠期糖尿病妇女2型糖尿病：一项系统回顾和荟萃分析，王1115-1128。估计非肥胖人群的小密度低密度脂蛋白胆固醇和非酒精性脂肪肝疾病，Huang 491-499。脂质代谢异常在妊娠期糖尿病中的作用：早期预测和产后预后，张15 - 25。脂质谱不同种族妊娠期糖尿病妇女的脂质谱：与胎儿生长的关系，dalfr<e:1> 355-363。一项关于恩格列清治疗难治性糖尿病伴胰岛素抵抗的长期安全性的多中心、开放标签、单组试验（emperor -02）， Hirota 1211-1219。肝脏脂肪变性代谢功能障碍相关的脂肪变性肝病：比传统标准更能预测2型糖尿病的发生——nagala研究，Sakai 1788-1796。肝移植术后新发糖尿病的危险因素及预测评分[j]。低出生体重与抵抗素基因rs1862513变异在成年期胰岛素抵抗和2型糖尿病中的相互作用：Toon基因组研究，吉田725-735。低碳水化合物饮食长期低碳水化合物饮食对2型糖尿病患者的疗效：一项系统回顾和荟萃分析，Ichikawa 1410-1421。东亚2型糖尿病患者的低碳水化合物饮食：随机对照试验的系统回顾和荟萃分析，Hironaka 1753-1762。低密度脂蛋白胆固醇钠-葡萄糖共转运蛋白2抑制剂对日本2型糖尿病患者血清低密度脂蛋白胆固醇的影响，Imada 843-850。β细胞自噬溶酶体在β细胞生理和糖尿病发生中的作用，中国医学杂志，656-668。基于亲属关系图卷积网络的线粒体糖尿病8个基因组保护等位基因的识别，Wang 52-62。基于非实验室参数和肌肉力量影响的不同机器学习算法识别未确诊糖尿病的性能：一项横断面研究，Xu 743-750。基于剪切波弹性成像放射组学的可解释机器学习模型预测糖尿病肾病患者心血管疾病，Dai 1637-1650。 巨噬细胞2型糖尿病小鼠新鲜自体血回输诱导巨噬细胞极化和抑制红细胞损伤的机制探讨，Hu 70-77。基于2011-2020年期间68,555例调查结果的日本糖尿病患者死亡原因：糖尿病死亡原因委员会报告，日本糖尿病学会（英文版），Nakamura 1821-1837。马凡氏综合征2型糖尿病、精氨酸抗利尿激素缺乏和马凡氏综合征的共存：1例报告，Le 964-967。基于亲属关系图卷积网络的线粒体糖尿病基因组保护等位基因的鉴定，Wang 52-62。成熟型糖尿病的年轻肝细胞核因子1B缺失，而不是基因内突变，可能更容易发生低镁血症，王121-130。危重患者血糖与死亡率之间的关系：MIMIC-IV数据库的回顾性分析，Li 931-938。机体组成与妊娠期糖尿病风险：单变量和多变量孟德尔随机化研究，高346-354。胱抑素C与糖尿病视网膜病变之间的因果关系：一项双样本孟德尔随机研究，阮1626 - 1636。1型糖尿病与癫痫风险：一项荟萃分析，Wu 364-373。产后生活干预预防妊娠期糖尿病妇女2型糖尿病：一项系统回顾和荟萃分析，王1115-1128。长期低碳水化合物饮食对2型糖尿病患者的疗效：一项系统回顾和荟萃分析，Ichikawa 1410-1421。代谢性减肥手术：韩国肥胖患者代谢性减肥手术后心率变异性的改善，Jang 1773-1780。代谢功能障碍相关脂肪性肝病在中国2型糖尿病患者中，小密度低密度脂蛋白胆固醇与高密度脂蛋白胆固醇比值升高与代谢功能障碍相关脂肪性肝病的风险增加相关，Yang 634-642。伊普列净和吡格列酮对2型糖尿病患者代谢功能障碍相关脂肪变性肝病的长期影响：一项随机、24周、主动对照试验的5年观察随访，Ito 1220-1230代谢结局：与对照组相比，间歇禁食16:8和14:10对肥胖合并2型糖尿病患者体重减轻和代谢结局的影响：一项随机对照试验，Sukkriang 1297-1305。代谢综合征、胰岛素抵抗与不同心血管健康状态下心血管事件风险的关系，Hosseinpour-Niazi 208-218。METTL3METTL3/YTHDF2 m6A轴通过表观遗传抑制PINK1和线粒体自噬介导糖尿病肾病的进展，Wang 288-299。糖尿病肾病中微量白蛋白的鉴定和验证-负离子通道1相关基因和免疫细胞浸润，林87-105。交感皮肤反应对2型糖尿病周围神经病变和肾病的早期检测，刘106 - 112。microrna研究南非人群中miR-486-5p和miR-novel-chr1_40444在血糖异常中的表达改变，Weale 1377-1389。中国2型糖尿病肾病患者循环血栓反应蛋白-1信使核糖核酸和微核糖核酸-194水平的关系：一项病例对照研究的结果mir -30a- 3p冬虫夏草多糖通过miR-30a-3p/TRIM16轴减弱糖尿病肾病，Zheng 300-314。miR-488-3pMiR-488-3p通过cyp1b1介导的Wnt/β-catenin信号通路靶向MeCP2促进伤口愈合，Zuo 145-158。高糖通过调节MiRNA let7d-5p水平促进动脉粥样硬化，Wang 711-724。米格列奈/伏格列糖固定剂量联合片米格列奈/伏格列糖固定剂量联合片与格列美脲对2型糖尿病患者血管内皮功能和血糖变异性的比较作用：一项随机对照试验，Tanaka 449-458。伊朗新生儿糖尿病患者的分子诊断遗传变异谱：揭示14个基因中的58个不同的变异，Mianesaz 1390-1402moj .日本糖尿病自我管理中饮食行为失调因素的探索性研究，Tsukamoto-Kawashima 874-881。危重患者血糖与死亡率之间的关系：MIMIC-IV数据库的回顾性分析，Li 931-938。1型和2型糖尿病死亡率负担：基于1990 - 2019年中国和全球死亡率负担贝叶斯年龄-时期队列分析的2030年预测，董623-633。 2型糖尿病社区患者糖化血红蛋白与全因死亡风险的相关性：一项前瞻性队列研究，He 939-945。老年糖尿病患者的多病管理：从老年医学的角度来看，Umegaki 1347-1354。基于非实验室参数和肌肉力量的影响，不同机器学习算法在识别未确诊糖尿病中的表现：一项横断面研究，Xu 743-750。依帕列净治疗后正常射血分数糖尿病患者心肌应变和心肌工作的改善[j]。全球新生儿糖尿病：更新2024，Barbetti 1711-1724。伊朗新生儿糖尿病患者的遗传变异分析：揭示14个基因中的58个不同的变异。日本视障糖尿病患者新生血管性青光眼的特征，Sugihara, 882-891。非老年糖尿病患者R-R间隔的年龄调整变异系数与自主神经和周围神经功能的关系，Sugimoto 186-196。神经传导的研究，电压依赖性阴离子通道1相关基因的鉴定和验证与糖尿病肾病的免疫细胞浸润，林87-105。交感皮肤反应对2型糖尿病周围神经病变和肾病的早期检测，刘106 - 112。胰岛素样生长因子-1水平降低可能是2型糖尿病患者周围神经病变的危险因素。netrin-1循环netrin-1水平降低与糖尿病神经病变患者角膜神经纤维丢失有关，Mondal 1068-1074肝移植术后新发糖尿病的危险因素及预测评分，白1105-1114。7-亚硝基-3-（三氟甲基）-5,6,7,8-四氢[1,2,4]三唑-[4,3- A]吡嗪污染西格列汀的癌症风险评估：一项回顾性队列研究，Sugiyama 1556-1565。夜尿多中心、开放标签、随机对照、减少夜间排尿频率的优势试验：TOP-STAR研究，Nakajima 1809-1817。一种新的预测模型用于优化老年人糖尿病筛查，Lin 1403-1409。非酒精性脂肪性肝病：非肥胖人群中估计的小密度低密度脂蛋白胆固醇和非酒精性脂肪性肝病，Huang 491-499。非酒精性脂肪肝伊普列净和吡格列酮对2型糖尿病患者代谢功能障碍相关脂肪变性肝病的长期影响：一项随机、24周、主动对照试验的5年观察随访，Ito 1220-1230代谢功能障碍相关脂肪变性肝病：比传统标准更能预测2型糖尿病的发生——NAGALA研究，Sakai 1788-1796伊朗新生儿糖尿病患者的遗传变异谱：揭示14个基因中58个不同的变异，Mianesaz 1390-1402。[营养学]产后早期营养过剩影响终生代谢风险：对胰腺β细胞质量和功能影响的证据。糖尿病和糖尿病肾病饮食治疗的营养质量，Tsuruta 973-981。产后早期肥胖和营养不良影响终生代谢风险：对胰腺β细胞质量和功能影响的证据，Burton, 263-274。1例2型糖尿病患者在使用tezepelumab治疗严重支气管哮喘后体重增加和血糖管理恶化，Umamoto 388-390。美国人群中血清尿酸与高密度脂蛋白胆固醇比值与胰岛素抵抗的关系：一项基于人群的分析，Zhou 762-771。观察性研究：1型糖尿病与癫痫风险：meta分析，Wu 364-373。职业健康：糖尿病治疗状况与职业事故的关系，Ogasawara 899-905。老年人：日本老年2型糖尿病患者开始服用口服降糖药后，肾脏功能与血糖控制之间关系的医学数据库分析，Suzuki 1057-1067。在线计算器交互式计算器估计胰岛素敏感性在1型糖尿病，Januszewski 594-597。香港华人在初级保健中发现前驱糖尿病和糖尿病的非实验室风险模型和评分算法的外部验证，Cheng 1317-1325。口服西马鲁肽和每周一次西马鲁肽注射的依从性和治疗停药12个月随访：日本真实世界数据，Horii 1578-1584。 口服降糖药2型糖尿病患者口服降糖药依从性的患病率：一项系统回顾和荟萃分析，boonpatharatthiti 1614-1625。糖尿病对口腔癌和口咽癌患者预后的影响：荟萃分析，Xu 1140-1150。口服糖耐量试验75 g口服糖耐量试验中多个阳性点是妊娠24周前诊断的妊娠期糖尿病早期胰岛素治疗的良好预测指标。日本2型糖尿病患者口服西马鲁肽的疗效和耐受性：来自糖尿病专科诊所的分析报告，Inokuchi 1202-1210。PIONEER REAL Japan：日本临床实践中口服西马鲁肽治疗成人2型糖尿病的多中心、前瞻性、真实世界研究的主要结果，Yabe 1566-1577。直立性低血压：非老年糖尿病患者R-R间隔的年龄调整系数与自主神经和周围神经功能的关系，Sugimoto 186-196。在没有妊娠糖尿病的妇女中，负荷后血糖比妊娠早期HbA1c更能预测不良妊娠结局，Rajabi 914-921。氧化应激通过Nrf2/PHB2途径抑制β-细胞中PHB2介导的有丝分裂，Liu 559-571。胰岛β细胞2型糖尿病患者胰岛β细胞的质量、功能和抗糖尿病药物的治疗意义。胰腺β-细胞线粒体ALDH2通过靶向CK2信号通路提高β-细胞的存活和抗阿霉素诱导的凋亡功能。ParkinMETTL3/YTHDF2 m6A轴通过表观遗传抑制PINK1和线粒体自噬介导糖尿病肾病的进展，Wang 288-299。使用自然语言处理的2型糖尿病患者报告的结果和治疗依从性：观察性国际糖尿病管理实践研究的第8波，Chan 1306-1316。2型糖尿病患者：中国2型糖尿病患者饮酒与血糖控制的关系，叶237-244。经皮冠状动脉介入治疗中糖化血红蛋白管理水平对冠状动脉生理的影响，定量血流比评估，陈336 - 345。外周神经功能2型糖尿病门诊患者的血糖变异性与腓肠神经传导速度相关：一种新的神经传导研究点护理设备的实用性，Morita 1075-1083。基于动态磁共振增强成像的糖尿病家兔急性肢体缺血骨髓微血管通透性和结构分析，杨584 - 593。7-亚硝基-3-（三氟甲基）-5,6,7,8-四氢[1,2,4]三唑啉-[4,3- A]吡嗪污染西格列汀相关癌症风险的药物流行病学评估：一项回顾性队列研究，Sugiyama 1556-1565。药物治疗日本糖尿病学会的共识声明：2型糖尿病患者药物治疗的建议算法-第2版（英文版），Bouchi 1326-1342。药物警戒：西马鲁肽的实际歧化分析：上市后药物警戒数据，杜1422-1433。足底压力测量在糖尿病足病：范围回顾，洛克哈特990-999。在一个预防医学研究中心，日本个体20年慢性肾脏疾病初级预防进展的危险因素：关注血浆葡萄糖水平的影响，Minami 1434-1443。从全基因组关联研究时代到精准医学，2型糖尿病的遗传研究进展，Imamura 410-422。黄精多糖通过增加糖尿病小鼠环鸟苷单磷酸蛋白激酶G信号通路，降低糖尿病性心肌病，Lei 823-834。老年糖尿病患者的综合用药管理：从老年医学的角度来看，Umegaki 1347-1354。人口归因分数：妊娠后糖尿病妇女新发糖尿病对健康的影响：来自香港地区数据的见解，Zhang 772-781。口服葡萄糖耐量试验后恢复空腹状态与未来糖尿病前期和2型糖尿病风险的关联程度：来自TLGS的见解，Masrouri 1743-1752。产后早期营养影响终生代谢风险：对胰腺β细胞质量和功能影响的证据，Burton, 263-274。餐后时间延迟会损害健康年轻人的葡萄糖耐量，Nakamura 172-176。 糖尿病前期患者在接受干预后发展为2型糖尿病的个体特征，以及尿肌醇作为糖尿病发展危险因素的评估，Yamagata 177-185。香港华人非实验室风险模型和评分算法在糖尿病前期和糖尿病初级保健病例发现中的外部验证，Cheng 1317-1325。高敏感性c反应蛋白与中老年人糖尿病前期进展和消退：一项前瞻性队列研究，Cheng 78-86。高敏感性c反应蛋白与中老年糖尿病前期进展和消退：一项前瞻性队列研究，Cheng 78-86。预测谷氨酸脱羧酶自身抗体酶联免疫吸附试验阳性的缓慢进展型1型糖尿病患者未来胰岛素缺乏的预测，川崎835-842。在没有妊娠期糖尿病的妇女中，负荷后葡萄糖比妊娠早期HbA1c更能预测不良妊娠结局，Rajabi 914-921。肝移植术后新发糖尿病的危险因素及预测评分，Bai 1105-1114。2型糖尿病患者自我报告低血糖风险预测模型的建立与验证：一项纵向队列研究，Xu 468-482。糖尿病发病的预测：尽管接受了干预，但从前驱糖尿病发展为2型糖尿病的个体的特征，以及尿肌醇作为糖尿病发展危险因素的评估，Yamagata 177-185。妊娠负荷后血糖比妊娠早期HbA1c更能预测妊娠不良结局，Rajabi 914-921。妊娠结局妊娠中期甘油三酯-葡萄糖指数预测妊娠期糖尿病妇女不良结局：一项回顾性多中心队列研究，Bai 1489-1499。产前营养对产后早期胰腺β细胞质量和功能影响的证据。黄体酮和脂肪q受体3Circ_0068087基因敲低在糖尿病肾病中以微核糖核酸/黄体酮和脂肪q受体3依赖的方式减弱高糖诱导的人小管上皮细胞损伤，Liu 159-171。氧化应激通过Nrf2/PHB2途径抑制β-细胞中PHB2介导的有丝分裂，Liu 559-571。前瞻性研究pioneer REAL Japan：日本临床实践中口服西马鲁肽治疗成人2型糖尿病的多中心、前瞻性、真实世界研究的基线特征，Suzuki 1047-1056。PIONEER REAL Japan：日本临床实践中口服西马鲁肽治疗成人2型糖尿病的多中心、前瞻性、真实世界研究的主要结果，Yabe 1566-1577。蛋白质分解代谢：糖皮质激素引发的脂肪营养不良急性骨骼肌损失：一例报告，Sasako 782-785。蛋白尿年轻发病的2型糖尿病会增加蛋白尿，但不会降低肾小球滤过率：一项日本队列研究，Saito 1444-1456。新发糖尿病对妊娠后糖尿病妇女健康的影响：来自香港地区数据的见解，Zhang 772-781。定量血流比在经皮冠状动脉介入治疗患者中评估血红蛋白A1c管理水平对冠状动脉生理的影响，Chen 336-345。固定剂量米格列奈/伏格糖与格列美脲对2型糖尿病患者血管内皮功能和血糖变异性的影响：一项随机对照试验，Tanaka 449-458。活性氧物质黄精多糖通过增加糖尿病小鼠环鸟苷单磷酸蛋白激酶G信号通路减少糖尿病心肌病，Lei 823-834。现实世界数据：基于既往冠状动脉疾病、脑血管疾病和2型糖尿病的心血管疾病风险分层，Oe 1464-1471。老年2型糖尿病患者的磺脲类药物处方模式：来自日本药房真实世界数据的综合分析，Yamazaki 1604-1613。使用自然语言处理的2型糖尿病患者报告的结果和治疗依从性：观察性国际糖尿病管理实践研究的第8波，1306-1316。调节性T细胞：调节性T细胞对db/db小鼠糖尿病性心肌病的保护作用，Zhang 1191-1201。残余胆固醇残余胆固醇，而不是其他传统的脂质或脂质比率，与中国普通人群未来糖尿病风险独立且正相关：一项为期3年的队列研究，Li 1084-1093。 远程压力测量糖尿病足病的足底压力测量：范围综述，洛克哈特990-999。肾囊肿中国2型糖尿病患者肾小球滤过率下降与单纯性肾囊肿有关，Qiaoling 26-33。耐药淀粉与2型糖尿病的临床研究进展低出生体重和抵抗素基因rs1862513变异对成年期胰岛素抵抗和2型糖尿病的相互作用：Toon基因组研究，吉田725-735。核糖体蛋白s26 RPS26基因多态性与中国不同类型糖尿病的相关性，Song 34-43。在没有妊娠期糖尿病的妇女中，负荷后血糖比妊娠早期HbA1c更能预测不良妊娠结局，Rajabi 914-921。香港华人非实验室风险模型和评分算法在糖尿病前期和糖尿病初级保健病例发现中的外部验证，Cheng 1317-1325。食盐限制多中心、开放标签、随机对照、减少夜间排尿频率的优势试验：TOP-STAR研究，Nakajima 1809-1817。高内脏脂肪区和肌肉减少症共存与老年糖尿病患者的动脉粥样硬化标志物相关：一项横断面研究，Sato 1510-1518。ScreeningSheffield一站式服务：改善糖尿病周围神经病变和其他糖尿病微血管并发症筛查摄取的潜在模式，Sloan 1355-1362。筛查方法2019冠状病毒病大流行前后妊娠期糖尿病筛查方法的比较：一项系统综述，Sun 500-516。自我管理：日本糖尿病患者自我管理教育和支持的执行率（使用国家数据库），Ihana-Sugiyama 861-866。SemaglutidePIONEER REAL日本：日本临床实践中口服semaglutide治疗成人2型糖尿病的多中心、前瞻性、真实世界研究的基线特征，Suzuki 1047-1056。semaglutide的现实世界歧化分析：上市后药物警戒数据，Du 1422-1433。在12个月的随访中，口服西马鲁肽和每周一次西马鲁肽注射的依从性和治疗停药：日本真实世界数据，Horii 1578-1584血管粘附蛋白-1在糖尿病及其并发症中的作用[j]。血清淀粉样蛋白A：糖尿病和COVID-19患者血清淀粉样蛋白A与预后的关系：一项回顾性队列研究，Qu 44-51。血清尿酸：在非糖尿病、糖尿病前期和糖尿病成人中，血清尿酸与空腹血糖水平呈倒u型关系：一项基于中国人群的研究，Shi 483-490。影响2型糖尿病患者严重动脉粥样硬化性血栓性脑梗死的因素：日本大规模索赔数据库分析，Horii 1651-1662。一项关于恩格列清治疗难治性糖尿病伴胰岛素抵抗的长期安全性的多中心、开放标签、单组试验（emperor -02）， Hirota 1211-1219。减少夜间排尿频率的多中心、开放标签、随机对照优势试验：TOP-STAR研究，Nakajima 1809-1817。7-亚硝基-3-（三氟甲基）-5,6,7,8-四氢[1,2,4]三唑-[4,3- A]吡嗪污染西格列汀的癌症风险评估：一项回顾性队列研究，Sugiyama 1556-1565。慢进行性1型糖尿病慢进行性1型糖尿病（SPIDDM）的新诊断标准（2023）：日本糖尿病学会1型糖尿病委员会报告（英文版），Shimada 254-257。预测谷氨酸脱羧酶自身抗体酶联免疫吸附试验阳性的缓慢进展型1型糖尿病患者未来胰岛素缺乏，川崎835-842。小密度低密度脂蛋白胆固醇在中国2型糖尿病患者中，小密度低密度脂蛋白胆固醇与高密度脂蛋白胆固醇比值升高与代谢功能障碍相关的脂肪肝疾病风险增加相关，Yang 634-642。社会剥夺与糖尿病肾病：欧洲观点，凯西541-556。日本社会经济地位收入/就业状况与糖尿病护理过程、健康行为和健康结果之间的关系：一项横断面研究，使用与问卷调查相关的索赔数据，Yamaoka 1684-1695。钠-葡萄糖共转运蛋白2抑制剂对日本2型糖尿病患者血清低密度脂蛋白胆固醇的影响，Imada 843-850。 钠-葡萄糖共转运蛋白2抑制剂治疗减少糖尿病性黄斑水肿患者类固醇注射给药频率：一项使用日本健康保险索赔数据库Ishibashi 1231-1238的队列研究。钠-葡萄糖共转运蛋白2抑制剂与二肽基肽酶-4抑制剂在日本启动的2型糖尿病患者的医疗资源利用和医疗成本：一个现实世界的管理数据库分析，Kashiwagi 374-387。小密度低密度脂蛋白胆固醇估算非肥胖人群的小密度低密度脂蛋白胆固醇与非酒精性脂肪肝疾病，Huang 491-499。伊普列净和吡格列酮对2型糖尿病患者代谢功能障碍相关脂肪变性肝病的长期影响：一项随机、24周、主动对照试验的5年观察随访，Ito 1220-1230研究南非人群中miR-486-5p和miR-novel-chr1_40444在血糖异常中的表达改变，Weale 1377-1389。类固醇注射钠-葡萄糖共转运蛋白2抑制剂治疗减少糖尿病黄斑水肿患者类固醇注射给药频率：一项使用日本健康保险索赔数据库Ishibashi 1231-1238的队列研究。脂质营养不良中皮质类固醇引发的急性骨骼肌损失：一例报告，Sasako 782-785。在将糖尿病足溃疡风险不同的患者进行分层时，哪些特征是最重要的？， Naemi 1094-1104。老年2型糖尿病患者的磺酰脲处方模式：日本药房真实数据的综合分析，Yamazaki 1604-1613。生存：糖尿病对口腔和口咽癌患者预后的影响：一项荟萃分析，Xu 1140-1150。交感皮肤反应在2型糖尿病周围神经病变和肾病早期检测中的应用，刘106 - 112。系统性冠脉风险评估2-糖尿病风险2-糖尿病风险模型和动脉僵硬度对亚洲2型糖尿病人群心血管事件的预测价值，Suwannasom 1266-1275。丹参酮IIA通过胚胎致死性异常视样蛋白1和酰基辅酶A合成酶长链家族成员4信号通路抑制铁下垂减轻糖尿病肾病肾足细胞损伤，Zhu 1003-1016。脂质和葡萄糖研究：口服糖耐量试验后恢复空腹状态与未来糖尿病前期和2型糖尿病风险的关联程度：来自TLGS的见解，Masrouri 1743-1752。肌理分析。基于动态磁共振增强成像的糖尿病兔肢体缺血的骨髓微血管通透性和肌理分析，杨584 - 593。tezepelumab治疗严重支气管哮喘后体重增加和血糖管理恶化的2型糖尿病病例，Umamoto 388-390。治疗惰性强制每月门诊可改善控制不良的2型糖尿病患者的治疗惰性，Tsai 227-236。日本2型糖尿病患者糖尿病对称感觉运动多神经病变的患病率和特征：日本糖尿病并发症及其预防的前瞻性研究（JDCP研究10），Kamiya 247-253。血栓反应蛋白1与糖尿病患者血管并发症的关系，郭197-207。中国2型糖尿病肾病患者循环血栓反应蛋白-1信使核糖核酸和微核糖核酸-194水平的关系：一项病例对照研究的结果。日本2型糖尿病患者口服西马鲁肽的疗效和耐受性：来自糖尿病专科诊所的分析报告，Inokuchi 1202-1210。兰斯大学医院2015 - 2020年过渡项目评估，Chibane 1519-1523。中国东南部地区2型糖尿病的患病率、认知、治疗和控制：一项基于人群的研究，胡1034-1041。使用自然语言处理的2型糖尿病患者报告的结果和治疗依从性：观察性国际糖尿病管理实践研究的第8波，Chan 1306-1316。 影响日本2型糖尿病患者单药伊米霉素临床疗效的因素，Hagi 1239-1247。妊娠中期甘油三酯-葡萄糖指数预测妊娠期糖尿病妇女不良结局：一项回顾性多中心队列研究，Bai 1489-1499。TXNIP/NLRP3炎性体calpeptin通过调节TXNIP/NLRP3炎性体改善糖尿病大鼠阿尔茨海默病样并发症的认知功能，Qiao 1365-1376。1型糖尿病交互式计算器估计1型糖尿病的胰岛素敏感性，Januszewski 594-597。老年1型糖尿病合并痴呆患者的整体认知和执行功能，Nagasawa 922-930。兰斯大学医院2015 - 2020年过渡方案评估，Chibane 1519-1523。1型糖尿病、COVID-19疫苗和短期安全性：来自全球COVAD研究的亚组分析，Chatterjee 131-138混合闭环系统对传感器增强泵治疗1型糖尿病患者血糖控制和心理方面的影响：一项前瞻性单中心观察研究，Akiyama 219-226。中国东南部地区2型糖尿病的患病率、认知、治疗和控制：一项基于人群的研究，胡1034-1041。2型糖尿病2型糖尿病小鼠新鲜自体血回输诱导巨噬细胞极化和抑制红细胞损伤的机制探讨，Hu 70-77。强制每月门诊可改善控制不良的2型糖尿病患者的治疗惰性，Tsai 227-236。亚洲不断变化的糖尿病状况-未满足的需求是什么？路加福音402-409。从全基因组关联研究时代到精准医学的2型糖尿病遗传研究展望，Imamura 410-422。进食后胰岛素分泌的短期恢复与2型糖尿病患者未来的血糖控制有关，Enkaku, 437-448。2型糖尿病、精氨酸抗利尿激素缺乏和马凡氏综合征共存：1例报告，Le 964-967。日本人的饮食行为和2型糖尿病发病率：基于人群的松下队列研究15，Toyokuni 1017-1025。PIONEER REAL Japan：日本临床实践中口服西马鲁肽治疗成人2型糖尿病的多中心、前瞻性、真实世界研究的基线特征，Suzuki 1047-1056。基于物联网的方法控制2型糖尿病患者的血糖：一项随机对照试验，Bouchi 1287-1296使用自然语言处理的2型糖尿病患者报告的结果和治疗依从性：观察性国际糖尿病管理实践研究的第8波，Chan 1306-1316。日本糖尿病学会的共识声明：2型糖尿病患者药物治疗的建议算法-第2版（英文版），Bouchi 1326-1342。研究南非人群中miR-486-5p和miR-novel-chr1_40444在血糖异常中的表达改变，Weale 1377-1389。长期低碳水化合物饮食对2型糖尿病患者的疗效：一项系统回顾和荟萃分析，Ichikawa 1410-1421。2型糖尿病患者使用黄嘌呤氧化还原酶抑制剂与胰岛素分泌能力的关系，Kitamura 1500-1509。综合数据平台结合饮食管理在成人糖尿病患者中的应用：一项前瞻性随机对照试验，Liu 1548-1555。tofogliflozin在日本2型糖尿病患者中的安全性和有效性：一项常规临床实践的多中心前瞻性观察研究，Yamada 1585-1595。henagliflozin抑制钠-葡萄糖共转运蛋白2可改善2型糖尿病患者的认知功能障碍。2型糖尿病患者严重动脉粥样硬化性脑梗死的影响因素：日本大规模索赔数据库分析，Horii 1651-1662。非诺贝特对2型糖尿病的影响，非诺贝特，1663-1668。2型糖尿病。氧化应激通过Nrf2/PHB2途径抑制β-细胞中PHB2介导的有丝分裂，Liu 559-571。社区老年2型糖尿病患者血清asprosin与左室舒张功能不全的相关性，Liang, 608-613。在中国2型糖尿病患者中，小密度低密度脂蛋白胆固醇与高密度脂蛋白胆固醇之比升高与代谢功能障碍相关的脂肪肝疾病风险增加相关，Yang 634-642。高糖通过调节miRNA let7d-5p水平促进动脉粥样硬化，Wang 711-724。钠-葡萄糖共转运蛋白2抑制剂对日本2型糖尿病患者血清低密度脂蛋白胆固醇的影响，Imada 843-850 糖尿病视网膜病变患者血清维生素D显著降低并可预测耀斑，庄867-873。糖化血红蛋白与社区2型糖尿病患者全因死亡风险的关系：一项前瞻性队列研究，He 939-945。儿童和青少年2型糖尿病病程及综合治疗对血糖水平的影响[j]，吴1026-1033。影响日本2型糖尿病患者伊米霉素单药治疗临床疗效的因素，Hagi 1239-1247。基于既往冠状动脉疾病、脑血管疾病和2型糖尿病的心血管疾病风险分层[j]， 1464-1471。口服葡萄糖耐量试验后恢复空腹状态与未来糖尿病前期和2型糖尿病风险的关联程度：来自TLGS的见解，Masrouri 1743-1752。代谢功能障碍相关脂肪变性肝病：比传统标准更能预测2型糖尿病的发生——NAGALA研究，Sakai 1788-1796低出生体重和抵抗素基因rs1862513变异对成年期胰岛素抵抗和2型糖尿病的相互作用：Toon基因组研究，吉田725-735。钠-葡萄糖共转运蛋白2抑制剂在亚洲人群中的有效性和安全性，Ha 285-287。心血管健康与糖尿病的相互作用：体重管理和风险降低的见解，h707 - 710。早期糖尿病多发神经病变的诊断方法进展，Naruse 820-822。当代胰岛素治疗的更新，蔡1000-1002。新冠肺炎大流行对糖尿病治疗的临床启示，Hamamoto 1363-1364。日本妊娠早期的临床挑战：妊娠期糖尿病的最新进展，Sugiyama, 1729-1731。2型糖尿病患者血清尿酸/高密度脂蛋白胆固醇比值与胰岛素抵抗的关系，周113-120。美国人群中血清尿酸与高密度脂蛋白胆固醇比值与胰岛素抵抗的关系：一项基于人群的分析，Zhou 762-771。2型糖尿病患者血清尿酸与高密度脂蛋白胆固醇比值与胰岛素抵抗的关系，周113-120。尿肌醇：糖尿病前期患者的特征，以及尿肌醇作为糖尿病发生危险因素的评估，Yamagata 177-185。1型糖尿病、COVID-19疫苗与短期安全性：来自全球COVAD研究的亚组分析，Chatterjee 131-138糖尿病患者血红蛋白A1c水平变化与糖尿病治疗相关生活质量之间的关系，Imai 1042-1046。血管粘附蛋白-1在糖尿病及其并发症中的作用，中华医学杂志，982-989。高内脏脂肪区和肌肉减少与老年糖尿病患者动脉粥样硬化标志物相关：一项横断面研究，Sato 1510-1518。维生素D：糖尿病视网膜病变患者血清维生素D显著降低并可预测耀斑，庄867-873。握力和腰围对血糖控制的影响：日本2型糖尿病患者门诊数据的前瞻性观察研究，Nakanishi 892-898。tofogliflozin在日本2型糖尿病患者中的安全性和有效性：一项常规临床实践的多中心前瞻性观察研究，Yamada 1585-1595。与对照组相比，间歇禁食16:8和14:10对肥胖合并2型糖尿病患者体重减轻和代谢结局的影响：一项随机对照试验，Sukkriang 1297-1305。伤口愈合mir -488-3p通过cyp1b1介导的Wnt/β-catenin信号通路靶向MeCP2促进伤口愈合，Zuo 145-158。XOR抑制剂：2型糖尿病患者使用黄嘌呤氧化还原酶抑制剂与胰岛素分泌能力的关系，Kitamura 1500-1509年轻发病糖尿病亚洲不断变化的糖尿病状况——未满足的需求是什么？路加福音402-409。日本的一项队列研究，Saito 1444-1456，年轻发病的2型糖尿病会增加蛋白尿，但不会降低肾小球滤过率。 纵向HbA1c变异性在预测2型糖尿病患者糖尿病感觉运动多神经病变发展中的预后价值：一项前瞻性队列观察研究，Lai 326-335。行为改变：基于物联网的2型糖尿病患者血糖控制方法：一项随机对照试验，Bouchi 1287-1296。β细胞功能：口服糖耐量试验中c肽曲线下面积与2型糖尿病视网膜病变的关系，Zhang 315-325。生物信息学，糖尿病肾病中负离子通道1相关基因与免疫细胞浸润的鉴定和验证，林87-105。生物信息学分析免疫球蛋白重定γ 1沉默降低强直反应增强结合蛋白的表达以减轻糖尿病肾病，Hu 572-583。生物标志物和Barthel指数与糖尿病患者年龄相关不良健康结局发生的关系，Umamoto 1675-1683。脂质异常在妊娠期糖尿病中的作用：早期预测和产后预后，Zhang 15-25。糖尿病肾病中负离子通道1相关基因与免疫细胞浸润的鉴定和验证，Lin 87-105。出生体重作为妊娠早期和晚期糖尿病的一个指标：日本环境与儿童研究，Tagami 751-761。日本糖尿病妇女出生体重与妊娠期体重增加的关系，Fujikawa Shingu 906-913。日本视力受损糖尿病患者的盲法特征分析，Sugihara 882-891。在健康的年轻人中，延迟的晚餐时间会损害葡萄糖耐量，Nakamura 172-176。混合闭环系统对传感器增强泵治疗1型糖尿病患者血糖控制和心理方面的影响：一项前瞻性单中心观察研究，Akiyama 219-226。一种优化老年人糖尿病筛查的新型预测模型，Lin 1403-1409。血糖监测仪红细胞压积水平对特定血糖仪准确性的影响：一项基于医院的研究，Pham 1472-1482。身体组成与妊娠期糖尿病的风险：单变量和多变量孟德尔随机研究，高346-354。日本人饮食行为和2型糖尿病发病率：基于人群的松下队列研究15，Toyokuni 1017-1025。Calpain-2Calpeptin通过调节TXNIP/NLRP3炎性体改善糖尿病大鼠阿尔茨海默病样并发症的认知功能，Qiao 1365-1376。癌症在糖尿病的癌症生物学更新：专注于降糖药，Kawakita 525-540。心踝血管指数系统冠状动脉风险评估2-糖尿病风险。2-糖尿病风险模型和动脉僵硬度对亚洲2型糖尿病人群心血管事件的预测价值，Suwannasom 1266-1275。心血管自主神经病变：韩国肥胖患者的代谢减肥手术后心率变异性的改善，Jang 1773-1780。妊娠后糖尿病妇女新发糖尿病对健康的影响：来自香港地区数据的见解，张772 - 781。中国老年糖尿病患者空腹血糖与全因死亡率和心血管事件的关系：一项基于人群的队列研究，Wang 1129-1139。基于剪切波弹性成像放射组学的可解释机器学习模型预测糖尿病肾病患者心血管疾病，Dai 1637-1650。心血管疾病。基于既往冠状动脉疾病、脑血管疾病和2型糖尿病的心血管疾病危险分层，[j] . 1464-1471。通过测量24-28孕周的随机血糖水平来筛查妊娠糖尿病的问题，Tomimoto 1797-1802。根据2011-2020年期间68,555例调查结果得出的日本糖尿病患者的死亡原因：糖尿病死亡原因委员会报告，日本糖尿病学会（英文版），Nakamura 1821-1837。蝉虫草多糖通过miR-30a-3p/TRIM16轴，Zheng 300-314减轻糖尿病肾病。细胞包封异种胰岛移植的长期疗效：包封技术和供体遗传性状的影响，Park 693-703。Rajabi 914-921：在没有妊娠期糖尿病的妇女中，妊娠后血糖比妊娠早期HbA1c更能预测不良妊娠结局。儿童2型糖尿病病程及综合治疗对儿童青少年血糖水平的影响[j]。 儿童和青少年持续血糖监测对1型糖尿病儿童和青少年血糖管理的变化系数的临床意义，Urakami 1669-1674。中国1型和2型糖尿病死亡率负担：基于1990 - 2019年中国和全球死亡率负担贝叶斯年龄-时期队列分析的2030年预测，董623-633。中国汉族人群RPS26基因多态性与中国不同类型糖尿病的关系，Song 34-43。高密度脂蛋白与糖尿病的关系：结构和功能的相关性。舞蹈病糖尿病纹状体病：用左旋多巴成功治疗高血糖舞蹈病/ballism， Tsukaguchi 1524-1527。慢性肾脏疾病：低剂量阿司匹林预防2型糖尿病和慢性肾脏疾病患者心血管死亡：一项真实世界的全国队列研究，Lin 459-467。慢性肾脏疾病进展：在日本预防医学研究中心，慢性肾脏疾病进展超过20年的一级预防的危险因素：关注血浆葡萄糖水平的影响，Minami 1434-1443。circ_0068087基因敲低可通过微核糖核酸/黄体酮和adipoQ受体3依赖的方式减轻糖尿病肾病中高糖诱导的人小管上皮细胞损伤，Liu 159-171。日本收入/就业状况与糖尿病护理过程、健康行为和健康结果之间的关系：一项横断面研究，使用与问卷调查相关的索赔数据，Yamaoka 1684-1695。使用国家数据库，Ihana-Sugiyama 861-866，对日本糖尿病患者进行糖尿病自我管理教育和支持的执行率。使用自然语言处理的2型糖尿病患者报告的临床结果和治疗依从性：观察性国际糖尿病管理实践研究的第8波，Chan 1306-1316。临床流行病学：在冠状病毒大流行的第一年，接受糖尿病护理对COVID-19感染和HbA1c水平之间关系的改变作用，使用基于全国人口的数据库Okada 953-963。氯吡格雷：氯吡格雷致复发性低血糖1例报告及综述，杜275-281。儿童和青少年1型糖尿病患者血糖管理中持续血糖监测的变异系数的临床意义，Urakami 1669-1674。R-R间隔变异系数结合即时神经传导装置和心电图的简化电生理方法可准确诊断糖尿病多发性神经病，Hayashi 736-742老年1型糖尿病伴痴呆患者的整体认知和执行功能，Nagasawa 922-930。认知障碍：henaglilozin抑制钠-葡萄糖共转运蛋白2改善2型糖尿病患者的认知障碍，Zhang 1596-1603。出生体重作为妊娠早期和晚期糖尿病的指标：日本环境与儿童研究，Tagami 751-761。残余胆固醇，而不是其他传统的脂质或脂质比率，与中国普通人群未来糖尿病风险独立且正相关：一项为期3年的队列研究，Li 1084-1093。联合靶向PI3K/AKT和MEK/ERK通路改善周围性糖尿病神经病变特征的协同作用，Pham 1537-1544。高桥63-66:SGLT2抑制剂用于老年东亚2型糖尿病患者的长期安全性和有效性。垂体agouti相关肽细胞：控制葡萄糖代谢的新参与者，Takahashi 67-69。二肽基肽酶-4抑制血管衰老作为动脉粥样硬化的新治疗方法，Yen 143-144。下丘脑和脑干中的葡萄糖依赖性胰岛素多肽受体系统通过不同的途径调节摄食和体重，Yada 283-284。胰岛移植的进展和挑战：来自协作胰岛移植注册的见解，Lee 423-425。解读心肺健康与2型糖尿病之间的因果关系，Ko 426-428。出生体重和晚年糖尿病风险，Sheu 557-558。二肽基肽酶-4抑制在体内的作用：二肽基肽酶-4抑制剂/肠道微生物组串扰为糖尿病管理提供了新的治疗选择，Yasuda 704-706。肠道菌群失调是糖尿病周围神经病变的新致病因素，Niimi 817-819。血糖指数和血糖负荷与2型糖尿病、心血管疾病、癌症和全因死亡率的关系评论，Hsieh 1545-1547。 通过胰高血糖素样肽-1和葡萄糖依赖性胰岛素多肽的作用调节葡萄糖和能量代谢，Zenimaru 1725-1726。关于“胰岛内a细胞g信号促进胰高血糖素释放”的评论，Kitamura 1727-1728。糖尿病并发症血糖变异性：测量、目标、对糖尿病并发症的影响，它真的重要吗？莫为5 - 14。连续血糖监测血糖变异性：测量、目标、对糖尿病并发症的影响，它真的重要吗？莫为5 - 14。固定剂量米格列奈/伏格列糖联合用药与格列美脲对2型糖尿病患者血管内皮功能和血糖变异性的影响：一项随机对照试验，Tanaka 449-458。2型糖尿病患者血糖危险指数与动脉僵硬度的关系，蔡614-622。2型糖尿病门诊患者的血糖变异性与腓肠神经传导速度相关：一种新的神经传导研究点护理设备的实用性，Morita 1075-1083。1型糖尿病β细胞内源性双链RNA编辑受损的可能病因学作用，Imai 1171-1173通过翻译体窥视慢性葡萄糖暴露和胰岛素分泌损伤，Helena 1174-1176。连续血糖监测对1型糖尿病儿童和青少年血糖管理的变异系数的临床意义，Urakami 1669-1674。连续血糖监测对胃切除术后低血糖的诊断价值，Son 1696-1699。暴发性1型糖尿病，一种未被充分认识的独特的1型糖尿病亚型：来自新加坡的病例系列，Tan 786-789角膜共聚焦显微镜。糖尿病神经病变患者循环netrin-1水平降低并与角膜神经纤维丢失有关。日本糖尿病自我管理中饮食失调行为因素的探索性研究，Tsukamoto-Kawashima 874-881。COVID-19糖尿病和COVID-19患者血清淀粉样蛋白A与预后的关系：一项回顾性队列研究，Qu 44-51。1型糖尿病、COVID-19疫苗和短期安全性：来自全球COVAD研究的亚组分析，Chatterjee 131-138在冠状病毒大流行的第一年，接受糖尿病护理对COVID-19感染与HbA1c水平之间关系的改变作用，使用基于全国人口的数据库Okada 953-963。2019冠状病毒病大流行前后妊娠期糖尿病筛查方法的比较：一项系统综述，Sun 500 - 516. c肽指数进食后胰岛素分泌的短期恢复与2型糖尿病患者未来血糖控制相关，Enkaku 437-448。2型糖尿病患者使用专业连续血糖监测降糖糖胰岛素/利拉鲁肽与甘精胰岛素U-100/利昔那肽的疗效和安全性比较，Kawaguchi 598-607。危重患者血糖与死亡率之间的关系：MIMIC-IV数据库的回顾性分析，Li 931-938。横断面研究：2型糖尿病患者胃肠道症状与失眠之间的关系：KAMOGAWA-DM队列研究，Minamida 946-952。糖尿病治疗状况与职业事故关系的横断面研究，Ogasawara 899-905。CYP1B1MiR-488-3p通过cyp1b1介导的Wnt/β-catenin信号通路靶向MeCP2促进伤口愈合，Zuo 145-158。胱抑素C与糖尿病视网膜病变之间的因果关系：一项双样本孟德尔随机研究，阮1626 - 1636。糖尿病和COVID-19患者血清淀粉样蛋白A与预后的关系：一项回顾性队列研究，Qu 44-51。产后早期营养过剩影响终生代谢风险：对胰腺β细胞质量和功能影响的证据，Burton, 263-274。低剂量阿司匹林预防2型糖尿病和慢性肾脏疾病患者心血管死亡：一项真实世界的全国队列研究，Lin 459-467。非糖尿病、糖尿病前期和糖尿病成人血清尿酸与空腹血糖水平的倒u型相关性：一项基于中国人群的研究，Shi 483-490。糖尿病中的癌症生物学更新：聚焦于降糖药，Kawakita 525-540。1型和2型糖尿病死亡率负担：基于1990 - 2019年中国和全球死亡率负担贝叶斯年龄-时期队列分析的2030年预测，董623-633。基于非实验室参数和肌肉力量影响的不同机器学习算法识别未确诊糖尿病的性能：一项横断面研究，Xu 743-750。肠道上皮细胞转化为胰岛素生成细胞治疗糖尿病，Accili 797-804。 糖尿病治疗状况与职业事故的关系，Ogasawara 899-905。中国东南部地区2型糖尿病的患病率、认知、治疗和控制：一项基于人群的研究，胡1034-1041。残余胆固醇，而不是其他传统的脂质或脂质比率，与中国普通人群未来糖尿病风险独立且正相关：一项为期3年的队列研究，Li 1084-1093。糖尿病对口腔癌和口咽癌患者预后的影响：一项meta分析，Xu 1140-1150。2型糖尿病患者口服降糖药依从性的患病率：一项系统回顾和荟萃分析，boonpathatharatthiti 1614-1625。生物标志物和Barthel指数与糖尿病患者年龄相关不良健康结局发生的关系，Umamoto 1675-1683。糖尿病并发症[j]，循环血栓反应蛋白-1水平升高与糖尿病血管并发症的关系，郭197-207。一站式服务：改善糖尿病周围神经病变和其他糖尿病微血管并发症筛查吸收的潜在模式，Sloan 1355-1362。2型糖尿病不同病程患者血清asprosin与代谢特征、并发症的相关性分析[j]， Ma 1781-1787。RPS26基因多态性与中国不同类型糖尿病的关系，Song 34-43。糖尿病患者血凝反应蛋白-1水平升高与血管并发症的关系[j]。2型糖尿病患者自我报告低血糖风险预测模型的建立和验证：一项纵向队列研究，Xu 468-482。社会剥夺和糖尿病肾病：欧洲观点，凯西541-556。依帕列净治疗后正常射血分数糖尿病患者心肌应变和工作的改善[j]。日本糖尿病妇女出生体重与妊娠期体重增加的关系，Fujikawa Shingu 906-913。2型糖尿病患者胃肠道症状与失眠之间的关系：KAMOGAWA-DM队列研究，Minamida 946-952糖尿病患者血红蛋白A1c水平变化与糖尿病治疗相关生活质量的关系，Imai 1042-1046。日本老年2型糖尿病患者开始服用口服降糖药，肾脏功能与血糖控制之间关系的医学数据库分析，Suzuki 1057-1067。产后生活干预预防妊娠期糖尿病妇女2型糖尿病：一项系统回顾和荟萃分析，王1115-1128。2-糖尿病风险模型和动脉僵硬度对亚洲2型糖尿病人群心血管事件的预测价值，Suwannasom 1266-1275。一种优化老年人糖尿病筛查的新型预测模型，Lin 1403-1409。semaglutide的现实世界歧化分析：上市后药物警戒数据，Du 1422-1433。全球新生儿糖尿病：更新2024，Barbetti 1711-1724。糖尿病1型胰岛移植在韩国的应用，Lee 1165-1170。中国2型糖尿病患者肾小球滤过率下降与单纯性肾囊肿相关，Qiaoling 26-33。抵抗淀粉与2型糖尿病的临床研究进展，中华医学杂志（英文版）；PIONEER REAL Japan：日本临床实践中口服西马鲁肽治疗成人2型糖尿病的多中心、前瞻性、真实世界研究的主要结果，Yabe 1566-1577。中国老年糖尿病患者空腹血糖与全因死亡率和心血管事件的关系：一项基于人群的队列研究，Wang 1129-1139。糖尿病治疗相关生活质量：糖化血红蛋白水平变化与糖尿病患者糖尿病治疗相关生活质量之间的关系，Imai 1042-1046。黄荆黄精多糖通过增加糖尿病小鼠环鸟苷单磷酸蛋白激酶G信号通路减少糖尿病心肌病，Lei 823-834。调节性T细胞对db/db小鼠糖尿病性心肌病的保护作用，Zhang 1191-1201。血管粘附蛋白-1在糖尿病及糖尿病并发症中的作用，中华医学杂志，982-989。糖尿病教育：日本糖尿病患者自我管理教育的实施率和支持（使用国家数据库），Ihana-Sugiyama 861-866。 糖尿病足在将患者分为不同的糖尿病足溃疡风险组时，哪些特征是最重要的？， Naemi 1094-1104。糖尿病足患者与非糖尿病足患者心脏电生理、结构和舒张功能的比较，白1276-1286。糖尿病足溃疡复发足底压力测量在糖尿病足疾病：一个范围回顾，洛克哈特990-999。暴发性1型糖尿病，一种未被充分认识的独特的1型糖尿病亚型：来自新加坡的病例系列，Tan 786-789社会剥夺与糖尿病肾病：欧洲观点，凯西541-556。糖尿病和糖尿病肾病饮食治疗的营养质量，Tsuruta 973-981。中国2型糖尿病肾病患者循环血栓反应蛋白-1信使核糖核酸和微核糖核酸-194水平的关系：一项病例对照研究的结果。日本的一项队列研究，Saito 1444-1456，年轻发病的2型糖尿病会增加蛋白尿，但不会降低肾小球滤过率。基于剪切波弹性成像放射组学的可解释机器学习模型预测糖尿病肾病患者心血管疾病，Dai 1637-1650。血管生成素样4是2型糖尿病患者糖尿病肾病的潜在生物标志物，Wang 1763-1772。糖尿病黄斑水肿钠-葡萄糖共转运蛋白2抑制剂治疗减少糖尿病黄斑水肿患者类固醇注射给药频率：一项使用日本健康保险索赔数据库Ishibashi 1231-1238的队列研究。糖尿病肾病。电压依赖性阴离子通道1相关基因与糖尿病肾病免疫细胞浸润的鉴定和验证，林87-105。交感皮肤反应对2型糖尿病周围神经病变和肾病的早期检测，刘106 - 112。Circ_0068087基因敲低可通过微核糖核酸/黄体酮和脂肪q受体3依赖的方式减轻糖尿病肾病中高糖诱导的人小管上皮细胞损伤，Liu 159-171。METTL3/YTHDF2 m6A轴通过表观遗传抑制PINK1和线粒体自噬介导糖尿病肾病的进展，Wang 288-299。冬虫夏草多糖通过miR-30a-3p/TRIM16轴，Zheng 300-314减轻糖尿病肾病。免疫球蛋白重定γ - 1沉默降低强直反应增强结合蛋白的表达以减轻糖尿病肾病，Hu 572-583。糖尿病神经病变循环netrin-1水平降低与糖尿病神经病变患者角膜神经纤维丢失有关，Mondal 1068-1074。胰岛素样生长因子-1水平降低可能是2型糖尿病患者周围神经病变的危险因素。一站式服务：改善糖尿病周围神经病变和其他糖尿病微血管并发症筛查吸收的潜在模式，Sloan 1355-1362。靶向PI3K/AKT和MEK/ERK通路改善周围性糖尿病神经病变特征的协同作用，Pham 1537-1544。糖尿病周围神经病变。电压依赖性阴离子通道1相关基因与糖尿病肾病免疫细胞浸润的鉴定和验证，林87-105。交感皮肤反应对2型糖尿病周围神经病变和肾病的早期检测，刘106 - 112。糖尿病多发性神经病变结合即时神经传导装置和心电图的简化电生理方法可准确诊断糖尿病多发性神经病变。2型糖尿病患者口服糖耐量试验中c肽曲线下面积与糖尿病视网膜病变的关系，张315 - 325。糖尿病视网膜病变患者血清维生素D显著降低并可预测耀斑，庄867-873。日本视障糖尿病患者的特征分析，Sugihara 882-891。胱抑素C与糖尿病视网膜病变之间的因果关系：一项双样本孟德尔随机研究，阮1626 - 1636。糖尿病纹状体病：用左旋多巴成功治疗高血糖舞蹈病/肾小球症，Tsukaguchi 1524-1527。基于动态增强磁共振成像的糖尿病家兔重度肢体缺血骨髓微血管通透性和结构分析，杨584 - 593。糖尿病对称感觉运动多神经病变在日本2型糖尿病患者中的患病率和特点：日本糖尿病并发症及其预防的前瞻性研究（JDCP研究10），Kamiya 247 - 257 .饮食抵抗淀粉与2型糖尿病：临床观点，金395-401。 饮食干预：综合数据平台结合饮食管理在成人糖尿病患者中的应用：一项前瞻性随机对照试验，Liu 1548-1555。饮食治疗糖尿病和糖尿病肾病的营养质量，Tsuruta 973-981。综合数据平台结合饮食管理在成人糖尿病患者中的应用：一项前瞻性随机对照试验，Liu 1548-1555。线粒体ALDH2通过靶向CK2信号通路改善β细胞存活和抗阿霉素诱导的凋亡功能，Karunakaran 684-692。简化电生理方法结合即时神经传导装置和心电图可准确诊断糖尿病多发性神经病变。东亚2型糖尿病患者的低碳水化合物饮食：随机对照试验的系统回顾和荟萃分析，Hironaka 1753-1762。日本糖尿病患者自我管理中饮食行为紊乱因素的探索性研究，Tsukamoto-Kawashima 874-881。日本人的饮食行为、坐姿行为和2型糖尿病发病率：基于人群的松下队列研究15，Toyokuni 1017-1025。日本和欧洲人群微血管病变的常见代谢物，Shojima 523-524。乌兰巴托协议：修订亚洲糖尿病术语以对抗污名，Seino 1533-1536。输出时钟基因在调节葡萄糖代谢中的作用，Taguchi 1707-1710。老年2型糖尿病患者的磺脲类药物处方模式：来自日本药房真实世界数据的综合分析，Yamazaki 1604-1613。胚胎致死性异常视样蛋白1丹参酮IIA通过胚胎致死性异常视样蛋白1和酰基辅酶A合成酶长链家族成员4信号通路抑制铁下垂减轻糖尿病肾病肾足细胞损伤，朱1003 - 1016。依帕列净治疗正常射血分数糖尿病患者心肌应变和工作的改善，程851-860。EPACEpac2激活介导胰高血糖素诱导的原代大鼠肝细胞糖生成。表观遗传变化葡萄糖代谢通过表观基因组变化部分调节β细胞功能，Kim 649-655。1型糖尿病与癫痫风险：meta分析，Wu 364-373。估计肾小球滤过率在预防医学研究中心对日本个体进行初级预防的20年慢性肾脏疾病进展的危险因素：关注血浆葡萄糖水平的影响，Minami 1434-1443。血管生成素样4是2型糖尿病患者糖尿病肾病的潜在生物标志物，Wang 1763-1772。不同种族妊娠期糖尿病妇女的脂质特征：与胎儿生长的关系，dalfr<e:1> 355-363。老年1型糖尿病伴痴呆患者的整体认知和执行功能，Nagasawa 922-930。空腹血糖：在非糖尿病、糖尿病前期和糖尿病成人中，血清尿酸和空腹血糖水平呈倒u型相关性：一项基于中国人群的研究，Shi 483-490。中国老年糖尿病患者空腹血糖与全因死亡率和心血管事件的关系：一项基于人群的队列研究，Wang 1129-1139。非诺贝特对2型糖尿病的影响，非诺贝特，1663-1668。快速血糖监测新鲜自体输血。2型糖尿病小鼠新鲜自体血回输诱导巨噬细胞极化和抑制红细胞损伤的机制探讨，Hu 70-77。足部溃疡在将糖尿病足部溃疡的不同风险分组时，哪些特征是最重要的？， Naemi 1094-1104。老年糖尿病患者的虚弱管理：来自老年医学的观点，Umegaki 1347-1354。暴发性1型糖尿病是1型糖尿病的一个未被充分认识的独特亚型：来自新加坡的病例系列，Tan 786-789。GAD抗体缓慢进展型1型糖尿病（SPIDDM）新诊断标准（2023）：日本糖尿病学会1型糖尿病委员会报告（英文版），Shimada 254-257。连续血糖监测对胃切除术后低血糖的诊断价值，Son 1696-1699。2型糖尿病患者胃肠道症状与失眠的关系：KAMOGAWA-DM队列研究，Minamida 946-952。基因编辑，包膜异种胰岛移植的长期疗效：包膜技术和供体遗传性状的影响，Park 693-703。 脂质营养不良中皮质类固醇引发的急性骨骼肌损失：一例报告，Sasako 782-785。遗传性胰岛素抵抗综合征一项多中心、开放标签、单组试验：恩格列清治疗难治性糖尿病合并胰岛素抵抗的长期安全性（EMPIRE-02）， Hirota 1211-1219。基于亲属关系图卷积网络的线粒体糖尿病8个基因组保护等位基因的遗传和发病机制研究，Wang 52-62。全基因组关联研究，从全基因组关联研究时代到精准医学对2型糖尿病遗传研究的展望，Imamura 410-422。脂质异常在妊娠期糖尿病中的作用：早期预测和产后预后，张15 - 25。母亲出生体重作为妊娠早期和晚期糖尿病的指标：日本环境与儿童研究，Tagami 751-761。妊娠期糖尿病机体组成与妊娠期糖尿病风险：单变量和多变量孟德尔随机研究，高346-354不同种族妊娠期糖尿病妇女的脂质特征：与胎儿生长的关系，dalfr<e:1> 355-363。COVID-19大流行前后妊娠期糖尿病筛查方法的比较：一项系统综述，Sun 500-516。妊娠后糖尿病妇女新发糖尿病对健康的影响：来自香港地区数据的见解，张772 - 781。妊娠中期甘油三酯-葡萄糖指数预测妊娠期糖尿病妇女不良结局：一项回顾性多中心队列研究，Bai 1489-1499。妊娠24-28周随机血糖水平筛查妊娠糖尿病的问题，Tomimoto 1797-1802。Kasuga 1803-1808: 75 g口服糖耐量试验中多个阳性点是妊娠24周前诊断的妊娠期糖尿病早期胰岛素治疗的良好预测指标。妊娠期体重增加日本糖尿病妇女婴儿出生体重与妊娠期体重增加的关系，Fujikawa Shingu 906-913。肾小球滤过率中国2型糖尿病患者肾小球滤过率的下降与单纯性肾囊肿有关，Qiaoling 26-33。胰高血糖素epac2激活介导原代大鼠肝细胞胰高血糖素诱导的糖生成。Imeglimin通过间接机制促进胰高血糖素分泌，改善高脂肪、高蔗糖饮食喂养小鼠的脂肪肝，Kikuchi 1177-1190。胰高血糖素样肽- 1imimimin通过间接机制促进胰高血糖素分泌，改善高脂肪、高蔗糖饮食喂养小鼠的脂肪肝，Kikuchi 1177-1190。日本2型糖尿病患者口服西马鲁肽的疗效和耐受性：来自糖尿病专科诊所的分析报告，Inokuchi 1202-1210。在原代大鼠肝细胞中，epac2激活介导胰高血糖素诱导的糖生成。葡萄糖激酶：葡萄糖激酶单倍体不足对长期高脂高糖饮食小鼠胰腺β细胞质量和功能的影响，Shigesawa 1732-1742。在没有妊娠期糖尿病的妇女中，负荷后血糖比妊娠早期HbA1c更能预测不良妊娠结局，Rajabi 914-921。葡萄糖代谢通过表观基因组改变部分调节β细胞功能，Kim 649-655。葡萄糖刺激胰岛素分泌。葡萄糖激酶单倍体不足对长期高脂高糖饮食小鼠胰腺β细胞质量和功能的影响，Shigesawa 1732-1742。谷氨酸脱羧酶。预测谷氨酸脱羧酶自身抗体酶联免疫吸附试验阳性的缓慢进展型1型糖尿病患者未来胰岛素缺乏，川崎835-842。糖化白蛋白与心衰患者不良结局的关系，Chen 1457-1463。糖化血红蛋白糖化白蛋白与心衰患者不良结局的关系，Chen 1457-1463。东亚2型糖尿病患者的低碳水化合物饮食：随机对照试验的系统回顾和荟萃分析，Hironaka 1753-1762。2型糖尿病患者血糖风险指数与动脉僵硬度的关系，蔡614-622。糖尿病病程及综合治疗对儿童及青少年2型糖尿病患者血糖水平的影响[j]，吴1026-1033。日本老年2型糖尿病患者开始服用口服降糖药，肾脏功能与血糖控制之间关系的医学数据库分析，Suzuki 1057-1067。
本文章由计算机程序翻译，如有差异，请以英文原文为准。
分享
查看原文 本刊更多论文
Volume 15

50-g Oral glucose challenge test

Problems in screening for gestational diabetes mellitus by measurement of casual blood glucose levels at 24–28 gestational weeks, Tomimoto 1797–1802.

β-Cell dysfunction

Glucose metabolism partially regulates β-cell function through epigenomic changes, Kim 649–655.

β-Cells

Role of β-cell autophagy in β-cell physiology and the development of diabetes, Yasasilka 656–668.

β-Cell mass

Effects of glucokinase haploinsufficiency on the pancreatic β-cell mass and function of long-term high-fat, high-sucrose diet-fed mice, Shigesawa 1732–1742.

Accuracy

Impact of hematocrit levels on the accuracy of specific blood glucose meters: A hospital-based study, Pham 1472–1482.

Acyl-coenzyme A synthetase long-chain family member 4

Tanshinone IIA suppresses ferroptosis to attenuate renal podocyte injury in diabetic nephropathy through the embryonic lethal abnormal visual-like protein 1 and acyl-coenzyme A synthetase long-chain family member 4 signaling pathway, Zhu 1003–1016.

Adherence

Modification effect of receipt of diabetes care on the association between COVID-19 infection and HbA1c level during the first year of the coronavirus pandemic using a nationwide population-based database, Okada 953–963.

Prevalence of adherence to oral antidiabetic drugs in patients with type 2 diabetes: A systematic review and meta-analysis, Boonpattharatthiti 1614–1625.

Aging

Association of biomarkers and Barthel Index with occurrence of age-related adverse health outcomes in individuals with diabetes, Umamoto 1675–1683.

Alcohol drinking

The association between alcohol drinking and glycemic management among people with type 2 diabetes in China, Ye 237–244.

Aldehyde dehydrogenase 2

Mitochondrial ALDH2 improves β-cell survival and function against doxorubicin-induced apoptosis by targeting CK2 signaling, Karunakaran 684–692.

Algorithm

A consensus statement from the Japan Diabetes Society: A proposed algorithm for pharmacotherapy in people with type 2 diabetes—2nd edition (English version), Bouchi 1326–1342.

Alzheimer's disease-like complications of DM

Calpeptin improves the cognitive function in Alzheimer's disease-like complications of diabetes mellitus rats by regulating TXNIP/NLRP3 inflammasome, Qiao 1365–1376.

Angiopoietin-like 4

Angiopoietin-like 4 is a potential biomarker for diabetic kidney disease in type 2 diabetes patients, Wang 1763–1772.

Antidiabetic drugs

Cancer biology in diabetes update: Focusing on antidiabetic drugs, Kawakita 525–540.

Pancreatic beta-cell mass and function and therapeutic implications of using antidiabetic medications in type 2 diabetes, Moon 669–683.

Anti-inflammatory activity

High-density lipoprotein in diabetes: Structural and functional relevance, Lui 805–816.

Anti-oxidative activity

High-density lipoprotein in diabetes: Structural and functional relevance, Lui 805–816.

Area under the C-peptide curve

Association between area under the C-peptide curve during an oral glucose tolerance test and diabetic retinopathy in type 2 diabetes patients, Zhang 315–325.

Arginine vasopressin deficiency

Coexistence of type 2 diabetes mellitus, arginine vasopressin deficiency, and Marfan syndrome: A case report, Le 964–967.

Arterial stiffness

Association between glycemia risk index and arterial stiffness in type 2 diabetes, Cai 614–622.

Asia

Changing landscape of diabetes in Asia – What are the unmet needs?, Luk 402–409.

Aspirin

Low-dose aspirin for prevention of cardiovascular mortality in patients with type 2 diabetes and chronic kidney disease: A real-world nationwide cohort study, Lin 459–467.

Asprosin

The correlation between serum asprosin and left ventricular diastolic dysfunction in elderly patients with type 2 diabetes mellitus in the community, Liang 608–613.

Association analysis between serum asprosin and metabolic characteristics, Complications in type 2 diabetic patients with different durations, Ma 1781–1787.

Asthma

A case of type 2 diabetes mellitus with weight gain and worsening of glycemic management after tezepelumab administration for severe bronchial asthma, Umamoto 388–390.

Atherosclerosis

High glucose promotes atherosclerosis by regulating miRNA let7d-5p level, Wang 711–724.

Coexistence of high visceral fat area and sarcopenia is associated with atherosclerotic markers in old-old patients with diabetes: A cross-sectional study, Sato 1510–1518.

Autoimmunity

Diabetes treatment by conversion of gut epithelial cells to insulin-producing cells, Accili 797–804.

Autophagy

Role of β-cell autophagy in β-cell physiology and the development of diabetes, Yasasilka 656–668.

Average age at death

Causes of death in Japanese patients with diabetes based on the results of a survey of 68,555 cases during 2011–2020: Committee report on causes of death in diabetes mellitus, Japan Diabetes Society (English version), Nakamura 1821–1837.

Average real variability

Prognostic value of longitudinal HbA1c variability in predicting the development of diabetic sensorimotor polyneuropathy among patients with type 2 diabetes mellitus: A prospective cohort observational study, Lai 326–335.

Behavioral change

Internet of things-based approach for glycemic control in people with type 2 diabetes: A randomized controlled trial, Bouchi 1287–1296.

Beta-cell function

Association between area under the C-peptide curve during an oral glucose tolerance test and diabetic retinopathy in type 2 diabetes patients, Zhang 315–325.

Bioinformatics

Identification and validation of voltage-dependent anion channel 1-related genes and immune cell infiltration in diabetic nephropathy, Lin 87–105.

Bioinformatics analysis

Immunoglobulin heavy constant gamma 1 silencing decreases tonicity-responsive enhancer-binding protein expression to alleviate diabetic nephropathy, Hu 572–583.

Biomarker

Association of biomarkers and Barthel Index with occurrence of age-related adverse health outcomes in individuals with diabetes, Umamoto 1675–1683.

Biomarkers

The role of lipid dysregulation in gestational diabetes mellitus: Early prediction and postpartum prognosis, Zhang 15–25.

Identification and validation of voltage-dependent anion channel 1-related genes and immune cell infiltration in diabetic nephropathy, Lin 87–105.

Birth weight

Maternal birth weight as an indicator of early and late gestational diabetes mellitus: The Japan Environment and Children's Study, Tagami 751–761.

Association between infant birth weight and gestational weight gain in Japanese women with diabetes mellitus, Fujikawa Shingu 906–913.

Blind

Characterization of the visually impaired patients with diabetes mellitus in Japan, Sugihara 882–891.

Blood glucose

Delayed dinnertime impairs glucose tolerance in healthy young adults, Nakamura 172–176.

Effects of hybrid closed-loop system on glycemic control and psychological aspects in persons with type 1 diabetes treated with sensor-augmented pump: A prospective single-center observational study, Akiyama 219–226.

A novel predictive model for optimizing diabetes screening in older adults, Lin 1403–1409.

Blood glucose monitors

Impact of hematocrit levels on the accuracy of specific blood glucose meters: A hospital-based study, Pham 1472–1482.

Body composition

Body composition and risk of gestational diabetes mellitus: A univariable and multivariable Mendelian randomization study, Gao 346–354.

Body mass index

Eating behaviors and incidence of type 2 diabetes in Japanese people: The population-based Panasonic cohort study 15, Toyokuni 1017–1025.

Calpain-2

Calpeptin improves the cognitive function in Alzheimer's disease-like complications of diabetes mellitus rats by regulating TXNIP/NLRP3 inflammasome, Qiao 1365–1376.

Cancer

Cancer biology in diabetes update: Focusing on antidiabetic drugs, Kawakita 525–540.

Cardio-ankle vascular index

Systematic Coronary Risk Evaluation 2-Diabetes risk.

Predictive value of Systematic Coronary Risk Evaluation 2-Diabetes risk model and arterial stiffness for cardiovascular events in the Asian population with type 2 diabetes mellitus, Suwannasom 1266–1275.

Cardiovascular autonomic neuropathy

Improvement of heart rate variability after metabolic bariatric surgery in Korean subjects with obesity, Jang 1773–1780.

Cardiovascular disease

Health impacts of new-onset diabetes in women post-gestational diabetes mellitus: Insights from Hong Kong's territory-wide data, Zhang 772–781.

Associations of fasting plasma glucose with all-cause mortality and cardiovascular events in older Chinese diabetes patients: A population-based cohort study, Wang 1129–1139.

Interpretable machine learning models based on shear-wave elastography radiomics for predicting cardiovascular disease in diabetic kidney disease patients, Dai 1637–1650.

Cardiovascular diseases

Risk stratification for cardiovascular disease based on prior coronary artery disease, cerebrovascular disease and type 2 diabetes mellitus, Oe 1464–1471.

Casual blood glucose

Problems in screening for gestational diabetes mellitus by measurement of casual blood glucose levels at 24–28 gestational weeks, Tomimoto 1797–1802.

Cause of death

Causes of death in Japanese patients with diabetes based on the results of a survey of 68,555 cases during 2011–2020: Committee report on causes of death in diabetes mellitus, Japan Diabetes Society (English version), Nakamura 1821–1837.

CCP

Cordyceps cicadae polysaccharides attenuate diabetic nephropathy via the miR-30a-3p/TRIM16 axis, Zheng 300–314.

Cell encapsulation

Long-term efficacy of encapsulated xenogeneic islet transplantation: Impact of encapsulation techniques and donor genetic traits, Park 693–703.

Cesarean

Post-load glucose is a stronger predictor of adverse pregnancy outcomes than first-trimester HbA1c in women without gestational diabetes, Rajabi 914–921.

Children

Influence of disease course and comprehensive management on blood glucose level in children and adolescents with type 2 diabetes mellitus, Wu 1026–1033.

Children and adolescents

Clinical significance of coefficient of variation in continuous glucose monitoring for glycemic management in children and adolescents with type 1 diabetes, Urakami 1669–1674.

China

Type 1 and type 2 diabetes mortality burden: Predictions for 2030 based on Bayesian age-period-cohort analysis of China and global mortality burden from 1990 to 2019, Dong 623–633.

Chinese Han population

Association of RPS26 gene polymorphism with different types of diabetes in Chinese individuals, Song 34–43.

Cholesterol efflux

High-density lipoprotein in diabetes: Structural and functional relevance, Lui 805–816.

Chorea

Diabetic striatopathy: Hyperglycemic chorea/ballism successfully treated with L-dopa, Tsukaguchi 1524–1527.

Chronic kidney disease

Low-dose aspirin for prevention of cardiovascular mortality in patients with type 2 diabetes and chronic kidney disease: A real-world nationwide cohort study, Lin 459–467.

Chronic kidney disease progression

Risk factors for chronic kidney disease progression over 20 years for primary prevention in Japanese individuals at a preventive medicine research center: Focus on the influence of plasma glucose levels, Minami 1434–1443.

Circ_0068087

Circ_0068087 knockdown attenuates high-glucose-induced human tubular epithelial cell injury in a microribonucleic acid/progestin and adipoQ receptor 3-dependent manner in diabetic nephropathy, Liu 159–171.

Claims analysis

Associations between income/employment status and diabetes care processes, health behaviors, and health outcomes in Japan: A cross-sectional study using claims data linked to a questionnaire survey, Yamaoka 1684–1695.

Claims data

Implementation rate of diabetic self-management education and support for Japanese people with diabetes using the National Database, Ihana-Sugiyama 861–866.

Clinical

Patient-reported outcomes and treatment adherence in type 2 diabetes using natural language processing: Wave 8 of the Observational International Diabetes Management Practices Study, Chan 1306–1316.

Clinical epidemiology

Modification effect of receipt of diabetes care on the association between COVID-19 infection and HbA1c level during the first year of the coronavirus pandemic using a nationwide population-based database, Okada 953–963.

Clopidogrel

Recurrent hypoglycemia induced by clopidogrel: A case report and mini review, Du 275–281.

Coefficient of variation

Clinical significance of coefficient of variation in continuous glucose monitoring for glycemic management in children and adolescents with type 1 diabetes, Urakami 1669–1674.

Coefficient of variation of R-R intervals

Simplified electrophysiological approach combining a point-of-care nerve conduction device and an electrocardiogram produces an accurate diagnosis of diabetic polyneuropathy, Hayashi 736–742.

Cognition

Global cognition and executive functions of older adults with type 1 diabetes mellitus without dementia, Nagasawa 922–930.

Cognitive impairment

Sodium–glucose cotransporter 2 inhibition through henagliflozin ameliorates cognitive impairment in patients with type 2 diabetes, Zhang 1596–1603.

Cohort study

Maternal birth weight as an indicator of early and late gestational diabetes mellitus: The Japan Environment and Children's Study, Tagami 751–761.

Remnant cholesterol, but not other traditional lipids or lipid ratios, is independently and positively related to future diabetes risk in Chinese general population: A 3 year cohort study, Li 1084–1093.

Combined approaches

Targeting PI3K/AKT and MEK/ERK pathways for synergic effects on improving features of peripheral diabetic neuropathy, Pham 1537–1544.

Commentary

Long-term safety and efficacy of SGLT2 inhibitor use in older east Asians with type 2 diabetes, Takahashi 63–66.

Pituitary gland agouti-related peptide cells: Novel player controlling glucose metabolism, Takahashi 67–69.

Dipeptidyl peptidase-4 inhibition targeting vascular senescence as a novel treatment for atherosclerosis, Yen 143–144.

Glucose-dependent insulinotropic polypeptide receptor systems in the hypothalamus and the brainstem regulate feeding and weight through distinct pathways, Yada 283–284.

Advancements and challenges in pancreatic islet transplantation: Insights from the Collaborative Islet Transplant Registry, Lee 423–425.

Deciphering the causal tapestry between cardiorespiratory fitness and type 2 diabetes mellitus, Ko 426–428.

Birthweight and risk of diabetes in later life, Sheu 557–558.

Effects of dipeptidyl peptidase-4 inhibition in vivo: Dipeptidyl peptidase-4 inhibitor/gut microbiome crosstalk suggests novel therapeutic options for diabetes management, Yasuda 704–706.

Gut microbiota dysbiosis as a novel pathogenic factor of diabetic peripheral neuropathy, Niimi 817–819.

Commentary on association of glycemic index and glycemic load with type 2 diabetes, cardiovascular disease, cancer, and all-cause mortality, Hsieh 1545–1547.

Regulation of glucose and energy metabolism through actions of glucagon-like peptide-1 and glucose-dependent insulinotropic polypeptide, Zenimaru 1725–1726.

Commentary on “Intra-islet a-cell Gs signaling promotes glucagon release”, Kitamura 1727–1728.

Complications of diabetes

Glycemic variability: Measurement, target, impact on complications of diabetes and does it really matter? Mo 5–14.

Continuous glucose monitoring

Glycemic variability: Measurement, target, impact on complications of diabetes and does it really matter? Mo 5–14.

Comparative effects of fixed-dose mitiglinide/voglibose combination and glimepiride on vascular endothelial function and glycemic variability in patients with type 2 diabetes: A randomized controlled trial, Tanaka 449–458.

Association between glycemia risk index and arterial stiffness in type 2 diabetes, Cai 614–622.

Glycemic variability is associated with sural nerve conduction velocity in outpatients with type 2 diabetes: Usefulness of a new point-of-care device for nerve conduction studies, Morita 1075–1083.

Possible etiological role of impaired endogenous double strand RNA editing in β-cells in type 1 diabetes, Imai 1171–1173.

A sneak peek into chronic glucose exposure and insulin secretion impairment through translatome, Helena 1174–1176.

Clinical significance of coefficient of variation in continuous glucose monitoring for glycemic management in children and adolescents with type 1 diabetes, Urakami 1669–1674.

Theragnostic utility of continuous glucose monitoring in post-gastrectomy hypoglycemia, Son 1696–1699.

Continuous subcutaneous insulin infusion

Fulminant type 1 diabetes, an underrecognized and unique subtype of type 1 diabetes: A case series from Singapore, Tan 786–789.

Corneal confocal microscopy

Circulating netrin-1 levels are reduced and related to corneal nerve fiber loss in patients with diabetic neuropathy, Mondal 1068–1074.

Cortisol

An exploratory study of factors in disordered eating behavior in diabetes self-management in Japan, Tsukamoto-Kawashima 874–881.

COVID-19

Association of serum amyloid A and prognosis in people with diabetes and COVID-19: A retrospective cohort study, Qu 44–51.

Type 1 diabetes, COVID-19 vaccines and short-term safety: Subgroup analysis from the global COVAD study, Chatterjee 131–138.

Modification effect of receipt of diabetes care on the association between COVID-19 infection and HbA1c level during the first year of the coronavirus pandemic using a nationwide population-based database, Okada 953–963.

COVID-19 pandemic

Comparing the screening methods for gestational diabetes mellitus before and during the COVID-19 pandemic: A systematic review, Sun 500–516.

C-peptide index

Short-term recovery of insulin secretion in response to a meal is associated with future glycemic control in type 2 diabetes patients, Enkaku 437–448.

Comparison of efficacy and safety of insulin degludec/liraglutide and insulin glargine U-100/lixisenatide in individuals with type 2 diabetes mellitus using professional continuous glucose monitoring, Kawaguchi 598–607.

Critically ill

Between blood glucose and mortality in critically ill patients: Retrospective analysis of the MIMIC-IV database, Li 931–938.

Cross-sectional studies

Association between gastrointestinal symptoms and insomnia in patients with type 2 diabetes: The KAMOGAWA-DM cohort study, Minamida 946–952.

Cross-sectional study

Relationship between diabetes treatment status and occupational accidents, Ogasawara 899–905.

CYP1B1

MiR-488-3p facilitates wound healing throughCYP1B1-mediated Wnt/β-catenin signaling pathway by targeting MeCP2, Zuo 145–158.

Cystatin C

Causal association between cystatin C and diabetic retinopathy: A two-sample Mendelian randomization study, Ruan 1626–1636.

Diabetes

Association of serum amyloid A and prognosis in people with diabetes and COVID-19: A retrospective cohort study, Qu 44–51.

Overnutrition in the early postnatal period influences lifetime metabolic risk: Evidence for impact on pancreatic β-cell mass and function, Burton 263–274.

Low-dose aspirin for prevention of cardiovascular mortality in patients with type 2 diabetes and chronic kidney disease: A real-world nationwide cohort study, Lin 459–467.

Inverted U-shaped associations between serumuric acid and fasting - plasma glucose level in non-diabetic, pre-diabetic, and diabetic adults: A population-based study in China, Shi 483–490.

Cancer biology in diabetes update: Focusing on antidiabetic drugs, Kawakita 525–540.

Type 1 and type 2 diabetes mortality burden: Predictions for 2030 based on Bayesian age-period-cohort analysis of China and global mortality burden from 1990 to 2019, Dong 623–633.

Performance of different machine learning algorithms in identifying undiagnosed diabetes based on nonlaboratory parameters and the influence of muscle strength: A cross-sectional study, Xu 743–750.

Diabetes treatment by conversion of gut epithelial cells to insulin-producing cells, Accili 797–804.

Relationship between diabetes treatment status and occupational accidents, Ogasawara 899–905.

Prevalence, awareness, treatment and control of type 2 diabetes in southeast China: A population-based study, Hu 1034–1041.

Remnant cholesterol, but not other traditional lipids or lipid ratios, is independently and positively related to future diabetes risk in Chinese general population: A 3 year cohort study, Li 1084–1093.

Impact of diabetes on the prognosis of patients with oral and oropharyngeal cancer: A meta-analysis, Xu 1140–1150.

Optimizing lipid control in Taiwanese diabetic patients: A collaborative consensus by the Diabetes Association of the Republic of China (Taiwan) and the Taiwanese Association of Diabetes Educators, Shen 1151–1160.

Prevalence of adherence to oral antidiabetic drugs in patients with type 2 diabetes: A systematic review and meta-analysis, Boonpattharatthiti 1614–1625.

Association of biomarkers and Barthel Index with occurrence of age-related adverse health outcomes in individuals with diabetes, Umamoto 1675–1683.

Diabetes complications

Relationship between elevated circulating thrombospondin-1 levels and vascular complications in diabetes mellitus, Guo 197–207.

Sheffield One-Stop Service: A potential model to improve the screening uptake of diabetic peripheral neuropathy and other microvascular complications of diabetes, Sloan 1355–1362.

Diabetes duration

Association analysis between serum asprosin and metabolic characteristics, Complications in type 2 diabetic patients with different durations, Ma 1781–1787.

Diabetes mellitus

Association of RPS26 gene polymorphism with different types of diabetes in Chinese individuals, Song 34–43.

Relationship between elevated circulating thrombospondin-1 levels and vascular complications in diabetes mellitus, Guo 197–207.

Development and validation of a prediction model for self-reported hypoglycemia risk in patients with type 2 diabetes: A longitudinal cohort study, Xu 468–482.

Social deprivation and diabetic kidney disease: A European view, Casey 541–556.

Improvements of myocardial strain and work in diabetes patients with normal ejection fraction after empagliflozin treatment, Cheng 851–860.

Association between infant birth weight and gestational weight gain in Japanese women with diabetes mellitus, Fujikawa Shingu 906–913.

Association between gastrointestinal symptoms and insomnia in patients with type 2 diabetes: The KAMOGAWA-DM cohort study, Minamida 946–952.

Association between variation in hemoglobin A1c levels and diabetes therapy-related quality of life in patients with diabetes, Imai 1042–1046.

Medical database analysis of the association between kidney function and achievement of glycemic control in older Japanese adults with type 2 diabetes who started with oral antidiabetic drugs, Suzuki 1057–1067.

Postpartum life interventions to prevent type 2 diabetes in women with gestational diabetes: A systematic review and meta-analysis, Wang 1115–1128.

Predictive value of Systematic Coronary Risk Evaluation 2-Diabetes risk model and arterial stiffness for cardiovascular events in the Asian population with type 2 diabetes mellitus, Suwannasom 1266–1275.

A novel predictive model for optimizing diabetes screening in older adults, Lin 1403–1409.

A real-world disproportionality analysis of semaglutide: Post-marketing pharmacovigilance data, Du 1422–1433.

Neonatal diabetes mellitus around the world: Update 2024, Barbetti 1711–1724.

Diabetes mellitus type 1

Islet transplantation in Korea, Lee 1165–1170.

Diabetes mellitus, type 2

Decline in measured glomerular filtration rate is associated with simple renal cyst in Chinese patients with type 2 diabetes, Qiaoling 26–33.

Resistant starch and type 2 diabetes mellitus: Clinical perspective, Kim 395–401.

PIONEER REAL Japan: Primary results from a multicenter, prospective, real-world study of oral semaglutide in adults with type 2 diabetes in Japanese clinical practice, Yabe 1566–1577.

Diabetes patient

Associations of fasting plasma glucose with all-cause mortality and cardiovascular events in older Chinese diabetes patients: A population-based cohort study, Wang 1129–1139.

Diabetes therapy-related quality of life

Association between variation in hemoglobin A1c levels and diabetes therapy-related quality of life in patients with diabetes, Imai 1042–1046.

Diabetic cardiomyopathy

Polygonatum sibiricum (Huang Jing) polysaccharide reduces diabetic cardiomyopathy through increasing cyclic guanosine monophosphate-protein kinase G signaling in diabetic mice, Lei 823–834.

Regulatory T cells protect against diabetic cardiomyopathy in db/db mice, Zhang 1191–1201.

Diabetic complications

The role of vascular adhesion protein-1 in diabetes and diabetic complications, Yen 982–989.

Diabetic education

Implementation rate of diabetic self-management education and support for Japanese people with diabetes using the National Database, Ihana-Sugiyama 861–866.

Diabetic foot

What characteristics are most important in stratifying patients into groups with different risk of diabetic foot ulceration?, Naemi 1094–1104.

Cardiac electrophysiology, structure and diastolic function in patients with diabetic foot versus those without diabetic foot, Bai 1276–1286.

Diabetic foot ulcer recurrence

Plantar pressure measurement in diabetic foot disease: A scoping review, Lockhart 990–999.

Diabetic ketoacidosis

Fulminant type 1 diabetes, an underrecognized and unique subtype of type 1 diabetes: A case series from Singapore, Tan 786–789.

Diabetic kidney disease

Social deprivation and diabetic kidney disease: A European view, Casey 541–556.

Nutrient quality in dietary therapy for diabetes and diabetic kidney disease, Tsuruta 973–981.

Relationship between circulating thrombospondin-1 messenger ribonucleic acid and microribonucleic acid-194 levels in Chinese patients with type 2 diabetic kidney disease: The outcomes of a case–control study, Ma 1248–1258.

Young-onset type 2 diabetes mellitus enhances proteinuria, but not glomerular filtration rate decline: A Japanese cohort study, Saito 1444–1456.

Interpretable machine learning models based on shear-wave elastography radiomics for predicting cardiovascular disease in diabetic kidney disease patients, Dai 1637–1650.

Angiopoietin-like 4 is a potential biomarker for diabetic kidney disease in type 2 diabetes patients, Wang 1763–1772.

Diabetic macular edema

Sodium–glucose cotransporter 2 inhibitor therapy reduces the administration frequency of steroid injection in patients with diabetic macular edema: A cohort study using the Japanese health insurance claims database, Ishibashi 1231–1238.

Diabetic nephropathy

Identification and validation of voltage-dependent anion channel 1-related genes and immune cell infiltration in diabetic nephropathy, Lin 87–105.

Sympathetic skin response for early detection of type 2 diabetic peripheral neuropathy and nephropathy, Liu 106–112.

Circ_0068087 knockdown attenuates high-glucose-induced human tubular epithelial cell injury in a microribonucleic acid/progestin and adipoQ receptor 3-dependent manner in diabetic nephropathy, Liu 159–171.

METTL3/YTHDF2 m6A axis mediates the progression of diabetic nephropathy through epigenetically suppressing PINK1 and mitophagy, Wang 288–299.

Cordyceps cicadae polysaccharides attenuate diabetic nephropathy via the miR-30a-3p/TRIM16 axis, Zheng 300–314.

Immunoglobulin heavy constant gamma 1 silencing decreases tonicity-responsive enhancer-binding protein expression to alleviate diabetic nephropathy, Hu 572–583.

Diabetic neuropathy

Circulating netrin-1 levels are reduced and related to corneal nerve fiber loss in patients with diabetic neuropathy, Mondal 1068–1074.

Diminished levels of insulin-like growth factor-1 may be a risk factor for peripheral neuropathy in type 2 diabetes patients, Zhong 1259–1265.

Sheffield One-Stop Service: A potential model to improve the screening uptake of diabetic peripheral neuropathy and other microvascular complications of diabetes, Sloan 1355–1362.

Targeting PI3K/AKT and MEK/ERK pathways for synergic effects on improving features of peripheral diabetic neuropathy, Pham 1537–1544.

Diabetic peripheral neuropathy

Identification and validation of voltage-dependent anion channel 1-related genes and immune cell infiltration in diabetic nephropathy, Lin 87–105.

Sympathetic skin response for early detection of type 2 diabetic peripheral neuropathy and nephropathy, Liu 106–112.

Diabetic polyneuropathies

Simplified electrophysiological approach combining a point-of-care nerve conduction device and an electrocardiogram produces an accurate diagnosis of diabetic polyneuropathy, Hayashi 736–742.

Diabetic retinopathy

Association between area under the C-peptide curve during an oral glucose tolerance test and diabetic retinopathy in type 2 diabetes patients, Zhang 315–325.

Serum vitamin D is substantially reduced and predicts flares in diabetic retinopathy patients, Zhuang 867–873.

Characterization of the visually impaired patients with diabetes mellitus in Japan, Sugihara 882–891.

Causal association between cystatin C and diabetic retinopathy: A two-sample Mendelian randomization study, Ruan 1626–1636.

Diabetic striatopathy

Diabetic striatopathy: Hyperglycemic chorea/ballism successfully treated with L-dopa, Tsukaguchi 1524–1527.

Diabetics with critical limb ischemia

Microvascular permeability and texture analysis of bone marrow in diabetic rabbits with critical limb ischemia based on dynamic contrast-enhanced magnetic resonance imaging, Yang 584–593.

Diabetic symmetric sensorimotor polyneuropathy

Prevalence and characteristics of diabetic symmetric sensorimotor polyneuropathy in Japanese patients with type 2 diabetes: The Japan Diabetes Complication and its Prevention Prospective study (JDCP study 10), Kamiya 247–253

Diet

Resistant starch and type 2 diabetes mellitus: Clinical perspective, Kim 395–401.

Dietary intervention

Application of the integrated data platform combined with dietary management for adults with diabetes: A prospective randomized controlled trial, Liu 1548–1555.

Dietary therapy

Nutrient quality in dietary therapy for diabetes and diabetic kidney disease, Tsuruta 973–981.

Digital platform

Application of the integrated data platform combined with dietary management for adults with diabetes: A prospective randomized controlled trial, Liu 1548–1555.

Doxorubicin

Mitochondrial ALDH2 improves β-cell survival and function against doxorubicin-induced apoptosis by targeting CK2 signaling, Karunakaran 684–692.

DPNCheck

Simplified electrophysiological approach combining a point-of-care nerve conduction device and an electrocardiogram produces an accurate diagnosis of diabetic polyneuropathy, Hayashi 736–742.

East Asians

Low-carbohydrate diets in East Asians with type 2 diabetes: A systematic review and meta-analysis of randomized controlled trials, Hironaka 1753–1762.

Eating behavior

An exploratory study of factors in disordered eating behavior in diabetes self-management in Japan, Tsukamoto-Kawashima 874–881.

Eating behaviors

Eating behaviors and incidence of type 2 diabetes in Japanese people: The population-based Panasonic cohort study 15, Toyokuni 1017–1025.

Editorial

Common metabolite for microangiopathy in Japanese and European populations, Shojima 523–524.

The Ulaanbaatar agreement: Revising diabetes terminology in Asia to combat stigma, Seino 1533–1536.

The roles of output clock genes in regulating glucose metabolism, Taguchi 1707–1710.

Elderly

Sulfonylurea prescription patterns in elderly patients with type 2 diabetes mellitus: A comprehensive analysis of real-world data from pharmacies in Japan, Yamazaki 1604–1613.

Embryonic lethal abnormal visual-like protein 1

Tanshinone IIA suppresses ferroptosis to attenuate renal podocyte injury in diabetic nephropathy through the embryonic lethal abnormal visual-like protein 1 and acyl-coenzyme A synthetase long-chain family member 4 signaling pathway, Zhu 1003–1016.

Empagliflozin

Improvements of myocardial strain and work in diabetes patients with normal ejection fraction after empagliflozin treatment, Cheng 851–860.

EPAC

Epac2 activation mediates glucagon-induced glucogenesis in primary rat hepatocytes, Shiozaki-Takagi 429–436.

Epigenetic change

Glucose metabolism partially regulates β-cell function through epigenomic changes, Kim 649–655.

Epilepsy

Type 1 diabetes and the risk of epilepsy: A meta-analysis, Wu 364–373.

Estimated glomerular filtration rate

Risk factors for chronic kidney disease progression over 20 years for primary prevention in Japanese individuals at a preventive medicine research center: Focus on the influence of plasma glucose levels, Minami 1434–1443.

Angiopoietin-like 4 is a potential biomarker for diabetic kidney disease in type 2 diabetes patients, Wang 1763–1772.

Ethnicity

Lipid profile in women of different ethnicity with gestational diabetes: Relationship with fetal growth, Dalfrá 355–363.

Executive function

Global cognition and executive functions of older adults with type 1 diabetes mellitus without dementia, Nagasawa 922–930.

Fasting plasma glucose

Inverted U-shaped associations between serumuric acid and fasting - plasma glucose level in non-diabetic, pre-diabetic, and diabetic adults: A population-based study in China, Shi 483–490.

Associations of fasting plasma glucose with all-cause mortality and cardiovascular events in older Chinese diabetes patients: A population-based cohort study, Wang 1129–1139.

Fenofibrate

Haptoglobin phenotype and levels in type 2 diabetes and effects of fenofibrate, Januszewski 1663–1668.

Flash glucose monitoring

Fresh autologous blood transfusion.

Exploration of the mechanism of reinfusion of fresh autologous blood in type 2 diabetes mice to induce macrophage polarization and inhibit erythrocyte damage, Hu 70–77.

Foot ulcer

What characteristics are most important in stratifying patients into groups with different risk of diabetic foot ulceration?, Naemi 1094–1104.

Frailty

Management of older adults with diabetes mellitus: Perspective from geriatric medicine, Umegaki 1347–1354.

Fulminant type 1 diabetes

Fulminant type 1 diabetes, an underrecognized and unique subtype of type 1 diabetes: A case series from Singapore, Tan 786–789.

GAD antibody

New diagnostic criteria (2023) for slowly progressive type 1 diabetes (SPIDDM): Report from Committee on Type 1 Diabetes of the Japan Diabetes Society (English version), Shimada 254–257.

Gastrectomy

Theragnostic utility of continuous glucose monitoring in post-gastrectomy hypoglycemia, Son 1696–1699.

Gastrointestinal diseases

Association between gastrointestinal symptoms and insomnia in patients with type 2 diabetes: The KAMOGAWA-DM cohort study, Minamida 946–952.

Gene editing

Long-term efficacy of encapsulated xenogeneic islet transplantation: Impact of encapsulation techniques and donor genetic traits, Park 693–703.

Generalized lipodystrophy

Corticosteroid-triggered acute skeletal muscle loss in lipodystrophy: A case report, Sasako 782–785.

Genetic insulin resistance syndrome

A multicenter, open-label, single-arm trial of the long-term safety of empagliflozin treatment for refractory diabetes mellitus with insulin resistance (EMPIRE-02), Hirota 1211–1219.

Genetics and pathogenesis

Identification of eight genomic protective alleles for mitochondrial diabetes by Kinship-graph convolutional network, Wang 52–62.

Genome-wide association studies

Perspectives on genetic studies of type 2 diabetes from the genome-wide association studies era to precision medicine, Imamura 410–422.

Gestational diabetes

The role of lipid dysregulation in gestational diabetes mellitus: Early prediction and postpartum prognosis, Zhang 15–25.

Maternal birth weight as an indicator of early and late gestational diabetes mellitus: The Japan Environment and Children's Study, Tagami 751–761.

Gestational diabetes mellitus

Body composition and risk of gestational diabetes mellitus: A univariable and multivariable Mendelian randomization study, Gao 346–354.

Lipid profile in women of different ethnicity with gestational diabetes: Relationship with fetal growth, Dalfrá 355–363.

Comparing the screening methods for gestational diabetes mellitus before and during the COVID-19 pandemic: A systematic review, Sun 500–516.

Health impacts of new-onset diabetes in women post-gestational diabetes mellitus: Insights from Hong Kong's territory-wide data, Zhang 772–781.

Second-trimester triglyceride-glucose index to predict adverse outcomes in women with gestational diabetes mellitus: A retrospective multicenter cohort study, Bai 1489–1499.

Problems in screening for gestational diabetes mellitus by measurement of casual blood glucose levels at 24–28 gestational weeks, Tomimoto 1797–1802.

Multiple positive points during the 75 g oral glucose tolerance test are good predictors for early insulin therapy in gestational diabetes mellitus diagnosed before 24 gestational weeks, Kasuga 1803–1808.

Gestational weight gain

Association between infant birth weight and gestational weight gain in Japanese women with diabetes mellitus, Fujikawa Shingu 906–913.

Glomerular filtration rate

Decline in measured glomerular filtration rate is associated with simple renal cyst in Chinese patients with type 2 diabetes, Qiaoling 26–33.

Glucagon

Epac2 activation mediates glucagon-induced glucogenesis in primary rat hepatocytes, Shiozaki-Takagi 429–436.

Imeglimin enhances glucagon secretion through an indirect mechanism and improves fatty liver in high-fat, high-sucrose diet-fed mice, Kikuchi 1177–1190.

Glucagon-like peptide-1

Imeglimin enhances glucagon secretion through an indirect mechanism and improves fatty liver in high-fat, high-sucrose diet-fed mice, Kikuchi 1177–1190.

Glucagon-like peptide 1 receptor agonist

Efficacy and tolerability of oral semaglutide in Japanese patients with type 2 diabetes mellitus: Analysis report from diabetes specialist clinics, Inokuchi 1202–1210.

Glucogenic action

Epac2 activation mediates glucagon-induced glucogenesis in primary rat hepatocytes, Shiozaki-Takagi 429–436.

Glucokinase

Effects of glucokinase haploinsufficiency on the pancreatic β-cell mass and function of long-term high-fat, high-sucrose diet-fed mice, Shigesawa 1732–1742.

Glucose

Post-load glucose is a stronger predictor of adverse pregnancy outcomes than first-trimester HbA1c in women without gestational diabetes, Rajabi 914–921.

Glucose metabolism

Glucose metabolism partially regulates β-cell function through epigenomic changes, Kim 649–655.

Glucose-stimulated insulin secretion

Effects of glucokinase haploinsufficiency on the pancreatic β-cell mass and function of long-term high-fat, high-sucrose diet-fed mice, Shigesawa 1732–1742.

Glutamic acid decarboxylase.

Prediction of future insulin-deficiency in glutamic acid decarboxylase autoantibody enzyme-linked immunosorbent assay-positive patients with slowly progressive type 1 diabetes, Kawasaki 835–842.

Glycated albumin

Association between glycated albumin and adverse outcomes in patients with heart failure, Chen 1457–1463.

Glycated hemoglobin

Association between glycated albumin and adverse outcomes in patients with heart failure, Chen 1457–1463.

Low-carbohydrate diets in East Asians with type 2 diabetes: A systematic review and meta-analysis of randomized controlled trials, Hironaka 1753–1762.

Glycemia risk index

Association between glycemia risk index and arterial stiffness in type 2 diabetes, Cai 614–622.

Glycemic control

Influence of disease course and comprehensive management on blood glucose level in children and adolescents with type 2 diabetes mellitus, Wu 1026–1033.

Medical database analysis of the association between kidney function and achievement of glycemic control in older Japanese adults with type 2 diabetes who started with oral antidiabetic drugs, Suzuki 1057–1067.

Patient-reported outcomes and treatment adherence in type 2 diabetes using natural language processing: Wave 8 of the Observational International Diabetes Management Practices Study, Chan 1306–1316.

Glycemic metrics in Japanese isCGM users—Analysis by diabetes type and therapy, Ogawa 1483–1488.

Glycemic management

The association between alcohol drinking and glycemic management among people with type 2 diabetes in China, Ye 237–244.

Safety and effectiveness of tofogliflozin in Japanese people with type 2 diabetes: A multicenter prospective observational study in routine clinical practice, Yamada 1585–1595.

Glycemic variability

Glycemic variability: Measurement, target, impact on complications of diabetes and does it really matter? Mo 5–14.

Glycemic variability is associated with sural nerve conduction velocity in outpatients with type 2 diabetes: Usefulness of a new point-of-care device for nerve conduction studies, Morita 1075–1083.

Glycosylated hemoglobin

Association between glycated hemoglobin and risk of all-cause mortality in community patients with type 2 diabetes: A prospective cohort study, He 939–945.

Growth

Overnutrition in the early postnatal period influences lifetime metabolic risk: Evidence for impact on pancreatic β-cell mass and function, Burton 263–274.

Handgrip strength

The impact of handgrip strength and waist circumference on glycemic control: Prospective, observational study using outpatient clinical data in Japanese patients with type 2 diabetes mellitus, Nakanishi 892–898.

Haptoglobin

Haptoglobin phenotype and levels in type 2 diabetes and effects of fenofibrate, Januszewski 1663–1668.

HbA1c

Effect of hemoglobin A1c management levels on coronary physiology evaluated by quantitative flow ratio in patients who underwent percutaneous coronary intervention, Chen 336–345.

HbA1c degradation

Evaluation of the transition program at the University Hospital of Reims from 2015 to 2020, Chibane 1519–1523.

HbA1c trajectory

Mandatory monthly outpatient visits could improve therapeutic inertia in patients with poorly controlled type 2 diabetes, Tsai 227–236.

HbA1c variability

Prognostic value of longitudinal HbA1c variability in predicting the development of diabetic sensorimotor polyneuropathy among patients with type 2 diabetes mellitus: A prospective cohort observational study, Lai 326–335.

Health care costs

Healthcare resource utilization and healthcare costs in patients with type 2 diabetes mellitus initiating sodium-glucose cotransporter 2 inhibitors vs dipeptidyl peptidase-4 inhibitors in Japan: A real-world administrative database analysis, Kashiwagi 374–387.

Healthcare quality assessment

Associations between income/employment status and diabetes care processes, health behaviors, and health outcomes in Japan: A cross-sectional study using claims data linked to a questionnaire survey, Yamaoka 1684–1695.

Health resources

Healthcare resource utilization and healthcare costs in patients with type 2 diabetes mellitus initiating sodium-glucose cotransporter 2 inhibitors vs dipeptidyl peptidase-4 inhibitors in Japan: A real-world administrative database analysis, Kashiwagi 374–387.

Healthy volunteers

Delayed dinnertime impairs glucose tolerance in healthy young adults, Nakamura 172–176.

Heart failure

Association between glycated albumin and adverse outcomes in patients with heart failure, Chen 1457–1463.

Heart rate variability

Associations of age-adjusted coefficient of variation of R-R intervals with autonomic and peripheral nerve function in non-elderly persons with diabetes, Sugimoto 186–196.

Cardiac electrophysiology, structure and diastolic function in patients with diabetic foot versus those without diabetic foot, Bai 1276–1286.

Improvement of heart rate variability after metabolic bariatric surgery in Korean subjects with obesity, Jang 1773–1780.

Hematocrit

Impact of hematocrit levels on the accuracy of specific blood glucose meters: A hospital-based study, Pham 1472–1482.

Hemoglobin A1c

Post-load glucose is a stronger predictor of adverse pregnancy outcomes than first-trimester HbA1c in women without gestational diabetes, Rajabi 914–921.

Henagliflozin

Sodium–glucose cotransporter 2 inhibition through henagliflozin ameliorates cognitive impairment in patients with type 2 diabetes, Zhang 1596–1603.

Hepatocyte nuclear factor 1B

Hepatocyte nuclear factor 1B deletion, but not intragenic mutation, might be more susceptible to hypomagnesemia, Wang 121–130.

High-density lipoprotein cholesterol

Association between serum uric acid-to-high-density lipoprotein cholesterol ratio and insulin resistance in patients with type 2 diabetes mellitus, Zhou 113–120.

hs-CRP

High sensitivity C-reactive protein and prediabetes progression and regression in middle-aged and older adults: A prospective cohort study, Cheng 78–86.

Hyperlipidemia

Optimizing lipid control in Taiwanese diabetic patients: A collaborative consensus by the Diabetes Association of the Republic of China (Taiwan) and the Taiwanese Association of Diabetes Educators, Shen 1151–1160.

Hypoglycemia

Recurrent hypoglycemia induced by clopidogrel: A case report and mini review, Du 275–281.

Development and validation of a prediction model for self-reported hypoglycemia risk in patients with type 2 diabetes: A longitudinal cohort study, Xu 468–482.

Islet transplantation in Korea, Lee 1165–1170.

Theragnostic utility of continuous glucose monitoring in post-gastrectomy hypoglycemia, Son 1696–1699.

Hypomagnesemia

Hepatocyte nuclear factor 1B deletion, but not intragenic mutation, might be more susceptible to hypomagnesemia, Wang 121–130.

Ideal cardiovascular health

The association between metabolic syndrome and insulin resistance with risk of cardiovascular events in different states of cardiovascular health status, Hosseinpour-Niazi 208–218.

IDegLira

Comparison of efficacy and safety of insulin degludec/liraglutide and insulin glargine U-100/lixisenatide in individuals with type 2 diabetes mellitus using professional continuous glucose monitoring, Kawaguchi 598–607.

IGHG1

Immunoglobulin heavy constant gamma 1 silencing decreases tonicity-responsive enhancer-binding protein expression to alleviate diabetic nephropathy, Hu 572–583.

IGlarLixi

Comparison of efficacy and safety of insulin degludec/liraglutide and insulin glargine U-100/lixisenatide in individuals with type 2 diabetes mellitus using professional continuous glucose monitoring, Kawaguchi 598–607.

Imeglimin

Imeglimin enhances glucagon secretion through an indirect mechanism and improves fatty liver in high-fat, high-sucrose diet-fed mice, Kikuchi 1177–1190.

Factors contributing to the clinical effectiveness of imeglimin monotherapy in Japanese patients with type 2 diabetes mellitus, Hagi 1239–1247.

Inflammation

Regulatory T cells protect against diabetic cardiomyopathy in db/db mice, Zhang 1191–1201.

Influence factors

Prevalence, awareness, treatment and control of type 2 diabetes in southeast China: A population-based study, Hu 1034–1041.

Injection

Adherence and treatment discontinuation of oral semaglutide and once-weekly semaglutide injection at 12-month follow-up: Japanese real-world data, Horii 1578–1584.

Insulin

Targeting PI3K/AKT and MEK/ERK pathways for synergic effects on improving features of peripheral diabetic neuropathy, Pham 1537–1544.

Multiple positive points during the 75 g oral glucose tolerance test are good predictors for early insulin therapy in gestational diabetes mellitus diagnosed before 24 gestational weeks, Kasuga 1803–1808.

Insulin autoimmune syndrome

Recurrent hypoglycemia induced by clopidogrel: A case report and mini review, Du 275–281.

Insulin infusion systems

Effects of hybrid closed-loop system on glycemic control and psychological aspects in persons with type 1 diabetes treated with sensor-augmented pump: A prospective single-center observational study, Akiyama 219–226.

Insulin-like growth factor-1

Diminished levels of insulin-like growth factor-1 may be a risk factor for peripheral neuropathy in type 2 diabetes patients, Zhong 1259–1265.

Insulin resistance

The association between metabolic syndrome and insulin resistance with risk of cardiovascular events in different states of cardiovascular health status, Hosseinpour-Niazi 208–218.

Association between serum uric acid-to-high-density lipoprotein cholesterol ratio and insulin resistance in an American population: A population-based analysis, Zhou 762–771.

Insulin secretion

Short-term recovery of insulin secretion in response to a meal is associated with future glycemic control in type 2 diabetes patients, Enkaku 437–448.

Pancreatic beta-cell mass and function and therapeutic implications of using antidiabetic medications in type 2 diabetes, Moon 669–683.

Insulin secretory capacity

Association of xanthine oxidoreductase inhibitor use with insulin secretory capacity inpatients with type 2 diabetes, Kitamura 1500–1509.

Insulin sensitivity

Interactive calculator to estimate insulin sensitivity in type 1 diabetes, Januszewski 594–597.

Intermittent fasting

Effect of intermittent fasting 16:8 and 14:10 compared with control-group on weight reduction and metabolic outcomes in obesity with type 2 diabetes patients: A randomized controlled trial, Sukkriang 1297–1305.

Intermittently scanned continuous glucose monitoring

Patient-reported outcomes and treatment adherence in type 2 diabetes using natural language processing: Wave 8 of the Observational International Diabetes Management Practices Study, Chan 1306–1316.

Internet of things

Internet of things-based approach for glycemic control in people with type 2 diabetes: A randomized controlled trial, Bouchi 1287–1296.

Intestine

Diabetes treatment by conversion of gut epithelial cells to insulin-producing cells, Accili 797–804.

Islets of Langerhans transplantation

Long-term efficacy of encapsulated xenogeneic islet transplantation: Impact of encapsulation techniques and donor genetic traits, Park 693–703.

Islet transplantation in Korea, Lee 1165–1170.

JDCP study

Prevalence and characteristics of diabetic symmetric sensorimotor polyneuropathy in Japanese patients with type 2 diabetes: The Japan Diabetes Complication and its Prevention Prospective study (JDCP study 10), Kamiya 247–253.

Kidney complications

Health impacts of new-onset diabetes in women post-gestational diabetes mellitus: Insights from Hong Kong's territory-wide data, Zhang 772–781.

Kidney function

Association analysis between serum asprosin and metabolic characteristics, Complications in type 2 diabetic patients with different durations, Ma 1781–1787.

Large-scale claims database

Factor affecting severe atherothrombotic cerebral infarction in patients with type 2 diabetes mellitus: Large-scale claim database analysis of Japan, Horii 1651–1662.

Latent autoimmune diabetes in adults

New diagnostic criteria (2023) for slowly progressive type 1 diabetes (SPIDDM): Report from Committee on Type 1 Diabetes of the Japan Diabetes Society (English version), Shimada 254–257.

L-dopa

Diabetic striatopathy: Hyperglycemic chorea/ballism successfully treated with L-dopa, Tsukaguchi 1524–1527.

Left ventricular diastolic dysfunction

The correlation between serum asprosin and left ventricular diastolic dysfunction in elderly patients with type 2 diabetes mellitus in the community, Liang 608–613.

Cardiac electrophysiology, structure and diastolic function in patients with diabetic foot versus those without diabetic foot, Bai 1276–1286.

Letter to the Editor

Longitudinal association of sedentary time with diabetes mellitus and markers of glucose metabolism in middle-aged and older adults: The Hisayama Study, Tsuda 245–246.

Comment on the article titled “Association of the triglyceride-glucose index with subclinical left ventricular dysfunction in type 2 diabetes mellitus patients: A retrospective cross-sectional study”, Naharci 517–518.

Comment on a recent article titled ‘Hepatocyte nuclear factor 1B deletion, but not intragenic mutation, might be more susceptible to hypomagnesemia’, Clissold 790.

Long-term safety of alginate-poly-L-ornithine microcapsules, enveloping human islet allografts, into nonimmunosuppressed patients with type 1 diabetes mellitus, Calafiore 1700–1701.

Maturity-onset diabetes of the young: A proposal for updated nomenclature, Tosur 1818–1819.

Coexistence of high visceral fat area and sarcopenia and atherosclerotic markers in older patients with diabetes: Is there an association?, Saleh 1820.

Lifestyle interventions

Postpartum life interventions to prevent type 2 diabetes in women with gestational diabetes: A systematic review and meta-analysis, Wang 1115–1128.

Lipid

Estimated small dense low-density lipoprotein cholesterol and nonalcoholic fatty liver disease in nonobese populations, Huang 491–499.

Lipid metabolism

The role of lipid dysregulation in gestational diabetes mellitus: Early prediction and postpartum prognosis, Zhang 15–25.

Lipid profile

Lipid profile in women of different ethnicity with gestational diabetes: Relationship with fetal growth, Dalfrá 355–363.

Lipoatrophic diabetes

A multicenter, open-label, single-arm trial of the long-term safety of empagliflozin treatment for refractory diabetes mellitus with insulin resistance (EMPIRE-02), Hirota 1211–1219.

Liver steatosis

Metabolic dysfunction-associated steatotic liver disease: A superior predictor for incident type 2 diabetes over traditional criteria—NAGALA study, Sakai 1788–1796.

Liver transplantation

Risk factors and prediction score for new-onset diabetes mellitus after liver transplantation, Bai 1105–1114.

Low birthweight

Interaction effect between low birthweight and resistin gene rs1862513 variant on insulin resistance and type 2 diabetes mellitus in adulthood: Toon Genome Study, Yoshida 725–735.

Low-carbohydrate diet

Efficacy of long-term low-carbohydrate diets for patients with type 2 diabetes: A systematic review and meta-analysis, Ichikawa 1410–1421.

Low-carbohydrate diets in East Asians with type 2 diabetes: A systematic review and meta-analysis of randomized controlled trials, Hironaka 1753–1762.

Low-density lipoprotein cholesterol

Effect of sodium–glucose cotransporter 2 inhibitors on serum low-density lipoprotein cholesterol in Japanese patients with type 2 diabetes mellitus, Imada 843–850.

Lysosome

Role of β-cell autophagy in β-cell physiology and the development of diabetes, Yasasilka 656–668.

Machine learning

Identification of eight genomic protective alleles for mitochondrial diabetes by Kinship-graph convolutional network, Wang 52–62.

Performance of different machine learning algorithms in identifying undiagnosed diabetes based on nonlaboratory parameters and the influence of muscle strength: A cross-sectional study, Xu 743–750.

Interpretable machine learning models based on shear-wave elastography radiomics for predicting cardiovascular disease in diabetic kidney disease patients, Dai 1637–1650.

Macrophages

Exploration of the mechanism of reinfusion of fresh autologous blood in type 2 diabetes mice to induce macrophage polarization and inhibit erythrocyte damage, Hu 70–77.

Malignant neoplasms

Causes of death in Japanese patients with diabetes based on the results of a survey of 68,555 cases during 2011–2020: Committee report on causes of death in diabetes mellitus, Japan Diabetes Society (English version), Nakamura 1821–1837.

Marfan syndrome

Coexistence of type 2 diabetes mellitus, arginine vasopressin deficiency, and Marfan syndrome: A case report, Le 964–967.

Maternally inherited diabetes and deafness

Identification of eight genomic protective alleles for mitochondrial diabetes by Kinship-graph convolutional network, Wang 52–62.

Maturity-onset diabetes of the young

Hepatocyte nuclear factor 1B deletion, but not intragenic mutation, might be more susceptible to hypomagnesemia, Wang 121–130.

Mean blood glucose

Between blood glucose and mortality in critically ill patients: Retrospective analysis of the MIMIC-IV database, Li 931–938.

Mendelian randomization

Body composition and risk of gestational diabetes mellitus: A univariable and multivariable Mendelian randomization study, Gao 346–354.

Causal association between cystatin C and diabetic retinopathy: A two-sample Mendelian randomization study, Ruan 1626–1636.

Meta-analysis

Type 1 diabetes and the risk of epilepsy: A meta-analysis, Wu 364–373.

Postpartum life interventions to prevent type 2 diabetes in women with gestational diabetes: A systematic review and meta-analysis, Wang 1115–1128.

Efficacy of long-term low-carbohydrate diets for patients with type 2 diabetes: A systematic review and meta-analysis, Ichikawa 1410–1421.

Metabolic bariatric surgery

Improvement of heart rate variability after metabolic bariatric surgery in Korean subjects with obesity, Jang 1773–1780.

Metabolic dysfunction-associated fatty liver diseases

Elevated small dense low-density lipoprotein cholesterol to high-density lipoprotein cholesterol ratio is associated with an increased risk of metabolic dysfunction-associated fatty liver disease in Chinese patients with type 2 diabetes mellitus, Yang 634–642.

Metabolic dysfunction-associated steatotic liver disease

Long-term effects of ipragliflozin and pioglitazone on metabolic dysfunction-associated steatotic liver disease in patients with type 2 diabetes: 5 year observational follow-up of a randomized, 24 week, active-controlled trial, Ito 1220–1230.

Metabolic outcomes

Effect of intermittent fasting 16:8 and 14:10 compared with control-group on weight reduction and metabolic outcomes in obesity with type 2 diabetes patients: A randomized controlled trial, Sukkriang 1297–1305.

Metabolic syndrome

The association between metabolic syndrome and insulin resistance with risk of cardiovascular events in different states of cardiovascular health status, Hosseinpour-Niazi 208–218.

METTL3

METTL3/YTHDF2 m6A axis mediates the progression of diabetic nephropathy through epigenetically suppressing PINK1 and mitophagy, Wang 288–299.

Microalbuminuria

Identification and validation of voltage-dependent anion channel 1-related genes and immune cell infiltration in diabetic nephropathy, Lin 87–105.

Sympathetic skin response for early detection of type 2 diabetic peripheral neuropathy and nephropathy, Liu 106–112.

MicroRNAs

Investigating the altered expression of miR-486-5p and miR-novel-chr1_40444 in dysglycemia in a South African population, Weale 1377–1389.

microRNA-194

Relationship between circulating thrombospondin-1 messenger ribonucleic acid and microribonucleic acid-194 levels in Chinese patients with type 2 diabetic kidney disease: The outcomes of a case–control study, Ma 1248–1258.

miR-30a-3p

Cordyceps cicadae polysaccharides attenuate diabetic nephropathy via the miR-30a-3p/TRIM16 axis, Zheng 300–314.

miR-488-3p

MiR-488-3p facilitates wound healing throughCYP1B1-mediated Wnt/β-catenin signaling pathway by targeting MeCP2, Zuo 145–158.

MiRNA let7d-5p

High glucose promotes atherosclerosis by regulating miRNA let7d-5p level, Wang 711–724.

Mitiglinide/voglibose fixed-dose combination tablet

Comparative effects of fixed-dose mitiglinide/voglibose combination and glimepiride on vascular endothelial function and glycemic variability in patients with type 2 diabetes: A randomized controlled trial, Tanaka 449–458.

Molecular diagnosis

Genetic variant profiling of neonatal diabetes mellitus in Iranian patients: Unveiling 58 distinct variants in 14 genes, Mianesaz 1390–1402.

Mood

An exploratory study of factors in disordered eating behavior in diabetes self-management in Japan, Tsukamoto-Kawashima 874–881.

Mortality

Between blood glucose and mortality in critically ill patients: Retrospective analysis of the MIMIC-IV database, Li 931–938.

Mortality rate

Type 1 and type 2 diabetes mortality burden: Predictions for 2030 based on Bayesian age-period-cohort analysis of China and global mortality burden from 1990 to 2019, Dong 623–633.

Mortality risk

Association between glycated hemoglobin and risk of all-cause mortality in community patients with type 2 diabetes: A prospective cohort study, He 939–945.

Multimorbidity

Management of older adults with diabetes mellitus: Perspective from geriatric medicine, Umegaki 1347–1354.

Muscle strength

Performance of different machine learning algorithms in identifying undiagnosed diabetes based on nonlaboratory parameters and the influence of muscle strength: A cross-sectional study, Xu 743–750.

Myocardial function

Improvements of myocardial strain and work in diabetes patients with normal ejection fraction after empagliflozin treatment, Cheng 851–860.

Neonatal

Neonatal diabetes mellitus around the world: Update 2024, Barbetti 1711–1724.

Neonatal diabetes

Genetic variant profiling of neonatal diabetes mellitus in Iranian patients: Unveiling 58 distinct variants in 14 genes, Mianesaz 1390–1402.

Neovascular glaucoma

Characterization of the visually impaired patients with diabetes mellitus in Japan, Sugihara 882–891.

Nerve conduction

Associations of age-adjusted coefficient of variation of R-R intervals with autonomic and peripheral nerve function in non-elderly persons with diabetes, Sugimoto 186–196.

Nerve conduction studies

Identification and validation of voltage-dependent anion channel 1-related genes and immune cell infiltration in diabetic nephropathy, Lin 87–105.

Sympathetic skin response for early detection of type 2 diabetic peripheral neuropathy and nephropathy, Liu 106–112.

Diminished levels of insulin-like growth factor-1 may be a risk factor for peripheral neuropathy in type 2 diabetes patients, Zhong 1259–1265.

Netrin-1

Circulating netrin-1 levels are reduced and related to corneal nerve fiber loss in patients with diabetic neuropathy, Mondal 1068–1074.

New-onset diabetes mellitus

Risk factors and prediction score for new-onset diabetes mellitus after liver transplantation, Bai 1105–1114.

Nitrosamines

Assessment of cancer risk associated with 7-nitroso-3-(trifluoromethyl)-5,6,7,8-tetrahydro[1,2,4] triazolo-[4,3-a]pyrazine-contaminated sitagliptin use: A retrospective cohort study, Sugiyama 1556–1565.

Nocturia

Multicenter, open-label, randomized controlled superiority trial for availability to reduce nocturnal urination frequency: The TOP-STAR study, Nakajima 1809–1817.

Nomograms

A novel predictive model for optimizing diabetes screening in older adults, Lin 1403–1409.

Nonalcoholic fatty liver disease

Estimated small dense low-density lipoprotein cholesterol and nonalcoholic fatty liver disease in nonobese populations, Huang 491–499.

Nonalcoholic fatty liver disease

Long-term effects of ipragliflozin and pioglitazone on metabolic dysfunction-associated steatotic liver disease in patients with type 2 diabetes: 5 year observational follow-up of a randomized, 24 week, active-controlled trial, Ito 1220–1230.

Metabolic dysfunction-associated steatotic liver disease: A superior predictor for incident type 2 diabetes over traditional criteria – NAGALA study, Sakai 1788–1796.

Novel variants

Genetic variant profiling of neonatal diabetes mellitus in Iranian patients: Unveiling 58 distinct variants in 14 genes, Mianesaz 1390–1402.

Nutrition

Overnutrition in the early postnatal period influences lifetime metabolic risk: Evidence for impact on pancreatic β-cell mass and function, Burton 263–274.

Nutrient quality in dietary therapy for diabetes and diabetic kidney disease, Tsuruta 973–981.

Obesity

Overnutrition in the early postnatal period influences lifetime metabolic risk: Evidence for impact on pancreatic β-cell mass and function, Burton 263–274.

A case of type 2 diabetes mellitus with weight gain and worsening of glycemic management after tezepelumab administration for severe bronchial asthma, Umamoto 388–390.

Association between serum uric acid-to-high-density lipoprotein cholesterol ratio and insulin resistance in an American population: A population-based analysis, Zhou 762–771.

Observational studies

Type 1 diabetes and the risk of epilepsy: A meta-analysis, Wu 364–373.

Occupational health

Relationship between diabetes treatment status and occupational accidents, Ogasawara 899–905.

Older adults

Medical database analysis of the association between kidney function and achievement of glycemic control in older Japanese adults with type 2 diabetes who started with oral antidiabetic drugs, Suzuki 1057–1067.

Online calculator

Interactive calculator to estimate insulin sensitivity in type 1 diabetes, Januszewski 594–597.

Opportunistic case finding

External validation of the Hong Kong Chinese nonlaboratory risk models and scoring algorithm for case finding of prediabetes and diabetes mellitus in primary care, Cheng 1317–1325.

Oral

Adherence and treatment discontinuation of oral semaglutide and once-weekly semaglutide injection at 12 month follow-up: Japanese real-world data, Horii 1578–1584.

Oral antidiabetic drugs

Prevalence of adherence to oral antidiabetic drugs in patients with type 2 diabetes: A systematic review and meta-analysis, Boonpattharatthiti 1614–1625.

Oral cancer

Impact of diabetes on the prognosis of patients with oral and oropharyngeal cancer: A meta-analysis, Xu 1140–1150.

Oral glucose tolerance test

Multiple positive points during the 75 g oral glucose tolerance test are good predictors for early insulin therapy in gestational diabetes mellitus diagnosed before 24 gestational weeks, Kasuga 1803–1808.

Oral semaglutide

Efficacy and tolerability of oral semaglutide in Japanese patients with type 2 diabetes mellitus: Analysis report from diabetes specialist clinics, Inokuchi 1202–1210.

PIONEER REAL Japan: Primary results from a multicenter, prospective, real-world study of oral semaglutide in adults with type 2 diabetes in Japanese clinical practice, Yabe 1566–1577.

Orthostatic hypotension

Associations of age-adjusted coefficient of variation of R-R intervals with autonomic and peripheral nerve function in non-elderly persons with diabetes, Sugimoto 186–196.

Outcome

Post-load glucose is a stronger predictor of adverse pregnancy outcomes than first-trimester HbA1c in women without gestational diabetes, Rajabi 914–921.

Oxidative stress

Oxidative stress suppresses PHB2-mediated mitophagy in β-cells via the Nrf2/PHB2 pathway, Liu 559–571.

Pancreatic β-cell

Pancreatic beta-cell mass and function and therapeutic implications of using antidiabetic medications in type 2 diabetes, Moon 669–683.

Pancreatic β-cells

Mitochondrial ALDH2 improves β-cell survival and function against doxorubicin-induced apoptosis by targeting CK2 signaling, Karunakaran 684–692.

Parkin

METTL3/YTHDF2 m6A axis mediates the progression of diabetic nephropathy through epigenetically suppressing PINK1 and mitophagy, Wang 288–299.

Patient-reported outcomes

Patient-reported outcomes and treatment adherence in type 2 diabetes using natural language processing: Wave 8 of the Observational International Diabetes Management Practices Study, Chan 1306–1316.

People with type 2 diabetes

The association between alcohol drinking and glycemic management among people with type 2 diabetes in China, Ye 237–244.

Percutaneous coronary intervention

Effect of hemoglobin A1c management levels on coronary physiology evaluated by quantitative flow ratio in patients who underwent percutaneous coronary intervention, Chen 336–345.

Peripheral nerve function

Glycemic variability is associated with sural nerve conduction velocity in outpatients with type 2 diabetes: Usefulness of a new point-of-care device for nerve conduction studies, Morita 1075–1083.

Permeability

Microvascular permeability and texture analysis of bone marrow in diabetic rabbits with critical limb ischemia based on dynamic contrast-enhanced magnetic resonance imaging, Yang 584–593.

Pharmacoepidemiology

Assessment of cancer risk associated with 7-nitroso-3-(trifluoromethyl)-5,6,7,8-tetrahydro[1,2,4] triazolo-[4,3-a]pyrazine-contaminated sitagliptin use: A retrospective cohort study, Sugiyama 1556–1565.

Pharmacotherapy

A consensus statement from the Japan Diabetes Society: A proposed algorithm for pharmacotherapy in people with type 2diabetes – 2nd edition (English version), Bouchi 1326–1342.

Pharmacovigilance

A real-world disproportionality analysis of semaglutide: Post-marketing pharmacovigilance data, Du 1422–1433.

Plantar pressure

Plantar pressure measurement in diabetic foot disease: A scoping review, Lockhart 990–999.

Plasma glucose

Risk factors for chronic kidney disease progression over 20 years for primary prevention in Japanese individuals at a preventive medicine research center: Focus on the influence of plasma glucose levels, Minami 1434–1443.

Polygenic risk scores

Perspectives on genetic studies of type 2 diabetes from the genome-wide association studies era to precision medicine, Imamura 410–422.

Polygonatum sibiricum polysaccharide

Polygonatum sibiricum (Huang Jing) polysaccharide reduces diabetic cardiomyopathy through increasing cyclic guanosine monophosphate-protein kinase G signaling in diabetic mice, Lei 823–834.

Polypharmacy

Management of older adults with diabetes mellitus: Perspective from geriatric medicine, Umegaki 1347–1354.

Population attributable fraction

Health impacts of new-onset diabetes in women post-gestational diabetes mellitus: Insights from Hong Kong's territory-wide data, Zhang 772–781.

Post-load plasma glucose

Linking extent of return to fasting state after oral glucose tolerance test to future risk of prediabetes and type 2 diabetes: Insights from the TLGS, Masrouri 1743–1752.

Postnatal

Overnutrition in the early postnatal period influences lifetime metabolic risk: Evidence for impact on pancreatic β-cell mass and function, Burton 263–274.

Postprandial period

Delayed dinnertime impairs glucose tolerance in healthy young adults, Nakamura 172–176.

Prediabetes

Characteristics of individuals who developed type 2 diabetes from prediabetes despite undergoing interventions, and evaluation of the performance of urinary myo-inositol as a risk factor for developing diabetes, Yamagata 177–185.

External validation of the Hong Kong Chinese nonlaboratory risk models and scoring algorithm for case finding of prediabetes and diabetes mellitus in primary care, Cheng 1317–1325.

Prediabetes progression

High sensitivity C-reactive protein and prediabetes progression and regression in middle-aged and older adults: A prospective cohort study, Cheng 78–86.

Prediabetes regression

High sensitivity C-reactive protein and prediabetes progression and regression in middle-aged and older adults: A prospective cohort study, Cheng 78–86.

Prediction

Prediction of future insulin-deficiency in glutamic acid decarboxylase autoantibody enzyme-linked immunosorbent assay-positive patients with slowly progressive type 1 diabetes, Kawasaki 835–842.

Post-load glucose is a stronger predictor of adverse pregnancy outcomes than first-trimester HbA1c in women without gestational diabetes, Rajabi 914–921.

Risk factors and prediction score for new-onset diabetes mellitus after liver transplantation, Bai 1105–1114.

Prediction model

Development and validation of a prediction model for self-reported hypoglycemia risk in patients with type 2 diabetes: A longitudinal cohort study, Xu 468–482.

Prediction of onset of diabetes

Characteristics of individuals who developed type 2 diabetes from prediabetes despite undergoing interventions, and evaluation of the performance of urinary myo-inositol as a risk factor for developing diabetes, Yamagata 177–185.

Pregnancy

Post-load glucose is a stronger predictor of adverse pregnancy outcomes than first-trimester HbA1c in women without gestational diabetes, Rajabi 914–921.

Pregnancy outcome

Second-trimester triglyceride-glucose index to predict adverse outcomes in women with gestational diabetes mellitus: A retrospective multicenter cohort study, Bai 1489–1499.

Prenatal

Overnutrition in the early postnatal period influences lifetime metabolic risk: Evidence for impact on pancreatic β-cell mass and function, Burton 263–274.

Progestin and adipoQ receptor 3

Circ_0068087 knockdown attenuates high-glucose-induced human tubular epithelial cell injury in a microribonucleic acid/progestin and adipoQ receptor 3-dependent manner in diabetic nephropathy, Liu 159–171.

Prohibitin2

Oxidative stress suppresses PHB2-mediated mitophagy in β-cells via the Nrf2/PHB2 pathway, Liu 559–571.

Prospective studies

PIONEER REAL Japan: Baseline characteristics of a multicenter, prospective, real-world study of oral semaglutide in adults with type 2 diabetes in clinical practice in Japan, Suzuki 1047–1056.

PIONEER REAL Japan: Primary results from a multicenter, prospective, real-world study of oral semaglutide in adults with type 2 diabetes in Japanese clinical practice, Yabe 1566–1577.

Protein catabolism

Corticosteroid-triggered acute skeletal muscle loss in lipodystrophy: A case report, Sasako 782–785.

Proteinuria

Young-onset type 2 diabetes mellitus enhances proteinuria, but not glomerular filtration rate decline: A Japanese cohort study, Saito 1444–1456.

Public health

Health impacts of new-onset diabetes in women post-gestational diabetes mellitus: Insights from Hong Kong's territory-wide data, Zhang 772–781.

Quantitative flow ratio

Effect of hemoglobin A1c management levels on coronary physiology evaluated by quantitative flow ratio in patients who underwent percutaneous coronary intervention, Chen 336–345.

Reactive hyperemia index

Comparative effects of fixed-dose mitiglinide/voglibose combination and glimepiride on vascular endothelial function and glycemic variability in patients with type 2 diabetes: A randomized controlled trial, Tanaka 449–458.

Reactive oxygen species

Polygonatum sibiricum (Huang Jing) polysaccharide reduces diabetic cardiomyopathy through increasing cyclic guanosine monophosphate-protein kinase G signaling in diabetic mice, Lei 823–834.

Real-world data

Risk stratification for cardiovascular disease based on prior coronary artery disease, cerebrovascular disease and type 2 diabetes mellitus, Oe 1464–1471.

Sulfonylurea prescription patterns in elderly patients with type 2 diabetes mellitus: A comprehensive analysis of real-world data from pharmacies in Japan, Yamazaki 1604–1613.

Real-world evidence

Patient-reported outcomes and treatment adherence in type 2 diabetes using natural language processing: Wave 8 of the Observational International Diabetes Management Practices Study, Chan 1306–1316.

Regulatory T cells

Regulatory T cells protect against diabetic cardiomyopathy in db/db mice, Zhang 1191–1201.

Remnant cholesterol

Remnant cholesterol, but not other traditional lipids or lipid ratios, is independently and positively related to future diabetes risk in Chinese general population: A 3 year cohort study, Li 1084–1093.

Remote pressure measurement

Plantar pressure measurement in diabetic foot disease: A scoping review, Lockhart 990–999.

Renal cyst

Decline in measured glomerular filtration rate is associated with simple renal cyst in Chinese patients with type 2 diabetes, Qiaoling 26–33.

Resistant starch

Resistant starch and type 2 diabetes mellitus: Clinical perspective, Kim 395–401.

Resistin

Interaction effect between low birthweight and resistin gene rs1862513 variant on insulin resistance and type 2 diabetes mellitus in adulthood: Toon Genome Study, Yoshida 725–735.

Ribosomal protein S26

Association of RPS26 gene polymorphism with different types of diabetes in Chinese individuals, Song 34–43.

Risk

Post-load glucose is a stronger predictor of adverse pregnancy outcomes than first-trimester HbA1c in women without gestational diabetes, Rajabi 914–921.

Risk prediction models

External validation of the Hong Kong Chinese nonlaboratory risk models and scoring algorithm for case finding of prediabetes and diabetes mellitus in primary care, Cheng 1317–1325.

Salt restriction

Multicenter, open-label, randomized controlled superiority trial for availability to reduce nocturnal urination frequency: The TOP-STAR study, Nakajima 1809–1817.

Sarcopenic obesity

Coexistence of high visceral fat area and sarcopenia is associated with atherosclerotic markers in old-old patients with diabetes: A cross-sectional study, Sato 1510–1518.

Screening

Sheffield One-Stop Service: A potential model to improve the screening uptake of diabetic peripheral neuropathy and other microvascular complications of diabetes, Sloan 1355–1362.

Screening methods

Comparing the screening methods for gestational diabetes mellitus before and during the COVID-19 pandemic: A systematic review, Sun 500–516.

Self-management

Implementation rate of diabetic self-management education and support for Japanese people with diabetes using the National Database, Ihana-Sugiyama 861–866.

Semaglutide

PIONEER REAL Japan: Baseline characteristics of a multicenter, prospective, real-world study of oral semaglutide in adults with type 2 diabetes in clinical practice in Japan, Suzuki 1047–1056.

A real-world disproportionality analysis of semaglutide: Post-marketing pharmacovigilance data, Du 1422–1433.

Adherence and treatment discontinuation of oral semaglutide and once-weekly semaglutide injection at 12 month follow-up: Japanese real-world data, Horii 1578–1584.

Semicarbazide-sensitive amine oxidase

The role of vascular adhesion protein-1 in diabetes and diabetic complications, Yen 982–989.

Serum amyloid A

Association of serum amyloid A and prognosis in people with diabetes and COVID-19: A retrospective cohort study, Qu 44–51.

Serum uric acid

Inverted U-shaped associations between serumuric acid and fasting - plasma glucose level in non-diabetic, pre-diabetic, and diabetic adults: A population-based study in China, Shi 483–490.

Severe atherothrombotic brain infarction

Factor affecting severe atherothrombotic cerebral infarction in patients with type 2 diabetes mellitus: Large-scale claim database analysis of Japan, Horii 1651–1662.

SGLT2 inhibitor

A multicenter, open-label, single-arm trial of the long-term safety of empagliflozin treatment for refractory diabetes mellitus with insulin resistance (EMPIRE-02), Hirota 1211–1219.

Multicenter, open-label, randomized controlled superiority trial for availability to reduce nocturnal urination frequency: The TOP-STAR study, Nakajima 1809–1817.

Sitagliptin phosphate

Assessment of cancer risk associated with 7-nitroso-3-(trifluoromethyl)-5,6,7,8-tetrahydro[1,2,4] triazolo-[4,3-a]pyrazine-contaminated sitagliptin use: A retrospective cohort study, Sugiyama 1556–1565.

Slowly progressive type 1 diabetes

New diagnostic criteria (2023) for slowly progressive type 1 diabetes (SPIDDM): Report from Committee on Type 1 Diabetes of the Japan Diabetes Society (English version), Shimada 254–257.

Prediction of future insulin-deficiency in glutamic acid decarboxylase autoantibody enzyme-linked immunosorbent assay-positive patients with slowly progressive type 1 diabetes, Kawasaki 835–842.

Small dense low-density lipoprotein cholesterol

Elevated small dense low-density lipoprotein cholesterol to high-density lipoprotein cholesterol ratio is associated with an increased risk of metabolic dysfunction-associated fatty liver disease in Chinese patients with type 2 diabetes mellitus, Yang 634–642.

Social deprivation

Social deprivation and diabetic kidney disease: A European view, Casey 541–556.

Socioeconomic status

Associations between income/employment status and diabetes care processes, health behaviors, and health outcomes in Japan: A cross-sectional study using claims data linked to a questionnaire survey, Yamaoka 1684–1695.

Sodium–glucose cotransporter 2 inhibitor

Effect of sodium–glucose cotransporter 2 inhibitors on serum low-density lipoprotein cholesterol in Japanese patients with type 2 diabetes mellitus, Imada 843–850.

Sodium–glucose cotransporter 2 inhibitor therapy reduces the administration frequency of steroid injection in patients with diabetic macular edema: A cohort study using the Japanese health insurance claims database, Ishibashi 1231–1238.

Sodium–glucose cotransporter 2 inhibitors

Healthcare resource utilization and healthcare costs in patients with type 2 diabetes mellitus initiating sodium-glucose cotransporter 2inhibitors vs dipeptidyl peptidase-4 inhibitors in Japan: A real-world administrative database analysis, Kashiwagi 374–387.

Small dense low-density lipoprotein cholesterol

Estimated small dense low-density lipoprotein cholesterol and nonalcoholic fatty liver disease in nonobese populations, Huang 491–499.

Long-term effects of ipragliflozin and pioglitazone on metabolic dysfunction-associated steatotic liver disease in patients with type 2 diabetes: 5 year observational follow-up of a randomized, 24 week, active-controlled trial, Ito 1220–1230.

South Africa

Investigating the altered expression of miR-486-5p and miR-novel-chr1_40444 in dysglycemia in a South African population, Weale 1377–1389.

Statin

Optimizing lipid control in Taiwanese diabetic patients: A collaborative consensus by the Diabetes Association of the Republic of China (Taiwan) and the Taiwanese Association of Diabetes Educators, Shen 1151–1160.

Steroid injection

Sodium–glucose cotransporter 2 inhibitor therapy reduces the administration frequency of steroid injection in patients with diabetic macular edema: A cohort study using the Japanese health insurance claims database, Ishibashi 1231–1238.

Steroid myopathy

Corticosteroid-triggered acute skeletal muscle loss in lipodystrophy: A case report, Sasako 782–785.

Stratification

What characteristics are most important in stratifying patients into groups with different risk of diabetic foot ulceration?, Naemi 1094–1104.

Sulfonylurea

Sulfonylurea prescription patterns in elderly patients with type 2 diabetes mellitus: A comprehensive analysis of real-world data from pharmacies in Japan, Yamazaki 1604–1613.

Survival

Impact of diabetes on the prognosis of patients with oral and oropharyngeal cancer: A meta-analysis, Xu 1140–1150.

Sympathetic skin response

Sympathetic skin response for early detection of type 2 diabetic peripheral neuropathy and nephropathy, Liu 106–112.

Systematic Coronary Risk Evaluation 2-Diabetes risk

Predictive value of Systematic Coronary Risk Evaluation 2-Diabetes risk model and arterial stiffness for cardiovascular events in the Asian population with type 2 diabetes mellitus, Suwannasom 1266–1275.

Tanshinone IIA

Tanshinone IIA suppresses ferroptosis to attenuate renal podocyte injury in diabetic nephropathy through the embryonic lethal abnormal visual-like protein 1 and acyl-coenzyme A synthetase long-chain family member 4 signaling pathway, Zhu 1003–1016.

Tehran Lipid and Glucose Study

Linking extent of return to fasting state after oral glucose tolerance test to future risk of prediabetes and type 2 diabetes: Insights from the TLGS, Masrouri 1743–1752.

Texture analysis

Microvascular permeability and texture analysis of bone marrow in diabetic rabbits with critical limb ischemia based on dynamic contrast-enhanced magnetic resonance imaging, Yang 584–593.

Tezepelumab

A case of type 2 diabetes mellitus with weight gain and worsening of glycemic management after tezepelumab administration for severe bronchial asthma, Umamoto 388–390.

Therapeutic inertia

Mandatory monthly outpatient visits could improve therapeutic inertia in patients with poorly controlled type 2 diabetes, Tsai 227–236.

The Simple Diagnostic Criteria for Diabetic Polyneuropathy

Prevalence and characteristics of diabetic symmetric sensorimotor polyneuropathy in Japanese patients with type 2 diabetes: The Japan Diabetes Complication and its Prevention Prospective study (JDCP study 10), Kamiya 247–253.

Thrombospondin-1

Relationship between elevated circulatingthrombospondin-1 levels and vascular complications in diabetes mellitus, Guo 197–207.

Relationship between circulating thrombospondin-1 messenger ribonucleic acid and microribonucleic acid-194 levels in Chinese patients with type 2 diabetic kidney disease: The outcomes of a case–control study, Ma 1248–1258.

Tolerability

Efficacy and tolerability of oral semaglutide in Japanese patients with type 2 diabetes mellitus: Analysis report from diabetes specialist clinics, Inokuchi 1202–1210.

Transition

Evaluation of the transition program at the University Hospital of Reims from 2015 to 2020, Chibane 1519–1523.

Treatment

Prevalence, awareness, treatment and control of type 2 diabetes in southeast China: A population-based study, Hu 1034–1041.

Treatment – Education

Patient-reported outcomes and treatment adherence in type 2 diabetes using natural language processing: Wave 8 of the Observational International Diabetes Management Practices Study, Chan 1306–1316.

Treatment response

Factors contributing to the clinical effectiveness of imeglimin monotherapy in Japanese patients with type 2 diabetes mellitus, Hagi 1239–1247.

Triglyceride-glucose index

Second-trimester triglyceride-glucose index to predict adverse outcomes in women with gestational diabetes mellitus: A retrospective multicenter cohort study, Bai 1489–1499.

TXNIP/NLRP3 inflammasome

Calpeptin improves the cognitive function in Alzheimer's disease-like complications of diabetes mellitus rats by regulating TXNIP/NLRP3 inflammasome, Qiao 1365–1376.

Type 1 diabetes

Interactive calculator to estimate insulin sensitivity in type 1 diabetes, Januszewski 594–597.

Global cognition and executive functions of older adults with type 1 diabetes mellitus without dementia, Nagasawa 922–930.

Evaluation of the transition program at the University Hospital of Reims from 2015 to 2020, Chibane 1519–1523.

Type 1 diabetes mellitus

Type 1 diabetes, COVID-19 vaccines and short-term safety: Subgroup analysis from the global COVAD study, Chatterjee 131–138.

Effects of hybrid closed-loop system on glycemic control and psychological aspects in persons with type 1 diabetes treated with sensor-augmented pump: A prospective single-center observational study, Akiyama 219–226.

Type 2

Prevalence, awareness, treatment and control of type 2 diabetes in southeast China: A population-based study, Hu 1034–1041.

Type 2 diabetes

Exploration of the mechanism of reinfusion of fresh autologous blood in type 2 diabetes mice to induce macrophage polarization and inhibit erythrocyte damage, Hu 70–77.

Mandatory monthly outpatient visits could improve therapeutic inertia in patients with poorly controlled type 2 diabetes, Tsai 227–236.

Changing landscape of diabetes in Asia – What are the unmet needs?, Luk 402–409.

Perspectives on genetic studies of type 2 diabetes from the genome-wide association studies era to precision medicine, Imamura 410–422.

Short-term recovery of insulin secretion in response to a meal is associated with future glycemic control in type 2 diabetes patients, Enkaku 437–448.

Coexistence of type 2 diabetes mellitus, arginine vasopressin deficiency, and Marfan syndrome: A case report, Le 964–967.

Eating behaviors and incidence of type 2 diabetes in Japanese people: The population-based Panasonic cohort study 15, Toyokuni 1017–1025.

PIONEER REAL Japan: Baseline characteristics of a multicenter, prospective, real-world study of oral semaglutide in adults with type 2 diabetes in clinical practice in Japan, Suzuki 1047–1056.

Internet of things-based approach for glycemic control in people with type 2 diabetes: A randomized controlled trial, Bouchi 1287–1296.

Patient-reported outcomes and treatment adherence in type 2 diabetes using natural language processing: Wave 8 of the Observational International Diabetes Management Practices Study, Chan 1306–1316.

A consensus statement from the Japan Diabetes Society: A proposed algorithm for pharmacotherapy in people with type 2diabetes – 2nd edition (English version), Bouchi 1326–1342.

Investigating the altered expression of miR-486-5p and miR-novel-chr1_40444 in dysglycemia in a South African population, Weale 1377–1389.

Efficacy of long-term low-carbohydrate diets for patients with type 2 diabetes: A systematic review and meta-analysis, Ichikawa 1410–1421.

Association of xanthine oxidoreductase inhibitor use with insulin secretory capacity inpatients with type 2 diabetes, Kitamura 1500–1509.

Application of the integrated data platform combined with dietary management for adults with diabetes: A prospective randomized controlled trial, Liu 1548–1555.

Safety and effectiveness of tofogliflozin in Japanese people with type 2 diabetes: A multicenter prospective observational study in routine clinical practice, Yamada 1585–1595.

Sodium–glucose cotransporter 2 inhibition through henagliflozin ameliorates cognitive impairment in patients with type 2 diabetes, Zhang 1596–1603.

Factor affecting severe atherothrombotic cerebral infarction in patients with type 2 diabetes mellitus: Large-scale claim database analysis of Japan, Horii 1651–1662.

Haptoglobin phenotype and levels in type 2 diabetes and effects of fenofibrate, Januszewski 1663–1668.

Type 2 diabetes mellitus

Oxidative stress suppresses PHB2-mediated mitophagy in β-cells via the Nrf2/PHB2 pathway, Liu 559–571.

The correlation between serum asprosin and left ventricular diastolic dysfunction in elderly patients with type 2 diabetes mellitus in the community, Liang 608–613.

Elevated small dense low-density lipoprotein cholesterol to high-density lipoprotein cholesterol ratio is associated with an increased risk of metabolic dysfunction-associated fatty liver disease in Chinese patients with type 2 diabetes mellitus, Yang 634–642.

High glucose promotes atherosclerosis by regulating miRNA let7d-5p level, Wang 711–724.

Effect of sodium–glucose cotransporter 2 inhibitors on serum low-density lipoprotein cholesterol in Japanese patients with type 2diabetes mellitus, Imada 843–850.

Serum vitamin D is substantially reduced and predicts flares in diabetic retinopathy patients, Zhuang 867–873.

Association between glycated hemoglobin and risk of all-cause mortality in community patients with type 2 diabetes: A prospective cohort study, He 939–945.

Influence of disease course and comprehensive management on blood glucose level in children and adolescents with type 2 diabetes mellitus, Wu 1026–1033.

Factors contributing to the clinical effectiveness of imeglimin monotherapy in Japanese patients with type 2 diabetes mellitus, Hagi 1239–1247.

Risk stratification for cardiovascular disease based on prior coronary artery disease, cerebrovascular disease and type 2 diabetes mellitus, Oe 1464–1471.

Linking extent of return to fasting state after oral glucose tolerance test to future risk of prediabetes and type 2 diabetes: Insights from the TLGS, Masrouri 1743–1752.

Metabolic dysfunction-associated steatotic liver disease: A superior predictor for incident type 2 diabetes over traditional criteria – NAGALA study, Sakai 1788–1796.

Type 2 diabetes susceptibility genes

Interaction effect between low birthweight and resistin gene rs1862513 variant on insulin resistance and type 2 diabetes mellitus in adulthood: Toon Genome Study, Yoshida 725–735.

Update

Effectiveness and safety of sodium–glucose cotransporter 2 inhibitors in Asian populations, Ha 285–287.

Interplay of cardiovascular health and diabetes: Insights into weight management and risk reduction, Hsu 707–710.

Advances in diagnostic methods for early-stage diabetic polyneuropathy, Naruse 820–822.

An update of contemporary insulin therapy, Tsai 1000–1002.

Clinical lessons for diabetes treatment from the COVID-19 pandemic, Hamamoto 1363–1364.

Clinical challenges in early pregnancy in Japan: An update on gestational diabetes, Sugiyama 1729–1731.

Uric acid

Association between serum uric acid-to-high-density lipoprotein cholesterol ratio and insulin resistance in patients with type 2 diabetes mellitus, Zhou 113–120.

Association between serum uric acid-to-high-density lipoprotein cholesterol ratio and insulin resistance in an American population: A population-based analysis, Zhou 762–771.

Uric acid-to-high-density lipoprotein cholesterol ratio

Association between serum uric acid-to-high-density lipoprotein cholesterol ratio and insulin resistance in patients with type 2 diabetes mellitus, Zhou 113–120.

Urinary myo-inositol

Characteristics of individuals who developed type 2 diabetes from prediabetes despite undergoing interventions, and evaluation of the performance of urinary myo-inositol as a risk factor for developing diabetes, Yamagata 177–185.

Vaccine

Type 1 diabetes, COVID-19 vaccines and short-term safety: Subgroup analysis from the global COVAD study, Chatterjee 131–138.

Variation in hemoglobin A1c

Association between variation in hemoglobin A1c levels and diabetes therapy-related quality of life in patients with diabetes, Imai 1042–1046.

Vascular adhesion protein-1

The role of vascular adhesion protein-1 in diabetes and diabetic complications, Yen 982–989.

Visceral fat area

Coexistence of high visceral fat area and sarcopenia is associated with atherosclerotic markers in old-old patients with diabetes: A cross-sectional study, Sato 1510–1518.

Vitamin D

Serum vitamin D is substantially reduced and predicts flares in diabetic retinopathy patients, Zhuang 867–873.

Waist circumference

The impact of handgrip strength and waist circumference on glycemic control: Prospective, observational study using outpatient clinical data in Japanese patients with type 2 diabetes mellitus, Nakanishi 892–898.

Weight loss

Safety and effectiveness of tofogliflozin in Japanese people with type 2 diabetes: A multicenter prospective observational study in routine clinical practice, Yamada 1585–1595.

Weight reduction

Effect of intermittent fasting 16:8 and 14:10 compared with control-group on weight reduction and metabolic outcomes in obesity with type 2 diabetes patients: A randomized controlled trial, Sukkriang 1297–1305.

Wound healing

MiR-488-3p facilitates wound healing throughCYP1B1-mediated Wnt/β-catenin signaling pathway by targeting MeCP2, Zuo 145–158.

XOR inhibitor

Association of xanthine oxidoreductase inhibitor use with insulin secretory capacity inpatients with type 2 diabetes, Kitamura 1500–1509.

Young-onset diabetes

Changing landscape of diabetes in Asia – What are the unmet needs?, Luk 402–409.

Young-onset type 2 diabetes mellitus enhances proteinuria, but not glomerular filtration rate decline: A Japanese cohort study, Saito 1444–1456.

求助全文
通过发布文献求助，成功后即可免费获取论文全文。 去求助
来源期刊
Journal of Diabetes Investigation
Journal of Diabetes Investigation ENDOCRINOLOGY & METABOLISM-
CiteScore
6.50
自引率
9.40%
发文量
218
审稿时长
6-12 weeks
期刊介绍： Journal of Diabetes Investigation is your core diabetes journal from Asia; the official journal of the Asian Association for the Study of Diabetes (AASD). The journal publishes original research, country reports, commentaries, reviews, mini-reviews, case reports, letters, as well as editorials and news. Embracing clinical and experimental research in diabetes and related areas, the Journal of Diabetes Investigation includes aspects of prevention, treatment, as well as molecular aspects and pathophysiology. Translational research focused on the exchange of ideas between clinicians and researchers is also welcome. Journal of Diabetes Investigation is indexed by Science Citation Index Expanded (SCIE).
×
引用
GB/T 7714-2015
复制
MLA
复制
APA
复制
导出至
BibTeX EndNote RefMan NoteFirst NoteExpress
×
提示
您的信息不完整，为了账户安全，请先补充。
现在去补充
×
提示
您因"违规操作"
具体请查看互助需知
我知道了
×
提示
现在去查看 取消
×
提示
确定
请完成安全验证×
copy
已复制链接
快去分享给好友吧!
我知道了
右上角分享
点击右上角分享
0
联系我们：info@booksci.cn Book学术提供免费学术资源搜索服务，方便国内外学者检索中英文文献。致力于提供最便捷和优质的服务体验。 Copyright © 2023 布克学术 All rights reserved.
京ICP备2023020795号-1
ghs 京公网安备 11010802042870号
Book学术文献互助
Book学术文献互助群
群 号：481959085
Book学术官方微信